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Cholera toxin, obtained as crude culture filtrates of the
bacterium Vibrio cholerae, was purified by a combination of ammonium
sulphate fractionation, ion-exchange chromatography on DEAE-cellulose, and
gel filtration cn Ultrogel AcA-44. The purified toxin migrated as a
homogeneous protein on SD5 and native polyacrylamide gels, and activated
/
adenylate cyclase in rat liver homogenates. Activation of rat liver
adenylate cyclase by cholera toxin was strictly dependent upon the presence
+ +
of NAD . In the absence of exogenous NAD , homogenates or membrane
preparations .were refractory to the toxin as a result of high levels of
endogenous NAD+ - utilising activities. Under conditions in which competition
for NAD+ by endogenous enzymes was minimised, the activity of cholera
toxin as a stimulator of adenylate cyclase was markedly enhanced and
activation of the enzyme occurred with a detectable toxin-specific
%
incorporation of [~^c] into TCA-precipitable material from ^adenine U-^cj-
NAD+. The results were consistent with the hypothesis that cholera
toxin acts by catalysing the ADP-ribosylation of an intracellular membrane-
bound acceptor protein, and that this modification is responsible for the
toxin-induced stimulation of adenylate cyclase activity.
Results are also presented which argue against the validity of
extrapolating from studies of the NADase activity of cholera toxin to the
mechanism of toxin action on adenylate cyclase. Under a variety of conditions,
NADase activity appeared to proceed independently of the physiologically
important ADP-ribosyltransferase activity. furthermore, culture filtrates
of V. cholerae were shown to contain a highly active NADase distinct from
cholera toxin, and the possibilities of NADase contamination, even in
apparently pure toxin preparations, are emphasised.
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Chapter I. Introduction
1.1. Definition of clinical cholera
Cholera is an acute infectious disease usually occurring
in epidemic form and characterised by severe diarrhoeal dehydration
of the body. Choleraic symptoms appear rapidly and victims can be
reduced from a state of normal health to one of extreme illness
in a matter of three to four hours, a fact which prompted Magendie
(quoted in De, 1961) to describe cholera as 'a disease which begins
where other diseases end, with death'. The disease state is the
result of intestinal colonisation by the bacterium Vibrio cholerae.
1.2. Clinical course of cholera
The early stages of cholera are characterised by copious
diarrhoea and vomiting, when fluid losses from the gut can often
exceed 1 litre per hour. The fluid itself, which is alkaline and
has a typical 'rice-water' appearance, is usually devoid of faecal
matter and contains characteristic quantities of sodium, potassium,
bicarbonate and chloride (Carpenter, 1971). As a result of choleraic
dehydration the victim enters a 'stage of collapse', in which rapid
drop in blood pressure, suspension of urinary excretion, muscular
cramps and laboured respiration are the major symptoms. Survivors
from the stage of collapse then display a gradual restoration of
normal functions and urinary excretion is re-established, although
in many cases the latter is again suspended and a state of post-
choleraic uraemia develops. This final stage of the disease is
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responsible for death in a small proportion of cases, but mortality
in cholera, which can approach 80% in the absence of effective
treatment, is greatest during the stage of collapse when circulatory
failure is a common cause of death (see De, 1961). The detailed
internal and external pathological changes associated with the
various stages of cholera have been described by De (1961).
1.3. Early events in the history of cholera.
Cholera is often prefixed with the term 'Asiatic' to indicate
the supposed geographical origin of the disease, although from a
detailed historical study, De (1961) concluded that a primary
Asiatic origin of cholera could not be. confirmed with certainty.
Regardless of its origin however cholera, on many occasions, has
demonstrated a remarkable ability to spread rapidly from its endemip
confinement in the Indian Sub-Continent to encircle the rest of the
world in pandemic out-breaks. The first well-recorded choleia pandemic
in 1817-1822 left Europe largely unscathed but in some of the
subsequent outbreaks of 1831-1837, 1848-1858, 1865-1875, 1883-1885
and 1892-1894, heavy mortalities were sustained throughout Europe. Amid
great confusion as to the nature and epidemiology of cholera during
these earlier periods, the work and insight of John Snow (1813-1858)
were of fundamental importance in establishing a sound basis for future
progress. Snow's connection between impure water supplies and choleraic
disease, and his (then) revolutionary concept that the spread of
infection in cholera was directly from the alimentary canal of one
patient to that of another (which he established during the 1848-1858
epidemic in Britain: see Snow, 1849 )> provided the first major clue
-3-
as to rational preventative measures during cholera outbreaks:
namely improved sanitation, and isolation of impure water supplies.
Since Snow had also pin-pointed the mucous membranes of the intestine
as being the tissue in which 'the mischief of cholera was at first
confined1, his work undoubtedly contributed'to the isolation and
detailed description of the causative agent of cholera by Koch in
1884. Koch, leading the German contingent to study cholera during
the epidemics in Egypt and India in 1883-1884, prepared mucous from
the intestines of cholera victims- as soon as possible after death
and observed short, curved, comma-shaped bacilli. Although Koch is
often credited with the first detailed description and characterisation
of the fcomma-bacillus' of cholera, he was not in fact the first to
observe the causative agent, and was himself unaware of the previous
description of an organism termed Vibrio cholerae by Pacini in 1854
who had observed 'millions of vibriones' in the intestines of cholera
patients. Even Pacini, whose nomenclature is accepted as the correct
one today, may not have been the first to recognise the cholera
vibrios. It seems likely that Pouchet in 1849 had already observed
V. cholerae in the dejecta of cholera patients, while the earliest
known claim to have seen the cholera bacillus, by Boehm in 1838,
cannot be verified (see Pollitzer, 1965).
1.4. Taxonomy of vibrios and identification of choleragenie organisms
In the words of Smith and Goodner (1965), 'the vibrios form
a vast sub-continent of -the bacterial world - regions which are almost
barren of exploration'. The lack of information on taxonomy of the
vibrios- is related to the great polymorphism found in this group,
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making the task of classification a difficult and unpleasant one.
However the choleragenic vibrios, have been well characterised and
De (1961) has summarised the criteria upon which identification of
V. cholerae has been bas.ed. Apart from possessing the typical
morphological features (the organism is a gram-negative, motile,
curved rod), the accepted bacterium must be able to ferment
mannose and saccharose but not arabinose, it should fail to
haemolyse sheep or goat erythrocytes, and it should be agglutinated
by D-Subgroup I serum.
However the classification of choleragenic vibrios has been
complicated by the occurrence of several forms which do not obey all
of the above criteria. In 1905 for example Gotslich (quoted in
Pollitzer, 1965) isolated six strains of vibrio from the dead bodies
of pilgrims returning from Mecca at the El Tor quarantine station
in the Sinai peninsula. Although the vibrios possessed all the known
features of V. cholerae, the subjects from which they were isolated
had shown no signs of choleraic disease, and on closer examination
of the 'El Tor vibrios' Kraus and Pribram (quoted in Pollitzer, 1965),
found all of them to be strongly haemolytic for sheep and goat
erythrocytes. The species name V.eltor was introduced for these
organisms in 1933 by Pribram (see Hugh, 1965) although Hugh (1965)
suggested that since V. eltor was so similar to classical V. cholerae,
it should be included under the species name of the latter and be
regarded as a natural variant or biotype of classical V. cholerae.
The haemolytic properties of the El Tor vibrios have in any case,
proved to be unstable and most of the V. eltor strains isolated
during the 1962-1963 cholera epidemic in New Guinea were either only
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weakly haemolytic or completely non-haemolytic (Mukerjee, 1965).
The classification scheme is further complicated by the
occurrence of a diverse group of non-agglutinable vibrios (NAG-
vibrios), so named because they are not agglutinated in cholera
0-5ubgroup I serum (see Finkelstein, 1973). Nevertheless these
organisms are capable of eliciting a cholera-like disease in man.
Because of the relative mildness and short duration of the diarrhoea-
genic effects induced by NAG-vibrios, Finkelstein (1973) has suggested
that they should be grouped together under the new species name
'Vibrio enteritidis' in order to distinguish them from the more
serious infections caused by the classical and El Tor biotypes of
V. cholerae.
Among the many hundreds of non-cholera vibrios (NCVs) i.e.
vibrios which are not associated with choleraic disease, several of
those studied by Smith and Goodner (1965) were found to mutate
spontaneously into highly choleragenic strains indistinguishable from
V. cholerae, and the authors emphasized the possible importance of
NCV mutations in the epidemiology of cholera.
1.5. Recognition of an exotoxin as the active principle in cholera.
After the isolation and characterisation of V. cholerae by
Koch in 1884, numerous experiments were conducted to establish definitively
that this organism was the causative agent of cholera, by attempting to
reproduce the symptoms of the disease in a variety of experimental
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animals after administration of live vibrios. Although some of these
experiments (summarised by De,1961) did result in the induction of
cholera-like symptoms, the lack of a consistently observed and easily
measured response precluded any definite assessment of the results.
Similarly, attempts to establish that 'toxicosis' was the result of a
'specific extracellular poison', as suggested by Koch in the 1880s, by
administration of cell-free extracts of V. cholerae cultures, also
gave rise to a great deal of confusion. There are probably many reasons
for the inconsistency of results during this period. Different workers
used different experimental animals and administered vibrios, or
extracts therefrom, by different routes (intravenously, intraperitoneally,
orally, intraintestinally, etc.) Methods of preparing V. cholerae
cultures and of extracting cell-free substances also varied widely and
undoubtedly, many of the diverse effects reported were the result of
irrelevant, non-specific toxicities arising artefactually with the
methods employed. It is surprising to note that few of these early
studies investigated the effects of V. cholerae, or extracts of the
organisms, on the intestine, and most workers concentrated on the
systemic and lethal effects of toxic preparations after intravenous or
intraperitoneal injection.
This was the growing state of confusion between 1884 and 1953,
at the end of which period, cholera toxin was beginning to be described
as an endotoxin. Then in 1953 a major advancement in cholera research
was made by De and Chatterje (De and Chatterje, 1953) who noted that
when live V. cholerae were injected into a loop of adult rabbit small
intestine, isolated from the rest of the gut by two ligatures, the loop
subsequently accumulated a large volume of fluid and became excessively
-7-
swollen. Although this model was originally conceived for diagnostic
purposes, it was soon adapted and improved upon to enable detailed
patho-physiological studies on cholera to be made (see for example,
5chafer and Lewis, 1965). The fluid accumulated in the intestinal
loops had all the gross characteristics of.the typical cholera stool,
and the technique provided the first reliable animal model for studies
on choleragenesis.
Soon afterwards Dutta and Habbu (1955) were able to produce
consistently, a fatal 1diarrhoeal disease in suckling rabbits, resembling
cholera in man, after intraintestinal injection of live V. cholerae.
The great importance of these two developments can be appreciated
by considering that only several years after their introduction, the
exotoxic nature of the active principle in cholera was firmly established
after 75 preceding years of confusion. In 1959 the laboratories of
both De and Dutta reported that identical responses, in their respective
model systems, to those observed with live suspensions of V. cholerae,
could be produced upon administration of cell-free culture filtrates of
the bacteria (De, 1959: Dutta et al, 1959).
When it was recognised that choleraic symptoms could be
induced by a heat-labile exotoxin, produced and secreted by V. cholerae,
progress was rapid and in 1969 purification of the active material,
known synonymously as cholera toxin, cholera enterotoxin or choleragen,
was reported (Finkelste.in and LoSpalluto, 1969 ). The purification of
cholera toxin by these workers is described fully in Ch. 4 of this
work. .
1.6. The structure of cholera toxin
The structure of cholera toxin purified b.y Finkelstein and
LoSpalluto, (1969) has now been studied extensively and current
knowledge on the subject has been reviewed recently by several authors
(van Heyningen, 1977a; Gill, 1977; Finkelstein, 1976).
The complete toxin molecule is a protein of molecular weight
82,000 - 84,000 daltons as determined in the ultracentrifuge by several
different groups (van Heyningen, 1976a; LoSpalluto and Finkelstein,
1972; Lai et al, 1976; Sattler et al, 1975), and the purified material
contains no. detectable quantities of either lipid or carbohydrate
(LoSpalluto and Finkelstein, 1972). That the toxin possesses a
subunit structure was first implied by the observation that, during
purification, a non-toxic but immunologically related antigen was also
recognised and purified (Finkelstein and LoSpalluto , 1969). This material,
designated choleragenoid, was subsequently found to be a spontaneous
degradation product (a natural toxoid) of cholera toxin (Finkelstein
et al,1971) and the' molecular weight of purified choleragenoid, determined
in the ultracentrifuge, was 56,000 daltons ( LoSpalluto and Finkelstein,
1972).
Subsequent studies on the subunit structure of cholera toxin
have revealed the characteristics summarised in Fig. 1.1. It has been
possible to generate a material identical to the purified choleragenoid
of Finkelstein and LoSpalluto by chromatography or electrophoresis of
cholera toxin in vhe presence of denaturing agents such as urea,














Figure 1.1. The subunit structure of cholera toxin.
van Heyningen, 1976a; Lai et al, 1976; Cuatrecasas et al, 1973;
Sattler et al, 1975; Finkelstein et al, 1974). In the presence
of these agents cholera toxin dissociates rapidly into two different
types of subunits designated A and B. The B subunit prepared in
this way (which is synonymous with choleragenoid) has a molecular
weight, determined in the ultracentrifuge, of about 54,000 daltons
(van Heyningen, 1976a), a value which is in good agreement with that
obtained by LoSpalluto and Finkelstein referred to above, for the
material they isolated during toxin purification. The toxin also
dissociates slowly into its subunits at room temperature and neutral
pH and the rate of dissociation is accelerated in buffers of low pH.
Such buffers are commonly employed for preparation of the toxin
subunits (van Heyningen, 1974a;,1976a). Subunit A of the toxin
migrates on SDS-polyacrylamide gels with a molecular weight of about
28,000 while studies with the ultracentrifuge have yielded a value
of 27,000 - 28,000 daltons (van Heyningen, 1976a) and therefore
intact cholera toxin (82,000 - 84,000 daltons) is composed of Subunit
A (27,000-28,000 daltons) plus choleragenoid (54,000-56,000 daltons).
Subunit A itself is made up of two polypeptide chains,
termed peptides A^ and l\2> joined by a single disulphide bridge and
upon treatment with thiols and electrophoresis in SDS or urea a small
5,000-7,000 dalton fragment (A ) is split off (van Heyningen, 1974a,
1976a, Lai et al, 1976; Sattler et al, 1975). Furthermore, when
harsher conditions are employed to dissociate intact cholera toxin,
such as boiling in 1%-SDS, the 56,000 dalton subunit is no longer
visible on subsequent SDS gel electrophoresis, and is replaced by
material of much lower molecular weight, the exact size of which was
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in dispute for some time, with different values being reported
in a variety of diffdrent analytical systems and even in the
ultracentrifuge (van Heyningen, 1976a; Sattler et al, 1975).
However the amino acid sequence of this low molecular weight
polypeptide has now been published independently by three different
groups, all showing good agreement, and all of which report a
molecular weight of about 11,600 (Nakashima et al, 1976; Kurosky
et al, 1977; Lai et al, 1977). It therefore appears that the
complete B portion of cholera toxin (54,000-56,000 daltons) must
be composed of 5 identical B subunits, a conclusion which was
reluctantly accepted owing to the rare, if not unknown, occurrence
of such a stoichiometry in other proteins (Klotz et al, 1975).
However, the evidence in favour of such a structure is now compelling
(see van Heyningen, 1977a; Gill, 1977). Each of the 5 B subunits
contains one intrachain disulphide bridge (Klapper et al, 1976).
Intact cholera toxin therefore consists of Subunit A,
comprising peptides and in covalent linkage, joined non-
covalently to choleragenoid, comprising 5 identical B subunits all
of which are in non-covalent association with each other. It is
possible to envisage only one three-dimensional structure for this
stoichiometry which would satisfy currently accepted principles of
protein aggregation (Klotz et al, 1975), namely a heterologous ring
of B subunits with subunit A in the centre as depicted in Fig. 1.2.
Some electron micrographs have provided support for thds model
(Dhtomo et al, 1976) as have cross-linking experiments with bifunctional
reagents, which indicate that links between B subunits are formed
more readily than between subunit A and the B subunits,and links
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Figure1.2.Proposedeometryfthchole aoxinsubunits (1:Planview;2:Frontiew).
between the peptide and B subunits more readily than between
and B subunits (van Heyningen, 1976a; 1977b; Gill, 1976a). The
model also receives support from' the observation that toxic protein
can be reconstituted from the separated A and B subunits, but not
from peptide A^ alone and B subunits (Gill, 1976a) indicating that
peptide A^ is essential as an 'adaptor' between peptide A^ and the
B subunits. Finally mercaptoethanol, which cleaves disulphide
bridges only, can release peptide from intact toxin leaving an
A^-BB complex behind (Sattler et al, 1975). Confirmation of this
proposed structure will of course be dependent on X-ray diffraction
studies. Crystals of cholera toxin and of choleragenoid were first
produced by Finkelstein and LoSpalluto (1972) although these were
unsuitable for such analysis. More recently Sigler et al (1977 )
have reported the .production of crystals suitable for X-ray analysis
(interestingly, these crystals support the unusual stoichiometry
of cholera toxin, and are consistent with 5B subunits per molecule).
To date however, no further work in this field has been reported.
1.7. Effects of cholera toxin on the smell intestine and
delineation of the primary choleraqenic response.
The demonstration that cell-free culture filtrates of
V. cholerae could induce fluid accumulation in ligated intestinal
loops (De, 1959) and could elicit choleraic disease in suckling
rabbits (Dutta et al, 1959), clearly indicated that a soluble exotoxin
elaborated by the bacteria was responsible for the production of
choleraic symptoms. Sack and Carpenter (1969) confirmed these
findings by demonstrating that fluid losses similar to those seen
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in the ligated rabbit ileal loop could also be induced in segments
of canine small bowel by culture filtrates of V. cholerae. That these
observations were of direct relevance to human cholera had been
shown previously by the experiments of Benyajati (1966), who was
able to produce the symptoms of cholera in human volunteers after oral
administration of V. cholerae culture filtrates. Elucidation of the
gross pathogenic mechanisms of fluid loss in cholera was achieved
by a remarkable combination of in vitro and in vivo studies- during
the years 1960-1970.
Since all previous studies on cholera had isolated the
small intestine as the primary site of action of the choleragenic
principle, most of the studies described below were performed on this
tissue. Direct confirmation of this assumption was not made until
.1966 however, when Sack and coworkers demonstrated that only the small
intestine contributes to the release of fluid during experimental
canine cholera (Sack et al, 1966). Later the same conclusion was
reached by Banwell et al (1970) from studies on convalescent and
acutely ill cholera patients. Thus although V. cholerae is present
in all regions of the gastrointestinal tract, from mouth to anus,
in human cholera (Gorbach et al, 1970), it is only in the small intestine
that the unique fluid secretory mechanisms are operative. Carpenter
et al (1968) extended this observation and noted that fluid loss in
the small intestine is greatest, per unit length, in the duodenum
and least in the ileum.
-1 3-
Early .workers had suggested that sloughing of the intestinal
mucosa occurred during cholera (see references cited in Pierce et al
1971a). It seems likely however that many of these observations were
made during post-mortem examinations several hours, and possibly much
longer in some cases, after death, when ndn-specific tissue degradation
would have been a complicating factor. More recent studies (see
Pierce et al 1971a) suggested that the intestinal mucosa remained
intact during cholera, when it was demonstrated that leakage of
plasma proteins into the bowel did not occur during the course of the
disease, indicating that no substantial denudation had occurred.
The light and electron microscopic studies of Elliott et al (1970),
using intestinal mucosa from choleraic dogs showed only minor changes
in intestinal morphology including slight capillary dilation and
increased production and discharge of mucous from the goblet cells.
As suggested by Carpenter (1972) these, and other observed minor
alterations, probably represent functional changes only, and are not
indicative of cell damage. The observations that several other
functions .of the small intestine are unaltered during cholera, such
as glucose absorption and glucose-related enhancement of water and
sodium absorption (Hirschhorn and Rosenberg, 1968; Pierce et al, 1968;
Carpenter et al, 1968; Iber et al, 1969; Love, 1965) and absorption
of glycine (Nalin et al, 1970), also argue against any significant
amount of cell damage occurring during the disease.
The first clue as to the mechanism by which cholera toxin
stimulates fluid secretion in the small intestine came with the
observations of Field et al (1968) who noted that when theophylline or
dibutyryl cAMP was applied to pieces of intestinal mucosa, stripped
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of muscularis and mounted in an Ussing Chamber, the normal transport
of Na+ from the mucosal to the serosal surface was inhibited, and
that transport of Cl~, also normally from mucosa to serosa, was
reversed, resulting in active CI secretion. Culture filtrates of
V. cholerae were then shown to produce exactly the same alterations
and the effect of theophylline was eliminated in tissues pretreated
with V. cholerae culture filtrates (Field et al, 1969). In 1970,
Al-Awqati using the same technique, obtained identical results with
the highly purified cholera toxin which had recently become available
(Al-Awqati et al, 1970a). Theophylline, an inhibitor of cAMP phospho¬
diesterase and dibutyryl cAMP, an analogue of cAMP which is resistant
to hydrolysis by phosphodiesterase, both serve to effectively raise
the intracellular concentration of cAMP when added to cells. Since
both treatments mimicked the effects of cholera toxin on the small
intestine, it was suggested that the toxin may act by altering the
levels of cAMP in intestinal epithelial cells. Further support for
this notion was provided by Al-Awqati et al (1970b) who showed that
the same changes in Na+ and CI- transport were induced by prostaglandin Ej_,
an agent known to increase cAMP levels via activation of adenylate
cyclase. The in vivo studies of Pierce et al (1971b) also lent
support when theophylline and several different prostaglandins were
shown to induce fluid loss from canine small bowel after infusion into the
mesenteric artery. The secreted fluid displayed the characteristics
of the typical cholera stool.
Kimberg et al (1971) and Sharp and Hynie (1971) were the
first workers to demonstrate a direct effect of cholera toxin on cAMP
metabolism. Both groups reported activation of the membrane-bound
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enzyme adenylate cyclase after cholera toxin treatment of gut
mucosal cells, and the time courses of cyclase activation correlated
well with the previously established time course of fluid accumulation
in ligated intestinal loops (Carpenter et al, 1968). The toxin had
7
no effect on phosphodiesterase activity and measurement of intracellular
cAMP levels in mucosal cells after toxin treatment confirmed that
marked elevation of the nucleotide concentration had occurred
(Kimberg et al, 1971; Schafer et al, 1970). As a final confirmation
of adenylate cyclase activation being the primary choleragenic
mechanism, Chen st al (1972) demonstrated elevated adenylate cyclase
activity in human intestinal mucosa during the course of naturally
acquired cholera.
1.8. Other activities of cholera toxin
The recognition that the primary action of cholera toxin
was activation of adenylate cyclase and therefore that the toxin's
main effect was to increase intracellular concentrations of cAMP,
provided an explanation for the many other activities of cholera
toxin which were being reported concurrently with the work described
in the previous section, and of additional activities reported
subsequently. A glance at Table 1.1. indicates the great diversity
of effects elicited by cholera toxin on many different cellular
systems which had defied all attempts to be rationalised and related
in a unifying hypothesis. However with the knowledge that cholera
toxin can increase intracellular levels of cAMP, many of these
observations can be readily explained. For example, lipolysis in
-1 6-




Ligated ileal loop Fluid accumulation De, 1953; 1959
Schafer and Lewis, 1965
Rabbit skin Increase in vascular
permeability
Craig, 1965
Rat/inouse foot pad □edema Finkelstein et al, 1969
Fat cells Lipolysis Greenouqh et al, 197G.
Liver cells/platelets Glycogenolysis Zieve et al, 1971
Gorman and Bitensky, 1972
Y1 adrenal cells Steroidogenesis
altered morphology
(Rounding)
Donta and King, 1973
Kwan and Wishnoy, 1974a
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Pierce et al, 1972
Pituitary Growth hormone release Rappaport and Grant, 1974
Sundberq et al, 1974.
Pancreas Insulin secretion Hahn et al, 1974
Immune system Various modulations
of immune response
Northrup and Fauci,1972
Chisari and Northrup, 1974
Cook et al, 1975
Sultzer and Craig, 1973
Strom et al, 1972
Warren et al, 1974






see Van Heyningen, 1977a,
Gill, 1977
Richards and Douglas, 1978
isolated fat cells is known to be under hormonal control and cAMP
acts as the 'second messenger' in this system (Rodbell and Jones, 1966).
Likewise glycogenolysis in liver cells depends on the activation of
phosphorylase, which again is under the ultimate control of cAMP
levels (Robison - et al, 1971). Steroidogenesis in the Y1 adrenal
cell line (derived from mouse adrenal cortex) is an event normally
controlled by ACTH, also via modulations of adenylate cyclase
activity and cAMP levels (Yasumura et al, 1966) and the alterations
in cell morphology induced by cholera toxin, both in this system and
in the Chinese Hamster Ovary (CHO) cell line, are also thought to be
cAMP-mediated events, since altered morphology is seen only and always
under conditions which result in increased intracellular levels of
cAMP (Kwan and Wishnow, 1974a,b; Donta and King, 1973; Johnson and
Pastan, 1972; Nozawa et al, 1975; Guerrant et al, 1974; Guerrant
and Brunton, 1977).
Some of the other effects of cholera toxin such as increase
in vascular skin permeability, induction of rat foot pad oedema, and
increased serum levels of alkaline phosphatase after intravenous
injection of toxin, are not sufficiently well understood to be related
directly to an effect of cAMP but it seems likely that this will be
the underlying cause of all cholera toxin effects. This contention
is supported by the final entry in Table 1.1. which indicates that
cholera toxin is capable of activating adenylate cyclase in virtually
all eukaryotic cell types and tissues studied to date. No attempt
has been made to list all of the systems in which toxin has been
tested, examples of which can be found in most recent reviews (van
Heyningen, 1977a; Gill, 1977; Finkelstein, 1976; Richards and
Douglas, 1978). Suffice it to say that 'it has become almost axiomatic
-17-
that if a particular reaction under study is not affected by cholera
enterotoxin, then the process is not cyclase/cAMP-mediated' (Finkelstein,
1976).
It is therefore evident that ell of the various activities of
cholera toxin are the result, not of differential effects on different
cell types, but of different cells responding in different ways to
the same basic signal, which is . increased cAMP concentrations. In
the small intestine, the only tissue which is normally exposed to
cholera toxin in nature, this response is fluid secretion. In other
cells specialised for different purposes, responses vary depending
on the function and metabolic characteristics of the cell type in
question, and invariably cholera toxin will activate those processes
which are normally 'under the control of cyclase-directed hormones.
There are of course exceptions; cholera toxin has no known effect
on procaryotic adenylate cyclases, an observation which is perhaps
not surprising since the enzyme from microorganisms bears little
resemblance to euearyotic cyclases (see for example, Peterkofsky
et al, 1978; Ozer and Schelt, 1978). There is also one eucaryotic
tissue, in which cAMP is known to be a mediator (toad bladder), on
which cholera toxin has been reported to have no effect (Lief and
Keusch, 1971). However the system has not been well studied and the
lack of toxin-responsiveness may simply reflect an absence of the
appropriate cholera toxin receptors on the cell surface (see following
section).
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Many of the activities listed in Table 1.1. have formed
the basis of accurate and convenient assays for cholera toxin. These
include rat foot pad oedema (Finkelstein et al, 1969), steroidogenesis
in Y1 adrenal cells (Dontaand King, 1973; Donta, 1974; Donta et al,
1976), CHD cell elongation (Guerrant et al, 1974; Guerrant and
Brunton, 1977), lipolysis in fat cells (Greenough et al, 1970)
and skin vascular permeability (Craig, 1965). A comparison of fat
cell , ileal loop and rabbit skin assay systems by Curlin et al (1973)
indicated good agreement among all three techniques.
1.9. The role of the cholera toxin subunits in activation
of adenylate cyclase.
The vast majority of research effort since 1971 has been
directed towards an understanding of the mechanisms involved in
cholera toxin stimulation of adenylate cyclase. Primarily it was
necessary to establish how the structure of the toxin was related
to its action and to answer such questions as 'How is cholera toxin
able to activate adenylate cyclase in almost all cells no matter
how far removed they may be from clinical cholera?' Many of these
questions have been resolved by studying the effects of cholera
toxin on simple cell systems, of which pigeon erythrocytes have
been especially popular. This system, introduced by Gill in 1974
(quoted in Gill, 1977), appeared to be ideally suited to a study of
cholera toxin action. The erythrocytes are readily available and
easily prepared, and are characterised by an extremely low basal
activity of adenylate cyclase which can be stimulated 20-30 fold
by cholera toxin (in other tissues with higher basal levels of
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adenylate cyclase, the effects of cholera toxin, although easily
observable, are much less dramatic). Although pigeon erythrocytes
appear to be particularly remote from any relevance to clinical
cholera, it has been generally assumed that activation' of adenylate
cyclase in the small intestine is not substantially different from
activation in other tissues, and indeed there are no reasons to
conclude otherwise, although there may be qualitative differences
between tissues (see Ch. 6.'). The choice of such simple cell systems
is therefore justified and almost all of the current knowledge on
cholera toxin action has been derived from studies in these systems.
It should also be noted that, had pigeon erythrocytes not been
chosen initially as a tissue of study, progress may well have been
much less rapid.(The reasons for making this statement will become
clear in the following section when the role of NAD+ in toxin action
is discussed. )
(
The years 1970-1976 saw the development of cholera
/
research from the stage at which highly purified cholera toxin had
only just become available, and when its effect on adenylate cyclase
was recognised for the first time, to the elucidation of the gross
mechanism of its action. The studies which were performed during
this period have been reviewed recently in detail by van Heyningen
(1977a) and Gill (1977) and only the major conclusions are summarised
here.
Although cholera toxin can be regarded as having certain
similarities with hormones, there are nevertheless important differences
in the actions of these molecules, one of which is that cholera toxin,
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unlike hormones which activate adenylate cyclase almost instant¬
aneously, displays a lag phase between addition to a population
of intact cells and the onset of cyclase activation. An early
report of Carpenter et al (1968), who observed a 30 min. lag
between the introduction of V. cholerae filtrates into canine
jejunal loops and the commencement of fluid accumulation, has
since been confirmed in all intact simple cell systems studied
including fat cells (Vaugha'n et al,1970; Cuatrecasas, 1973a),
pigeon erythrocytes (van Heyningen and King, 1975; Gill and King,
1975) and rat liver (Houslay and Elliott, 1979). Furthermore
an unpublished observation of Carpenter and Sack (alluded to by
Pierce et al, 1971a), that cholera toxin placed within a canine
jejunal loop produces its full effect even if attempts are made to
flush it out of the loop or to neutralise it with specific antibodies
within 1 min. after its introduction, has also been confirmed in
simpler cell systems, and extracellular antitoxin added to a population
of intact cells after the addition of cholera toxin but before the
onset of cyclase activation, cannot 'rescue' the cells from the
subsequent effect of the toxin (Gill and King, 1975). These
observations suggested that cholera toxin was bound rapidly to the
surfaces of cells and was thereafter unavailable for neutralisation
with antitoxin.
That the toxin does bind tightly to cells at specific receptor
sites was the culmination of a series of experiments initiated.by the
observations of van Heyningen and co-workers in 1971, who noted that
if cholera toxin was preincubated with a mixture of brain gangliosides,
its subsequent effect on gut cells was prevented (van Heyningen, et al,197l).
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Numerous studies performed subsequently have shown that cholera
toxin exhibits a strong binding affinity for the monosialoganglioside
Gm^ (for reviews of gandjlioside structure and function, see van
Heyningen, 1974b; Fishman and Brady, 1976) and that, of all
gangliosides, only Gm^ significantly inhibits the action of cholera
toxin on intact cells (van Heyningen et al, 1971; Holmgren et al,
1973; Staerk et al, 1974; King and van Heyningen, 1975; Cuatrecases
et al, 1973; Battler et al, 1977; King and van Heyningen, 1973,
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Cuatrecasas, 1973b; Wiegandt et aj 1976.) Studies with I**
cholera toxin have revealed that the toxin also binds rapidly to
cell surfaces with a dissociation constant in all cells studied of
around 10~^M, indicative of very tight binding (Walker et al, 1974;
Cuatrecasas, 1973a,b,c; Holmgren et al, 1974, 1975). Since gangliosides
are ubiquitous components in the plasma membranes of cells (van
Heyningen, 1974b; Fishman and Brady, 1976) these observations
strongly suggested that cholera toxin binds to gangliosides. and
specifically Grn^ on the surfaces of cells, and that Gm^ is
probably the natural in vivo receptor for the toxin. This hypothesis
has now been thoroughly tested and most results are consistent with
it. The Gm content of plasma membranes can be altered in several
1
ways and in all cases, any treatment which increases the Gm^ content
of a cell leads to an increase in the amount of cholera toxin which
can be bound, and to an increase in the observed physiological
response elicited by the toxin (Cuatrecasas, 1973b ; Gill and
King, 1975; King et al, 1976; Holmgren et al, 1974; King and
van Heyningen, 1973; Haksar et al, 1974; Staerk et al, 1974;
Hollenberg et al, 1974; Moss et al, 1976a, Mullin et al, 1976;
Fishman et al, 1976; Moss et al, 1977a). It should be noted however
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that the increase in physiological response seen with these treat¬
ments is not always directly related to the amount of toxin which
can be bound, and there is good evidence for a large amount of
non-productive binding (but nevertheless specific binding), even
in untreated cells (see for example, King 'et al, 1976). If Gm^ is
the natural cholera toxin receptor then the extraordinary promiscuity
of cholera toxin referred to earlier, which enables it to affect
'all cells, cay be explained, in that gangliosides, including Gm,
are widely distributed in nature and are ubiquitous components of
cellular plasma membranes, although the relative amounts of
individual gangliosides vary from cell to cell (van Heyningen, 1974b,
Fishman and Brady, 1976).
Many studies have also revealed that it is only Subunit B
of the toxin molecule which shows affinity for Gm^ ganglioside, and
Subunit A displays no binding affinity for either gangliosides or
cells (van Heyningen, 1974a; Cuatrecasas et a1,1 973; Holmgren and Lonnroth,
1975; Sattler et al, 1975). Indeed choleragenoid, the natural
toxoid of cholera toxin containing only the B-subunits, also binds
to cells and to Gm in an almost identical fashion to intact cholera
1
toxin, with the important difference that the binding to cells is
totally non-productive and causes no increase in adenylate cyclase
activity (King and van Heyningen, 1975). This, and the observations
that once choleragenoid is bound to cells, intact toxin can no longer
bind and its action is prevented (Holmgren et al, 1974; Gill and
King, 1975; Cuatrecas'as 1973c; Pierce, 1973), indicated that both
species must compete for the same Gm^ binding sites, and since
cholera genoid displayed no activity, Subunit A of the toxin must
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necessarily be responsible for the activation of adenylate cyclase.
Direct evidence for this latter conclusion was first
provided by van Heyningen and King (1975) who demonstrated activation
of adenylate cyclase in pigeon erythrocytes by both intact toxin
and by purified Subunit A. With intact cells, both species
exhibited the characteristic lag phase before the onset of cyclase
activation while in lysed cells, both induced immediate cyclase
activation on addition. The results of Gill and King (1975) using
the same system, were similar, and these workers also demonstrated
activity of Subunit A but in this case, the subunit was active only
in lysed cells and displayed no activity towards intact erythrocytes.
Like the results of van Heyningen and King however, both Subunit A
and intact toxin had an immediate effect in lysed cell systems, and
intact toxin displayed its characteristic lag phase when tested
on whole cells. In the same report Gill and King extended their
observations and showed that peptide A of the toxin alone was the
I ^
active species.
The abolition of the lag phase in broken cell systems had
been observed previously. Zieve et al (1970) first reported such
an effect in sonicated human platelets and in rat liver homogenates,
and the phenomenon is now known to be a general one in all broken
cell systems studied. Only Cuatrecasas and his group have reported
fundamentally different results to those described above. Bennett
et al (1975) and Sahyoun and Cuatrecasas (1975), working with,isolated
fat cells, also demonstrated an activity of Subunit A but in contrast
to other workers' results, the subunit in this system was found to
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activate adenylate cyclase in intact cells with no lag phase, while
intact cholera toxin exhibited its usual lag phase. The model
proposed by these workers to account for their observations is
described in the following section.
The results of this period can be conveniently summarised
as follows. Binding of cholera toxin to cells is via Subunit B of
the toxin interacting with t'he ganglioside Gm_^ on cell surfaces.
There then fallows a lag phase during which no cyclase activation
occurs and in which extensive washing of the cells or addition of
antitoxin cannot prevent the subsequent activation process. In
broken cell systems the lag phase'is abolished. Subunit A, and
specifically peptide A^, is the active moiety of the toxin which,
in lysed cell systems, activates adenylate cyclase immediately
upon addition. Addition of Subunit A to intact cells can result
in cyclase activation although perhaps not in all cases. Subunit
B of the toxin is devoid of activity, can inhibit the action of
toxin on intact cells, and is required only for the initial attach¬
ment of cholera toxin to cell surfaces.
1.10. The nature of the lag phase and theories of toxin action.
Since there is no known instance of cholera toxin activation
of adenylate cyclase in intact cells occurring without a lag phase,
the length of which varies widely depending on cell type, this
unique characteristic must be an integral part of any proposed theory
for the mechanism of toxin action. (Even in .the experiements referred
to above in which subunit A of the toxin was reported to have an
immediate
the usual
effect on intact cells, the whole toxin still exhibited
lag phase).
Cuatrecasas and his group have developed a model to
explain the action of cholera toxin, in which lateral mobility of
toxin-receptor (Gm^ ) complexes in the plane of the plasma membrane
is the central idea (Sahyoun and Cuatrecasas, 1975). In this model,
depicted in Fig. 1.3., cholera toxin -is proposed to bind initially
and rapidly through one of its B subunits to a molecule of Gjrn on
1
the cell surface, an event which results in the lateral movement
of the toxin- Gm^complex in the plane of the plasma membrane. During
this period of lateral mobility, further attachments between the
toxin and the cell membrane are established through the remaining
B subunits, by collisions with other ganglioside molecules. It
was suggested that active subunit A of the toxin could be released
only on the attainment of such multivalent attachment sites, the
time taken to achieve this constituting the lag phase. The final
establishment of the correct configuration then destabilises the
toxin molecule resulting in the release of subunit A and its spontan¬
eous incorporation into the lipid bilayer where it is free to
interact directly with adenylate cyclase in a 1:1 association, <
causing activation of the enzyme. Their observation that subunit
A of the toxin activated adenylate cyclase in intact fat cells
without a lag phase, was accounted for in this model by supposing
that the rather hydrophobic nature of the subunit allowed it to
penetrate lipid bilayers spontaneously and unaided, causing
immediate cyclase activation.
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Figure 1.3. Binding model of cholera toxin action after
Sahyoun and Cuatrecasas (1975)














Much evidence in support of this model was collected by
these workers, and their results can be summarised as follows:
(i) Lateral mobility of toxin-receptor complexes was
observed on the surfaces of rat lymphocytes using
fluorescin-labelled cholera toxin and treatments which
prevented this movement, also inhibited toxin action
(Craig and Cuatrecasas, 1975).
(ii) Correlations were observed between the temperature
dependence of toxin action and of membrane fluidity
(Bennett and Cuatrecasas, 1975).
(iii) The duration of the lag phase was independent of the
toxin concentration (Craig and Cuatrecasas, 1976).
c
I '■ "
(iv) Cyclase activation by cholera toxin occurred in the
presence of various metabolic inhibitors and 'negligible'
intracellular levels of the toxin were detected during
the activation process (Bennett and Cuatrecasas, 1975).
(v) Adenylate cyclase activity could be precipitated with
antibodies against subunit A of cholera toxin, provided
that cyclase activation had occurred (Sahyoun and
Cuatrecasas, 1975).
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(vi) Solubilised adenylate cyclase comigrated with I
125 '
on gel filtration after activation by I-cholera
toxin, and adenylate cyclase activity could be adsorbed
on agarose-subunit A derivatives (Bennett et al, 1975a).
(vii) The kinetics of the activation process, studied in
intact toad erythrocytes, were considered to be indicative
.of a bimolecular association between subunit A and adenylate
cyclase (Bennett and Cuatrecasas, 1975).
At the same time, a completely different theory of toxin
action was proposed by Gill (1975) who suggested that subunit A of
cholera toxin was an enzyme which catalysed an unknown intracellular
reaction leading to adenylate cyclase activation. (This was analogous
to the known action of diphtheria toxin which catalyses the NAD+-
dependent ADP-ribosylation of elongation factor 2 : see Ch. 6.1.).
I
The theory received considerable support from the demonstration that
NAD+ was a necessary cofactor for the toxin-induced activation of
adenylate cyclase in lysed pigeon erythrocytes (Gill, 1975), an
observation which has subsequently been confirmed in many broken
cell systems including rat liver (Martin et al, 1977: Flores
et al, 1976), various cancer cells' (Bitensky et al, 1975; Wheeler
et al, 1976), thyroid membranes (Mullin et a1, 1976) and fibroblast
membranes (Moss et al, 1976a). NAD+ by itself was not the only
necessary factor required, and ATP as well as one or more unidentified
macromolecular cytosolic factors, were also implicated (Gill, 1975; 1976b)
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This demonstration of an NAD4 requirement highlights the
good fortune (alluded to in the previous section) of the choice of
pigeon erythrocytes as a tissue of study. Most cells contain
endogenous NADase activities which rapidly hydrolyse cellular NAD4
on lysis, and such tissues quickly become * refractory to cholera toxin.
Zieve et al (1970) were the first workers to describe activation of
adenylate cyclase by cholera toxin in a broken cell system (rat
liver homogenate), but because the observed activation was Only
very slight - undoubtedly due to NAD+ depletion (see Chs. 5 and 6)-
the observation received little attention and was not investigated
further. Pigeon erythrocytes, unlike most cells, completely lack
endogenous NADase activities and intracellular levels of NAD4" in
these cells are sufficient to allow consistent effects of cholera
toxin to be observed after lysis. In order to demonstrate the NAD4
requirement, endogenous NAD+ was first destroyed by addition of an
insoluble NADase (Gill, 1975).
I \
.Further support for the enzymic theory of toxin action
comes from the observed kinetics of adenylate cyclase activation
in broken cell systems, which show typical enzymic characteristics
of temperature dependence and linearity with time and with subunit A
concentration (Gill, 1976b). Cyclase activation can also occur
with extremely small amounts of cholera toxin, perhaps as little as
1 molecule per cell, and this in itself argues strongly against a 1:1
binding mechanism. In thisre'spect the observations of Cuatrecasas
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and coworkers that negligible amounts of I-cholera toxin are
detected inside cells during cyclase activation, is of no consequence
to an .enzymic theory of toxin action, since the necessary quantities
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of a catalytic subunit A to fully activate adenylate cyclase are
probably too small to be detected with conventional techniques.
To a certain extent, both of these early theories can now
be combined in a unifying hypothesis, the'model of Cuatrecasas being
used to explain the lag phase and that of Gill to explain the
subsequent events occurring after penetration of the membrane by
subunit A. All of the data reported by Cuatrecasas concerning
membrane fluidity and the dependence on this of toxin action, can
easily be incorporated into a theory in which the final event at
the end of the lag phase is the penetration of subunit A to the ce^l
interior where it catalyses an enzymic reaction, rather than penetration
into the membrane and direct interaction with adenylate cyclase.
Similarly, the kinetic results of Cuatrecasas, which he considered
to be suggestive of a bimolecular association between toxin and
adenylate cyclase, were obtained with intact toad erythrocytes in
which the complex events leading to penetration of the membrane by
subunit A-may have masked the true kinetics of a toxin-catalysed
process within the cell. The kinetics of the activation process
in broken cell systems are undoubtedly characteristic of an enzyme ■
(Gill, 1976b).
The evidence of Cuatrecasas in support of a direct associ¬
ation between subunit A and adenylate cyclase is perhaps more
difficult to reconcile with this unifying hypothesis. However, in
almost all cases, the effects observed in these experiments were
extremely small and the hydrophobic nature of subunit A may have
produced some non-specific adsorptive effects. Furthermore, if
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subunit A is an-enzyme, one of its substrates is presumably a part
of the adenylate cyclase complex, and it is perhaps not surprising
that some degree of affinity exists between subunit A and adenylate
cyclase if this is analogous to the affinity displayed by an enzyme
for its substrate.
In this unifying hypothesis therefore, the lag phase of
cholera toxin action is accounted for by the time taken for the
toxin to establish multivalent attachment sites on the cell surface
favouring the release and penetration of subunit A through the membrane,
In this process, lateral mobility of toxin - Gm^ complexes in the
plane of the membrane is probably an important consideration and
low temperatures or inhibitors of membrane fluidity, by inhibiting
lateral mobility, would prevent toxin action. Speculations as to
the possible mechanisms by which subunit A penetrates the lipid
bilayer have been discussed by Gill (1976a).
-Once inside the cell, subunit A acts as an enzyme and in
an unknown NAD+-dependent process, catalyses activation of adenylate
cyclase. The observations of Sahyoun and Cuatrecasas(1975) relating
to the activity of subunit A in intact ceils without a lag phase,
cannot be explained by this theory. The phenomenon, which invokes
serious teleological questions as to why V. cholerae should
elaborate a toxin with an apparently useless B subunit (especially
when the structure of this subunit is so unusual and perhaps unique),
may be due to some peculiarity of fat cells or of the particular
experimental conditions employed by these workers. Most researchers
now agree that subunit B of cholera toxin has the important function
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of concentrating at a cell surface (via tight binding to Gm^
ganglicsides) an active subunit A, thereby enabling an unlikely
event (penetration of a large molecule through a lipid bilayer)
to become more likely.
One important aspect of toxin action has recently come
into some doubt. It has been considered probable (and has been
assumed for convenience in the above discussion) that subunit A'
must dissociate from the rest of the toxin molecule before it can
activate adenylate cyclase, an idea that has received support from
the observation that treatments which favour dissociation of subunit
A (and of the active species, peptide A^), such as preincubation in
the presence of low concentrations of 5DS and thiols, enhance the
subsequent ability of the toxin to activate adenylate cyclase in
broken cell systems (van Heyningen, 1976a; Gill, 1976b). However,
van Heyningen, using cross-linked cholera toxin in which all subunits
of the toxin were attached covalently to each other in an A^-A2~5B
complex (by treatment with the bifunctional reagent l\l, l\l' - bis
(carboximidomethyl) tartaramide dimethyl ester dihydrochloride),
demonstrated that this material was still able to activate adenylate
cyclase, not only in broken cells, but also in intact pigeon
erythrocytes (van Heyningen, 1977b). Activation proceeded with
the same characteristics as seen with untreated toxin and in the
experiments with intact cells, was shown not to be due to a small
degree of cell lysis, or to a small amount of un-crosslinked toxin.
The inevitable conclusion was that subunit A did not have to
dissociate from the rest of the toxin before its activity could be
expressed, and at first glance the results appear to contra-indicate
-32-
an enzymic mechanism of action for subunit A inside the cell.
However, as suggested by the author, it may simply be sufficient
that subunit A be exposed on the cytoplasmic face of the plasma
membrane where it can still engage in a catalytic reaction while
bound to the B subunits on the cell suface. Another possibility
is that intracellular proteases may be able to cleave some or all
of the subunit at the inner face of the membrane which could then
dissociate from the rest of the molecule and enter the cytosol
completely. This latter possibility is supported by the observation
that at least one cell type, sarcoma 180 cells, can elaborate
proteases which are capable of cleaving cholera toxin into fragments
(many of which are smaller than sybunit A itself) which are still
able to activate adenylate cyclase (Matuo et al, 1976).
Investigations carried out concurrently with the work
described in this report have now made an enzymic mechanism of
toxin action almost undeniable and the major conclusions arising
from these studies are summarised in Ch. 1.12. Before describing
these results however, it is helpful to consider some aspects of
the enzymology of adenylate cyclase.
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1.11. Enzymoloqy of adenylate cyclase
Adenylate cyclase, a complex regulatory enzyme occurring
as an integral protein in cellular plasma membranes, is responsible
for the' formation of cAMP from ATP:
ATP^==^cAMP + PPi
The true substrate is in fact ATP-Mg++ (Perkins; 1973)
and some of the many techniques which have been employed for the
difficult assay of this enzyme are discussed in Ch. '3.3.
Adenylate cyclase normally displays low levels of activity
and in some tissues, such as pigeon erythrocytes, these levels
are only just detectable with sensitive assay methods. The activity
of the enzyme under these conditions is usually referred to as
'basal activity'. This activity can be stimulated by a variety
of agents including many of the catecholamine, peptide and glyco-
peptide hormones, prostaglandins, and cholera toxin. Additionally
other agents, such as fluoride and other halide anions, and
guanylnucleotides, are also capable of stimulating basal adenylate
cyclase activity. The latter group of compounds, which are
becoming increasingly implicated in the regulatory mechanisms of
adenylate cyclase, appear to play a central role in mediating the
action of many stimulatory agents on the enzyme.
Guanylnucleotides were first implicated as regulators of
adenylate cyclase activity by Rodbell et al (1971a; 1971b), when
they were reported to enhance glucagon-stimulated cyclase activity
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in liver plasma membranes. Soon afterwards, many hormone-responsive
adenylate cyclase systems were found to be under the regulatory
control of these nucleotides (Goldfine et al, 1972; Krishna et a1,
1972; Wolff and Cook, 1973; Bockaert et al, 1972; LeRay e t a .1, 1972;
Harwood et al, 1973).
In, a report published in 1974, Londos and coworkers
introduced an analogue of GTP in which the terminal -P-O-P- bonds
were replaced by -P-N-P, and this compound, 5 1-guanylylimidodiphos-
phate (Gpp (NH)p), was shown to be a potent activator of adenylate
cyclase systems (Londos et al 1974). Gpp(NH)p was studied further
by Pfeuffer and Helmreich (1975), along with two other guanyl-
nucleotide analogues:
(i) 5'-guanylylmethylenediphosphonate (GpptCH^Jp)- with a
terminal -P-C-P- grouping.
(ii) Guanosine 5'-□-(3-thiotriphosphate) (GTPyS)- with
a terminal sulphur on the ^-phosphorus atom.
All three analogues, which are characterised by their
relative resistance to hydrolysis by intracellular GTPases, caused
marked elevation of adenylate cyclase activity when added by themselves,
and induced enhanced responsiveness to isoprotorenol when substituted
for GTP in incubations with the hormone (Pfeuffer and Helmreich,
1975). These actions of the GTP analogues, which closely resemble
those of cholera toxin (see following section), have since been
confirmed in most cell systems studied (Lefkowitz, 1974; Lereau
et al, 1978; Spiegel et al, 1977; Palmer and Palmer, 1978;
Ignarro and Grass, 1978; Young and Stansfield, 1978; Fischer and
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Sharp, 1978). The fact that the GTP analogues were not metabolised
or bound covalently to adenylate cyclase (Pfeuffer and Helmreich,
1975) ruled out any possibility of.phosphorylation or guanylylation
of the cyclase as a regulatory mechanism. Later, Spiegel et al (1977),
using another GTP analogue - Guanosine-5'-q., P-rnethylenetriphosphate
(in which a -CH^- group occurs between the a ar,d P phosphorus atoms)
- also ruled out pyrophqsphorylation as a possible mechanism in
guanylnucleotide action.
Pfeuffer-and Helmreich (1975) also reported the separation
of a guanylnucleotide binding protein from solubilised preparations
of pigeon erythrocyte membranes, and presented evidence for the
importance of this fraction in conferring hormone responsiveness
to adenylate cyclase. The authors speculated that adenylate cyclase
in the membrane is normally in an inhibited state and that inhibition
is released by the interaction of guanylnucleotides with a regulatory
subunit. This latter entity would correspond to the 'transducer'
element postulated earlier by Rodbell's group as being an intergral
component of hormone-receptor-adenylate cyclase interactions
(see Birnbaumer, 1973). In a series of papers these workers went
on to demonstrate the existence of specific GTP-binding sites in
plasma membranes and presented evidence for the occurrence of multi-
site transition states involving guanylnucleotides, in the stimulation
of adenylate cyclase by hormones (Rodbell et al, 1974; Salomon
and Rodbell, 1975). These observations resulted in the demonstration
that GTP affects hormone receptor conformation and adenylate cyclase
activity through independent guanylnucleotide sites with different
properties, and that the hormone receptor is a separate entity,
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distinct from adenylate cyclase (Lad et al,1977; Welton et al, 1977).
Binding of GTP to the nucleotide site associated with the receptor
(l\l^) was shown to alter the conformation of the receptor in such
a way as to increase its affinity for glucagon, a process that
probably involves dissociation of the receptor-nucleotide binding
site complex. The resulting hormone-receptor complex was then
proposed to bind uniquely to adenylate cyclase only when the nucleo¬
tide site associated with the cyclase () was occupied by GTP, the
resulting 'coupled' adenylate cyclase forming a high affinity receptor
state, stabilised by the hormone, and exhibiting a high for the
catalysis of cAMP production. These interrelationships are illustrated
diagramatically in Fig. 1.4.
The possible role of an adenylate cyclase-associated GTPase
activity in the regulation of this enzyme, suggested by some of the
observations noted above, received direct support from the results
of Cassel and Selinger (1976) who described the stimulation of such
an activity in turkey erythrocyte membranes by adrenalin. They
distinguished two types of GTPase activity in these membranes; one,
a non-specific or basal GTPase which operated in the absence of
hormone effectors and was apparently unconnected to adenylate cyclase
regulation, and another which only became apparent on addition of
adrenalin and which exhibited a high'specificity and affinity for
GTP. Levinson and Blume (1977), in a detailed study of the effects
of guanylnucleotides and divalent cations on the activity of adenylate
cyclase, also implicated the importance of a Mg++-dependent GTPase
activity in the regulatory processes. The studies with cholera toxin
described in the following section have helped to clarify the role of
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1.12. Effects-of cholera toxin on hormone-responsive adenylate
cyclase systems and the molecular mechanism of toxin
action.
Several studies on the kinetics of adenylate cyclase
after activation by cholera toxin have indicated that toxin stimu¬
lation occurs without a change in the apparent Km of the cyclase
for its substrate ATP-Mg++, and that activation is best described
by an increase in the V of the enzyme (Franks, 1576: GlossmannJ
max
and Struck, 1977). However several other properties of the enzyme
are altered dramatically after toxin stimulation. Generally, toxin-
treated adenylate cyclase displays enhanced responses to a variety
of hormones. For example, the toxin caused an apparent increase
in the sensitivity of turkey erythrocytes to catecholamines
(Rudolph et al, 1977) and increased the apparent affinity of
isoprotorenol, ACTH, glucagon, and vasoactive intestinal polypeptide
(VIP) for cyclase activation in rat adipocytes (Bennett et al,1975b) .
Field (1974) has also reported an increase in the maximum adrenalin-
stimulatable activity of adenylate cyclase after toxin-treatment of
turkey erythrocytes, and adenylate cyclase responses to prostaglandin
in liver were enhanced after prior incubation with cholera toxin
(Su et al, 1976). In intestinal mucosa however, the prostaglandin
response was unaltered by cholera toxin (Kimberg et al, 1971, 1974.)
The above are only a small selection of the recorded hormonal
enhancement effects of cholera toxin and a more comprehensive list
of references has been compiled by Gill (1977). It is interesting to -
note that at least some of these effects may be of direct relevance to
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clinical cholera. VIP for example is capable of activating adenylate
cyclase in intestinal mucosa (Simon and Kather, 1978) where it may
have an important physiological role in the regula.tion of intestinal
fluid secretion. The increased responsiveness of -adenylate cyclase
to VIP stimulation after toxin-treatment of fat cells was also
observed in intestinal mucosal cells (Bennett et al, 1975b), and
these workers suggested that enhanced VIP responsiveness may at
least contribute to the fluid losses observed in clinical cholera.
Contrary to its effect on hormonal responses, cholera toxin
treatment often results in a decreased ability of adenylate cyclase
to respond to stimulation by fluoride ions (Field, 1974; Petrella
and Zenser, 1976), and Field (1974) has suggested that adenylate
cyclase in the turkey erythrocyte membrane may exist in two inter¬
convertible forms; one which is catecholamine-responsive but fluoride-
insensitive, and another which is fluoride-sensitive but not coupled
to P-adrenergic receptors. In this model cholera toxin would
stabilise the cyclase in its catecholamine receptor-coupled form,
thereby explaining the toxin-induced enhancement of hormonal
responsiveness at the expense of fluoride sensitivity.
In the enhancement of catecholamine responsiveness,
cholera toxin apparently does not increase either the number or
affinity of P-adrenergic receptors, since the binding characteristics
of (-) alprenolol (a P-blocker), and its displacement by isoproto-
rendl, were unchanged after toxin treatment (Rudolph et al, 1977).
The observations of Katz and Greenough (1975) also suggest that
cholera toxin does not interact with hormone receptor sites.
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Propanolol, a g-blocker, inhibited adrenalin-stimulation of adenylate
cyclase in isolated fat cells but had no effect on choler.a toxin
action. Conversely, choleragenoid, which inhibited the action of
toxin, did not alter cyclase activation by adrener-gic agents. A
complete cy and 8 receptor blockade by combined treatments with
propanolol and adrenalin (the latter also interacts with (-^-adrenergic
receptors) did not inhibit the action of cholera toxin, suggesting
that no relationship or interactions existed between the toxin receptor
and either q, or B-adrenergic receptors. In the enhancement of peptide
hormone responsiveness on .the other hand, cholera toxin has been
reported to increase the apparent affinity of several hormones for
125
their receptors, and to decrease the rate of dissociation of I-
glucagon from rat hepatocytes (Bennett et al, 1975b).
The first clue as to the detailed mechanism of cholera toxin
action was provided by Cassel and Selinger (1977). After their
previous demonstration that catecholamines induced a specific adenylate
cyclase-associated GTPase activity in pigeon erythrocyte membranes
(Cassel and Selinger, 1976), the same authors reported that cholera
toxin selectively inhibited about £>□/£ of the cat.echolamine-stimulated
GTPase while having no effect on the basal GTPase activity. As the
concentration of cholera toxin was increased, catecholamine-stimulated
GTPase activity was progressively inhibited, and both basal and
isoprotorenol-stimulated adenylate cyclase activities increased in
parallel. The authors reasoned therefore that if cholera toxin action
was dependent upon the inhibition of a cyclase-associated GTPase
activity, then after cholera toxin treatment, GTP should act in the
same manner as the non-hydrolysable analogue Gpp (NH)p in causing
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high and persistent activation of the enzyrne. Experimental data were
completely in agreement with this hypothesis and isoprotorenol+ GTP
synergisticaily activated adenylate cyclase in toxin-treated membranes
to the same extent as isoprotorenol + Gpp (l\IH)p in untreated membranes
(Cassel and Selinger, 1977).
□n the basis of these observations, a model was proposed
for adenylate cyclase regulation in which the guanylnucleotide
binding site (the of Rodbell and coworkers) plays a dual role as
depicted in Fig. 1.5.• In the presence of hormone and GTP,adenylate
cyclase is activated through an increased affinity for GTP at the
regulatory site. The active adenylate cyclase is then returned to
its inactive state by hydrolysis of GTP at the same site - 'the turn-
off GTPase.' Thus hormones act by continually generating an active
cyclase species through an increased affinity for GTP, and the
activation induced by hormones can only be transitory because of the
continual regeneration of the inactive cyclase through the internal
GTPase reaction. The extent of cyclase activation induced by a
particular hormone will presumably be dependent upon the extent of
increased affinity for GTP and will be limited by the rate of the
GTPase reaction. Since cholera toxin inhibits the catecholamine-
induced GTPase activity, it was proposed that the toxin catalysed an
irreversible covalent modification of the guanylnucleotide site which
prevents GTP hydrolysis and thereby 'traps' the adenylate cyclase in
its active state. Gpp(NH)p and similar non-hydrolysable GTP analogues
mimic the action of cholera toxin by binding to the guanylnucleotide
regulatory site in the same way as GTP, but because of their subsequent
inability to participate in the GTPase reaction, the cyclase is again
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ATP cAMP
Figure 1.5. The regulatory GTPase cycle of adenylate
cyclase after Cassel and Selinger (1977).
trapped in its active state. The model- can also explain the
enhancement of hormonal effects by cholera toxin. After toxin-
treatment the hormone-induced binding of GTP to the regulatory
site will generate the active form of the enzyme and because the
GTPase is inhibited, this form will accumulate to an extent not
normally seen in the presence of hormone alone and the stimulatory
effects of the latter will therefore be magnified.
The above model of toxin action implies that GTP itself
must be a necessary cofactor for cholera toxin action, while in few
previous experiments was GTP knowingly added to cholera toxin
incubations with-'membranes. However the guanylnucleotides in general
are effective in extremely low concentrations, and the success of
previous studies probably reflects either that sufficient endogenous
GTP was present, or that sufficient GTP had in fact been added along
with commercial ATP preparations, in which GTP is a common contaminant
(Kimura et al, 1976). That GTP is in fact essential for toxin
stimulation of adenylate cyclase was demonstrated by Lin et al (1978)
who observed that if careful steps were taken to remove all traces
of endogenous GTP, and if highly purified ATP preparations were
employed during assay, then toxin-stimulation of cyclase activity
could only be expressed if GTP was added after the toxin treatment.
Since GTP was only required after toxin treatment, and addition of
GTP after removal of toxin by extensive washing could still elicit
high and persistent activation, the nucleotide is not strictly a
cofactor for the modification of adenylate cyclase by cholera toxin,
but in the absence of GTP, this modification cannot be expressed as
increased adenylate cyclase activity.
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Direct evidence in support of this model of toxin action
was provided by the combined observations of Pfeuffer (1977) and
of Cassel and Pfeuffer (1978). The former author, in an extension
of his previous studies (Pfeuffer and Helmreich, 1975), had
described dissociation and purification by affinity chromatography
of a 42,000 dalton guanylnucleotide binding protein from solubilised
preparations of pigeon erythrocyte membranes. The latter workers
then demonstrated the specific incorporation of [ ^P j from NAD+
radioactively labelled in the ADP-ribose moiety, into a 42,000
dalton protein from the same membranes, catalysed by cholera toxin.
The labelled protein possessed a GTP-binding activity and evidence
was presented to show that the covalent modification of this protein
by cholera toxin was probably an ADP-ribosylation and that this
modification was responsible for the toxin-induced activation of
adenylate cyclase.
At about the same time, Gill and Meren (1978), also using
pigeon erythrocytes, obtained essentially similar results although
in this case, there were substantial toxin-specific ADP-ribosylations
of several other proteins. Nevertheless, the 42,000 dalton peptide
was the major product and was ADP-ribosylated before all others.
To date, similar experiments have been conducted in mouse 549
lymphoma cells, turkey erythrocytes, human erythrocytes (Kaslow
et al, 1979)1 and rat adipocytes (Malbon and Gill, 1979), and in all
cases, a 42,000 dalton GTP-binding protein has been the major substrate
for ADP-ribosylation by cholera toxin.
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From several recent observations (Levinson and Blume, 1977;
Cassel and Selinger, 1978), it seems likely that the GTPase activity
does not result in the dissociation of GDP from the guanylnucleotide
site, since catecholamines were shown to induce the displacement of
bound GDP by GTP. The regulatory GTPase cycle of adenylate cyclase
is therefore probably more accurately represented as shown in Fig. l.fj.
This diagram also takes account of the possibility that the GTPase
cycle involves an association-dissociation step in which the guanyl¬
nucleotide binding protein with bound GTP only acquires a GTPase
activity when in association with the catalytic unit of adenylate
cyclase (Ross and Gilman, 1977 , Levinson and Blume, 1977; Johnson
et al, 1978a; 1978b). After GTP hydrolysis, the guanylnucleotide
binding protein-GDP complex dissociates, and reassociation with
adenylate cyclase occurs only after displacement of bound GDP by GTP,
a process which is stimulated by hormones.
Since cholera toxin can activate adenylate cyclase in the
absence of hormones, it follows that the GTPase cycle must be in
continual operation with the enzyme oscillating between active and
inactive states, although to date it has not been possible to detect
a cyclase-associated GTPase activity in the absence of hormones.
This may simply reflect the fact that in the basal activity state,
the rate of the internal GTPase may be so low as to be undetectable
with conventional techniques. If the cycle is in continual operation
then, in an analogous fashion to the 'futile cycle' of fructose
diphosphatase where the continual hydrolysis of ATP is the price
paid for a sensitive control mechanism, GTP hydrolysis may be the
expense incurred in maintaining adenylate cyclase under strict and
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Figure 1.6. Regulation of adenylate cyclase activity by
hormones and guanylnucleotides and the mechanism






The current state of knowledge on the interaction of hormone
receptors with adenylate cyclase, on the action of cholera toxin, and
on the role of guanyl-nucleotides in these events has been discussed
recently by Cassel et al (1977), Pfeuffer (1979) and Levitzki and
Helmreich (1979).
1.13. Enzymic activities of cholera toxin
From the previous section, it is clear that there is now
good evidence to suggest that cholera toxin catalyses the NAD+ -
dependent ADP-ribosylation of a guanylnucleotide binding protein
associated with adenylate cyclase. However these observations have
only recently come to light and for several years prior to this,
and since the demonstration of an NAD requirement for toxin action
by Gill (1975), various attempts were made to establish the enzymic
nature of cholera toxin, including the experiments reported in Ch. 5.
of this work. Since the cofactor requirement was for NAD+ and
since diphtheria toxin was already known to have certain structural
similarities with cholera toxin and to catalyse the ADP-ribosylation
of elongation factor 2 (see Ch. 6), it was reasonable to postulate
that a similar enzymic activity may be a feature of cholera toxin.
Nevertheless, attempts by Gill (1975) to deomonstrate cleavage of
NAD+ in pigeon erythrocyte lysates in the presence of cholera toxin
were unsuccessful. In these experiments Gill used concentrations of
toxin which, although sufficient to cause full adenylate cyclase
activation, in retrospect were probably insufficient to demonstrate
detectable cleavage of NAD+.
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The first reported enzymic activity of cholera toxin was
the observation by Moss et al (1976b) of a toxin-associated NADase
activity. The authors demonstrated hydrolysis of N.AD+ by cholera
toxin which was dependent on time and on the concentration of toxin,
although activity could only be easily observed with extremely large
amounts of toxin (1D0 to 500 Pg/ml), and only in the presence of
x certain buffers. NADase activity was detected in sodium acetate,
pH 6.2 but not in Tris/HCl, 'pH 8.0, glycine/HCl, pH 8.0 or 8.5, or
hydrazine/HC1, pH 9.5. The use of phosphate buffers produced the
highest NADase activities and surprisingly, activity was stimulated
10-fold by increasing the potassium phosphate concentration from
50mM to 400mM. All of the phosphate buffers described were used at
pH 7.0.
NADase activity was also dependent on the' presence of DTT
in high concentrations (20mM) and the authors suggested that this
dependence.may reflect a necessity for dissociation of Subunit A or
peptide A^, before expression of activity. The effects of phosphate
and acetate in high concentrations were explained in a similar fashion.
Subunit A of the toxin was shown to be the active species and NADase
activity comigrated with the toxin on polyacrylarnide gel electrophoresis
and on gel filtration with Biogel P-60. The calculated of the
toxin for NAD+ was 3.8 mM.
Because diphtheria toxin was known to catalyse the slow
hydrolysis of NAD+ (a reflection of its true ADP-ribosyltransferase
activity), the demonstration of a cholera toxin-associated NADase
activity was suggested to be an entirely analogous situation and was
therefore investigated further by the same workers. In a subsequent
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paper (Mess et al, 1977b) ganglioside Grn^ (and to a lesser extent.
Gm^, Gm^ and Gd-^) were shown to inhibit the NADase activity of both
intact cholera toxin and of subunit A, a surprising result since
subunit A exhibits no affinity for, or interactions with, gangliosides
(CH.1.9.) Various other compounds also inhibited the reaction, of
which adenine and adenosine were the most effective. The relative
potencies of the inhibitors tested were essentially similar to those
found earlier with diphtheria toxin, with the important difference
that values for inhibition of the NADase activity of cholera toxin
were always 1 to 2 orders of magnitude higher than those reported
for diphtheria toxin (values ranged from 3mM for adenine to l60mM
for nicotinamide mononucleotide). The authors pointed out that this
difference may have been due to the higher salt concentrations employed
in their assays which routinely contained 200 to 400 mM-potassium
phosphate.
Since cholera toxin had been shown to possess an NADase
activity, it was logical to investigate the possibility that it could
ADP-ribosylate as well. Moss and Vaughan (1977) reported enhancement
of the NADase activity by L-arginine, D-arginine, and the most effective
compound, L-arginine methyl ester (ARG-OMe). In the presence of 75mM
ARG-OMe NADase activity was elevated about 5-fold, and again maximal
activity was observed, both in the presence and absence of ARG-OMe,
in phosphate buffers where activity increased dramatically with
increasing phosphate concentration. Direct evidence for an ADP-ribo-
syltransferase activity of cholera toxin was also presented. After
incubation of the toxin in the presence of [adenine U - ~^c] NAD+
and f3H] arginine, a reaction product, containing both [ H 1 and f cl
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in the ratio to be expected in an ADP-ribose-arginine adduct, was
isolated by thin layer chromatography.
Some of the results reported in Ch. 5. of this work argue
against the validity of drawing meaningful conclusions about the action
of cholera toxin from experiments of the above type. A full discussion
of these arguments is presented in Ch. 6. but it should be noted at
this stage that, unlike studies on the NADase activity of diphtheria
toxin where results are generally of direct relevance to the action of
the toxin as an ADP-ribosyltransferase, there are few observations
arising from studies on the NADase activity of cholera toxin which
can be related to the action of this toxin on adenylate cyclase. For
example the Km value for NAD+ (3.8mM) is about four times greater
than the concentration! of NAD+ with which maximum cyclase activation
is usually observed in broken cell systems, and the dependence of the
NADase reaction on unusually high concentrations of particular salts,
especially phosphate, has no similarities to the toxin's action on
adenylate cyclase which can occur in many different simple buffer
systems. Similarly the inhibition of NADase activity by gangliosides
is difficult to reconcile with the ineffectiveness of these molecules
in inhibiting the action of either intact toxin or of subunit A in
broken cell systems. Probably, as suggested by van Heyningen (1977a),
this is a non-specific effect as is often seen with gangliosides,
particularly when present at the high concentrations (50P'M) used in
this work: the critical micellar concentration of ganglioside Gm^
has been reported to be around 1-2 x lO"-^!^ or less (Formisano et al
1978 ) .
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Finally, the concentrations of the substances tested for
enhancement of NADase activity were extremely high (75rnM) making it
difficult to derive any meaningful comparisons to the action of cholera
toxin on adenylate cyclase, either in vivo or in vitro.
Nevertheless there are some interesting observations related
, to the above work from which the latter derives some support, and which
may have some relevance to the mechanism of toxin action. T'repel
et al (1977), using similar incubation conditions to those of the
above workers, demonstrated the self-ADP-ribosylation' of cholera toxin
in which subunit A acted both as catalyst and acceptor protein. About
0.8 pmoles of ADP-ribose were incorporated per pmole of toxin. In
a completely unrelated and earlier peice of work, Holmgren and Lonnroth
(1976) described several treatments which inhibited the action of
cholera toxin in mouse thymocytes, one of which was the chemical
modification of the toxin with arginyl-directed agents (1,2-cyclo-
hexanedione and phenanthrenequinone).
Self-ADP-ribosylation is a reaction also catalysed by diphtheria
toxin. Again, this occurs at a much slower rate than the physiologically
significant reaction and is not considered to be of any importance
in the toxin's action on elongation factor 2. Similarly Trepel and
coworkers concluded that self-ADP-ribosylation of cholera toxin,
although providing more similarities with diphtheria toxin, could not
as yet be assigned any definite physiological significance. However
it is not inconceivable that once inside a cell, the action of subunit A
on adenylate cyclase may be enhanced, or even dependent upon, the
initial self-ADP-ribosylation of the subunit using the cell's endogenous
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stores of NAD+. .Since arginine was reported to enhance the NADase
activity of cholera toxin, presumably by acting as an acceptor of
ADP-ribose (Moss and Vaughan, 1977), and since toxin action is inhibited
by specific arginyl-directed reagents (Holmgren and Lonnrath, 1976),
it remains a possibility that self-ADP-ribbsylation of an arginine
moiety is of importance in the early stages of toxin action.
Experimental investigation of such a hypothesis would be difficult,
owing to the very small amounts of ADP-ribose incorporated into
subunit A, but the use of [^p] NAD+, instead of the £ j NAD+
employed by Trepel and coworkers, may facilitate such studies.
M0ss and Vaughan (1978) have also been able to isolate a
protein from turkey erythrocyte cytosol which is capable of ADP-
ribosylating several purified proteins and of activating adenylate
cyclase, albeit to a very small extent (about 1.5-fold in the presence
of NAD+ and ATP). The authors suggested that ADP-ribosylation of
adenylate cyclase may already be a normal regulatory control mechanism
within the.cell which is exploited to its fullest extent by cholera
toxin. If this were true, one would expect to find activities capable
of removing the ADP-ribose residues so incorporated. For cholera
toxin at least however, no cellular factors capable of reversing the
toxin-induced modification of adenylate cyclase have as yet been
detected.
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1.14. Aims of the project
The aims of the work presented in this report can be
summarised briefly as follows:
(i) to develop a simple method for the purification of cholera
toxin from crude culture filtrates of V. cholerae.
(ii) to investigate the NADase activity of cholera toxin in
relation to its effects on adenylate cyclase.
(iii) to investigate the passible enzymic nature of cholera
toxin in activating adenylate cyclase in rat liver membranes,
and in particular, to study the putative ADP-ribosylation.
The various assay systems which were set up for the above
purposes are described fully in Ch. 3.
Chapter 2 METHODS
2.1. Purification of cholera toxin
Crude culture filtrates of the bacterium Vibrio cholerae,
obtained from the Wellcome Research Laboratories (see Appendix I),
were the starting material for preparation of purified cholera toxin.
The filtrates were centrifuged at 100,000g x 30 min. on a Beckman
L2-65B ultracentrifuge and the supernatant, after dialysis against
50mM-Tris/HC1, pH 7.4,.was subjected to the purification scheme
outlined below. All operations were performed at 4°C.
The pellet from the 100,000g cpntrifugation, which probably
consisted of dead bacteria and insoluble cell fragments, contained no
cholera toxin antigen and was discarded.
2.1.1. Ammonium sulphate fractionation
Samples of culture filtrate supernatant were diluted 10-fold
with 50mM-Tris/HC1, pH 7.4, and solid, finely ground ammonium sulphate
was added slowly and with stirring to 60% of room temperature saturation.
After stirring for 30 min, the mixture was centrifuged at 20,000g x 20min.
in an MSE-1B high speed centrifuge, the supernatant was discarded, and
the pellet resuspended in, and dialysed against, 50mM-Tris/HC1, pH 7.4.
2.1.2. DEAE-cellulose column chromatography
The dialysed ammonium sulphate fraction was applied to a
2.5 cm x 7 cm column of DEAE-cellulose equilibrated in 50mM-Tris/HC1,
pH 7.4 and eluted overnight with 200ml of a linear O-lOOrnM NaCl gradient
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at a flow rate of 15ml/hour. 3ml-fTactions were collected and
after gradient elution, the column was washed with 20ml of 2M-
NaCl before being re-equilibrated in 50mM-Tris/HCl, pH 7.4.
Protein elution profiles were monitored by measuring the
absorbance at 280 nm. of each fraction, and alternate fractions
were tested for the presence of cholera toxin as described in
Ch. 2.2.1. Fractions containing toxin were pooled, dialysed against
0.1M-Tris/HC1, O.lM-NaCl, pH 7.4, and freeze-dried. The product
was resuspended in a small volume of the same buffer.
2.1.3. .Gel filtration on Ultroqel ACa -44
The resuspended fractions from the previous step were
applied to a 2cm x 92 cm column of Ultrogel ACa-44 gel filtration
medium, equilibrated in 0.lM-Tris/HC1, O.lM-NaCl, pH 7.4, and
eluted overnight with the same buffer at a flow rate of 5cm/hour.
2ml-fractions were collected and analysed as described above for
the DEAE-^cellulose column. Fractions containing cholera toxin
were pooled, dialysed against 5DmM-Tris/HC1, pH 7.4, freeze-dried
and resuspended in a small volume of the same buffer. Purified
toxin was stored in small aliquots at -20°C before use. Purification




Qualitative detection of cholera toxin was routinely
performed by testing for reaction against antitoxin using the
technique of Ouchterlony immunodiffusion.
3.15g of noble agar and 12 mg of sodium azide were added
to 60 ml of water. The mixture was heated in a boiling water bath
until homogeneous, and 5 ml aliquots were pipetted into each of
12 vials. For use, 5 ml of 0 . 1M-I\la ^PO^ > 1.8% IMaCl, pH 7.0 were
added to one vial and after heating in a boiling water bath until
homogeneous, 2ml of the suspension were pipetted into each of five
glass microscope slides (pre-washed in chromic acid). The agar
was allowed to set and slides were stored in a sealed, humid
container before use.
Using an Ouchterlony cutter, two rings of six wells each
with a central well (all of 6 pi capacity) were cut on each slide
Antiserum raised against cholera toxin in rabbits (see below) or
purified antitoxin therefrom, was placed in the central wells and
samples for analysis, in the surrounding wells. Diffusion was
allowed to occur in a humid atmosphere overnight and toxin-antitoxin
precipitates were viewed under a desk lamp on the following day.
For strongly antigenic solutions, immunoprecipitates were visible
after 3 to 4 hours diffusion time.
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2.2.2. Preparation of cholera antitoxin
Antiserum against purified cholera toxin, prepared in
rabbits as described earlier (van Heyningen, 1976a), was provided.
For some experiments it was necessary to purify antitoxin IgG in
order to remove contaminating enzyme activities in the crude
antiserum.
The serum was dialysed overnight at room temperature against
18$ Na^SO^, pH 7.0. Precipitated protein was collected by centri-
fugation at l,200g x 10 min, the supernatant discarded, and the
pellet res.uspended in a small volume of water. After a further
dialysis against 15$ Na^SO^ the precipitate, containing antitoxin
IgG, was collected .by centrifugation as above and resuspended in
a small volume of SOmM-Na^P0^, 0.9$ NaCl, pH 7.0, Antitoxin was
stored at -20°C when not in use.
2.3. Electrophoretic techniques
2.3.1. Sodium dodecyl sulphate (5D5)-polyacrylamide gel
electrophoresis.
5$ and 10$ polyacrylamide-SDS gels were prepared according
to Weber et al (1972). Protein samples (20 - 100u.l) were mixed
with 5 Pi of 50$ 2 -mercaptoethanol in water, 5pl of 1.OmM-
phenylmethylsulphonylfluoride (PMSF) in propan-2-ol, and 5pl of
10$ SDS. After incubation in a boiling water bath for 1 min. and
cooling to room temperature, 5pl of 0.1$ bromophenol hlue marker
dye were added, followed by one drop of glycerol. Samples were
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applied to gels and electrophoresed a t BmA/gel for about 5 hours,
when the marker dye was about 1 cm. from the bottom of each gel.
Gels were stained■either for 1 to 2 hours at 37°C or overnight at
room temperature in 0.25$ (w/v) Coomassie Brilliant Blue R-250,
45.4$ methanol, 9.2$ glacial acetic acid, and destained electro-
phoretically (50V) in 5$ methanol, 7.5$ glacial acetic acid for
30 to 60 min. Destained gels were stored in 7$ acetic acid.
For determination of molecular weights, gels were cali¬
brated with the following standard proteins: cytochrome C (11,700),
myoglobin (17,200), ^ -globulin L-chain (23,500), aldolase (40,000),
ovalbumin (43,000), -globulin H-chain (50,000), and bovine serum
alubumin (68,000). Using these proteins the standard curve shown
in Fig. 2.1. of electrophoretic mobility on 10$ gels against log
of molecular weight, was obtained. This curve was subsequently
usedfor molecular weight determinations in the range 10,000 to 70,000.
2.3.2. Native polyacrylamide gel electrophoresis.
Native 6.3$ polyacrylamide gels were prepared according
to Davis (1964) without a stacking or sample gel. Protein samples
(20-100U-1) were mixed with 5Ul of 0.1$ bromophenol blue marker dye
and one drop of glycerol, applied to gels, and electrophoresed at
1-2 mA/gel for 1-2 hours when the marker dye was about 1 cm from
the bottom of each gel. Gels were stained and destained as described
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Fig.2.1. Calibration nf 1□^-polyacryla.rnide 5D5 gels for molecular weight
determinations.
25t.il of 1mg/ml solutions' of the standard proteins were
electrophoresed on 10%-polyacrylamide 5DS gels as described in Ch.2.3.1.
After staining and destaining, the mobilities relative to the dye
front were recorded.
2.3.3. Elution of active proteins from native polyacrylamide gels
In some • experiments native polyacrylamide gels were not
stained for protein but-were used for elution and .subsequent assay
of active protein species from slices of the gels.
Samples were electrophoresed as described above and the
distance travelled by the marker dye noted. Eels were sliced into
2 mm-segments which were eluted for 24 hours in a shaking water bath
at 25°C into about 0.4 ml of water. Gel slices were removed, the
eluates freeze-dried, and the residues resuspended in 3D p.1 of
water for .assay.
2.3.4. Determination of radioactive proteins in polyacrylamide
gel slices.
Samples containing radioactively labelled proteins were
electrophoresed in either native or 5D5 polyacrylamide gels as
described above. Eels were sliced into 2 mm-segments and each slice
placed in a scintillation vial immersed in 0.2 ml of NCS tissue
solubiliser (see Appendix I). The vials were capped and heated in
an oven at 50°C for 2 hours. After cooling to room temperature, 5ml
of toluene-based scintillator (Ch.2.6.1.) were added, and samples
counted for radioactivity in a Searle Mk III liquid scintillation
spectrometer.
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2.4. Column chromatographic techniques
2.4.1. Preparation and storage of columns
All ion exchange and gel filtration media were suspended
in the desired buffer, mixed, and the resin allowed to settle.
The supernatant was decanted and the procedure repeated several
times. This served both to remove 'fines' and to allow rapid
equilibration after pouring the columns. Resins were finally
suspended in an equal volume of buffer, the slurry poured into
glass wool-plugged columns .and packing was allowed to proceed
under gravity. Several column volumes were passed through the
packed columns until the pH of the effluent was identical to that
of the applied buffer, the criterion taken to indicate that equili¬
bration was complete. When not in use, columns were stored at 4°C
in the presence of 0.02'jS sodium azide.
2.4.2. Use of columns
All column chromatographic procedures were conducted at
4°C and the pH of the buffers quoted was the pH at this temperature.
Elution of columns was usually achieved with the aid of a peristaltic
pump situated after the column and buffer reservoir, and connected to
a Gilson automatic fraction collector. Pump speeds were selected to
ensure that the pressures exerted on columns did not exceed the maxima
stated in the manufacturer's handbook.
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2.5. Preparation of tissues for assay.
The tissue chosen as the starting material for preparation
of adenylate cyclase fractions was rat liver. 5everal different
buffer systems were employed for the preparation of rat liver
homogenates.
2.5.1. Buffer systems
A. Rat livers were perfused, washed, and homogenised in
75mM-Tris/HCl, 12.5 mM-MgCl2, pH 7.4.
B. Rat livers were perfused with 130 mM-KCl, 20mM-
potassium acetate, pH 7.4, washed in lOmM-Tris/HC1,
pH 7.4, and homogenised in lOrnM-Tris/HC1, 20mM-MgCl2,
5mM-EDTA, 0.25% sucrose, pH 7.4.
C. Rat livers were perfused and washed as in Buffer
System B, and homogenised in 10 mM-Tris/HCl, 20mM-
-MgCl , 5mM-EDTA, 25% sucrose, pH 7.4.
D. Rat livers were perfused, washed, and homogenised
in lOmM-Hepes, lmM-MgCl2> 0.25M-sucrose, pH 7.4.
The procedures described below were common to all of the above
buffer systems and in any one preparation, one buffer system was
adhered to throughout. All operations were performed at 0-4°C.
-59-
2.5.2. Preparation of rat liver homoqenates
A male rat was killed by a blow to the head, the liver
was exposed and perfused in situ through the portal vein. The
liver was excised, placed in about 50 ml of washing medium, and
after blotting on filter paper, weighing, and cutting into small
pieces, the tissue was homogenised in 2-3 volumes of the appropriate
buffer. Homogenisation was carried out by hand using 10 strokes of
a teflon-on-glass homogeniser. After filtration through one layer
of muslin, the filtrate was taken as crude rat liver homogenate.
2.5.3. Preparation of crude rat liver membranes
A homogenate prepared as described in Ch. 2.5.2. was
centrifuged at 2,000g x 10 min. on an M5E-18 centrifuge. The
supernatant was discarded, the pellet resuspended, washed, and
centrifuged a further two times, and finally resuspended in a small
volume of -the appropriate homogenisation buffer.
2.5.4. Preparation of rat liver cytosol.
The supernatant from the first low-speed centrifugation
described in Ch. 2.5.3. was centrifuged at 100,000g x 30 min. on a
Beckman L2-65B ultracentrifuge and the supernatant taken as rat
liver cytosol.
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2.5.5. Preparation of purified rat liver plasma membranes
Plasma membranes were purified from rat liver as described
by Pilkis et al (1974).
2.5.6. Preparation of solubilised adenylate cyclase fractions.
Solubilisation of adenylate cyclase from the particulate
preparations described above was achieved by adding a one-tenth
volume of Lubrol-PX in the appropriate buffer to give the desired
final concentration (%, v/v) of detergent. After mixing for 3D s.
and centrifugation at 100,000g x 30 min. on a Beckman L2-65B ultra-
centrifuge, the clear supernatant was taken as the solubilised
preparation.
2.5.7. Preparation of pigeon erythrocyte cytosol.
"Pigeon erythrocyte lysates were obtained as described
earlier (van Heyningen, 1977b) and cytosol was prepared by centri-
fugation at 100,000g x 30 min. as described above for rat liver
cytosol (Ch. 2.5.4.).
2.6. Protein estimation ,
Protein was determined by the method of Bradford (1976).
Protein reagent was prepared by dissolving lOOmg of Coomassie
Brilliant Blue G in 50 ml of 95?o ethanol, adding 100 ml of QB%
orthophosphoric acid, and diluting to 1 litre with distilled water.
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For protein estimation, 0.1 ml of sample (containing ID
to lOOPg of protein) was added to 5 ml of protein reagent and the
resulting blue colour was measured after 2 min, and before 1 hour
by recording the absorbance at 595 nm. Blanks consisted of 0.1 ml
of the appropriate buffer in which the protein samples were dissolved.
For each batch of protein reagent made up, a standard curve of protein
concentration (pg per 0.1 ml of sample) against A^gc, nm was constructed
using bovine serum albumin as standard. An example of such a curve
is illustrated in Fig. 2.2. All experimental determinations were
made on the linear portions of standard curves.
2.7. Liquid scintillation counting techniques
2.7.1. Scintillators
All radioactive samples, except those from adenylate cyclase
assays, were counted in 5 ml of a toluene-based scintillator containing
7g PPO, 0.6g dimethyl P0P0P, 150g naphthalene, 300 ml ethyleneglycol
monoethylether, and toluene to 1 litre. Adenylate cyclase assay
samples were counted in 10 ml of a scintillator containing 3g PPO, 257 ml
Triton X-100, 37 ml ethyleneglycol monoethylether, 106 ml ethanol, and
xylene to 1 litre.
2.7.2. Background and standard vials
During preparation of samples for counting, care was taken to
ensure that all samples were identical with respect to volume of
scintillator, amount of quencher, etc. and for each experiment, back¬
ground and standard vials were also counted.
The background vial was identical to all other experimental
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Fig.2.2. Standard curve of protein concentration against absorbance
at 595nm. in the Bradford method of protein estimation.
A 1mg/ml solution of BSA in water was made up and increasing
volumes up to 8Dul were placed in a series of tubes. The volume in each
tube was made up to 0.1ml with water, 5ml of protein reagent were added
and the absorbance at 595nm was determined as described in Ch.2.6.
in this vial were subtracted from the values obtained in the
experimental vials.
The standard vial for any particular experiment consisted
of a known amount of the assay medium (containing radioactive
substrate) used in the experiment, under identical conditions to
assay samples in the experimental vials. Counts arising in this
vial served as an estimate of the c.p.m. or d.p.m. of radioactive
substrate added to each assay.
2.7.3. Use of the Searle Mk III liquid scintillation spectrometer
Radioactive samples were usually counted in the Searle
Mk III liquid scintillation spectrometer. This was a computerised
machine which was programmed before use with sets of quenched [J
and [ ~^C] standards supplied by Amersham/Searle. Each standard in
the [] or [~^C ] series contained the same number of d.p.m. but
owing to the variation in quench, each was counted with a different
efficiency. During programming, the counter was instructed to store
each standard counted, along with its counting efficiency, in the
memory banks which therefore retained quench correction curves for
both [] and isotopes. For any sample counted subsequently,
the machine was therefore able to calculate the counting efficiency
and print out absolute d.p.m. values directly. The counter was
usually used in the variable quench mode in which optimum discrim¬
inator settings were established automatically for each sample before
commencing counting. For most samples, individual counting efficiencies
did not vary significantly, but for the complex adenylate cyclase
assay samples (Ch. 3.3.) efficiences tended to vary to a greater extent.
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2.7.4. Use of the Packard Tricarb liquid scintillation spectrometer
Counting samples in the Packard Tricarb liquid scintillation
spectrometer was exactly as described above except that, in this
case, the machine was unable to compute d.p.m. values directly.
However since all vials in any particular experiment (including the
standard vial) contained the same volume of sample and scintillator
etc. it was assumed that all vials would be counted with the same
efficiency (counting the same samples in the Searle Mk III on the
variable quench mode confirmed this assumption). Because of this,
and since the standard vial provided an estimate of the c.p.m. of
labelled substrate added to each assay, computation of absolute
d.p.m. values was unnecessary and specific enzyme activities could
be calculated directly from c.p.m. values.
The packard Tricarb counter was however of limited use
when applied to the complex adenylate cyclase assay samples and
for this reason, these samples were always counted in the Searle
Mk III counter.
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Chapter 3. Assay Methods
3.1. NAD GLYC0HYDR0LA5E ASSAY.
3.1.1. Introduction
NAD glycohydrolases (NADases) are a class of enzymes
(EC 3.2.2.5.) which catalyse hydrolysis of the nicetinarnide-
ribose bond of NAD+ yielding nicotinamide, adenosine-diphosphate
ribose (ADP-ribose) and' a proton:
^v^conh2 CONH
+ h20.
-Ny + ADP-ribose + H+
ADP-ribose
Most early assays of NADase activities depended on the
measurement of residual levels of NAD+ after incubation with enzyme.
NAD+ was originally assayed as 'V-factor' in cultures of Haemophilus
parainfluenzae. Lwoff and Lwoff (1937) noted that the growth of this
bacterium was dependent on the presence of a vitamin (V)-factor
(now known to be NAD+) in the culture medium, and they developed an
assay for NAD+ based on the extent to which an unknown sample containing
NAD+ could support the growth of H. parainfluenzas cultures. The
theory and specificity of this assay have been discussed by Kohn (1938).
A more convenient assay for NAD was introduced by Negelein
and Wulff (1937) who used ethanol and alcohol dehydrogenase to
convert NAD+ to NADH when the concomitant increase in absorbance at
340 nm was a measure of the original amount of NAD in a sample.
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The assay was further charac terised and simplified by Racker (1950).
NAD determinations were again simplified by Colowick et al
(1951) who exploited the observation that NAD+ reacted with cyanide or
bisulphite to form complexes having absorption spectra resembling
those obtained by enzymatic reduction of NAD+. These authors
developed a method for the determination of NAD+ by measuring the
amount of cyanide complex which formed on addition of an assay
sample to a standard 1M-KCN solution. . NADase activities determined
by this method were essentially identical to those obtained by the
alcohol dehydrogenase method. Cyanide addition occurs on the nico¬









The fact that NAD hydrolysis liberates a proton has also
been exploited in the development of manometric (Mcllwain and
Rodnight, 194?) and potentiometric (Zatman et al, 1954) assay methods.
Most of the above assays, requiring large volumes for
analysis, were unsuitable for the present work where the limited
availability of cholera toxin necessitated the use of assays on a
miniature scale, and a radioactive assay was therefore employed. NAD+
radioactively labelled with [ "^c] in the carbonyl moiety was used
as substrate, and the product, [ carbonyl-^C J nicotinamide, was
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separated from unreacted ^carbonyl-^C j NAD+ before counting.
Separation of nicotinamide and NAD+ on small columns of Dowex 1-
formate (X2: 200-400 mesh) has been described by Ueda et al (1975)
and a similar method was also employed by Moss et al (I976b)in their
original demonstration of the NADase activ'ity of cholera toxin. In
the work reported here, a simple and efficient separation of nico¬
tinamide and NAD+ was effected by chromatography on strips of DEAE-
cellulose paper, in a method similar to that already described for
separation of NAD+ and i\IADP+ (Apps and Nairn, 1975).
3.1.2. Method.
3.1.2.1. Incubations and Assay Media.
NADase activities of cholera toxin fractions were determined
initially in the assay medium described by Moss et al (1976b). Assays,
in a total volume of 15 to 50jj.1 contained 100 to 400 mM potassium
phosphate .(KH2P04« 12H20) , 20 mM-DTT, 0.5 to 5mM-NAD+, and 4 to 20 nCi
of £carbonyl-^-^C ] NAD+, pH 7.0. In later experiments, low concentrations
of potassium phosphate (lOmM), 200mM-sodium acetate, pH 6.2, or 50rnM-
Tris/HCl, pH 7.4 were substituted for the high concentration phosphate
buffer.
NADase activities of rat liver fractions were conducted in
the appropriate homogenisation buffer (Ch.2.5.1.) containing NAD+
and [ carbonyl-^C J NAD+ as above.
-67-
Assays were initiated by the addition of enzyme sample
and after an incubation at 25 or 37°C, reactions were terminated by
the addition of 25% TCA. Precipitated protein was removed by
centrifugation at l,200g x 5 min. and aliquots of each supernatant
(usually 10 p.1) taken for estimation of [^cj-nicotinamide.
|14 1
3.1.2.2. Separation of | CJNicotinamide.
r 14 i
[ C J nicotinamide produced during assay was separated
from unreacted ^carbonyl-^C J NAD+ by chromatography on DEAE-cellulose
paper. Sheets of Whatman DE-B1 paper (46 cm x 57 cm) were cut into
2 cm x 20 cm strips and an assay sample was applied 2 cm from one end
of each strip. 2U1 of a 100 mg/ml solution of nicotinamide were also
applied along with each sample to enable visualisation of nicotinamide
spots under short-wave ultraviolet light. The strips were suspended
in small chromatography tanks (up to 20 per tank) and ascending
development in 0.12M-formic acid / NH^, pH 3.1 was allowed to proceed
for about 1 hour, when the solvent front was about 1 cm from the top
of each strip. The strips were dried in an oven at 5D°C, viewed under
short-wave ultraviolet light, and the nicotinamide spots marked in
pencil.
3.1.2.3. Liquid Scintillation Counting Conditions
The nicotinamide spots were cut out directly into scintill¬
ation vials containing -5 ml of toluene-based scintillator (Ch.2.7.1.)
and counted for radioactivity either in a Packard Tricarb or a Searle
Mk. Ill liquid scintillation spectrometer. Background vials contained
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an equivalent blank piece of DE-B1 paper and standard vials contained
known amounts of the assay media used in each experiment, (containing
[carbonyl-^C J I\1AD+ substrate) dried onto an equivalent piece of DE-81
paper.
3.1.3. Characterisation of Assay Method
3.1.3.1. Separation of NAD+ and its' hydrolysis products on DE-81 paper
The separation of NAD+ and nicotinamide on DE-81 was assessed
visually. lOOmg/ml solutions of the two compounds in water were made
up and applied to 3 strips as follows:
Strip 1 3 pi of nicotinamide
Strip 2 3 pi of I\1AD+
Strip 3 3 ill Df nicotinamide + 3 pi of I\1AD+
After development and visualisation under U.V. light, nico¬
tinamide on strip 1 had migrated with an Rf value of 0.9 and NAD+ on
Strip 2 with an R-p of 0.5. (R^. values are quoted as distance from origin
to front of spot / distance from origin to solvent front). On strip 3 the
two compounds had migrated with the same R-p values as in strips 1 and 2
and were clearly separated from each other. A similar experiment in
which 10 pi of lM-Kh^PCL'I2H2O were applied along with each sample gave
identical results showing that samples of high ionic strength could
also be separated efficiently in this system.
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Separation was assessed quantitatively by applying a
sample of partially hydrolysed NAD+ (from an incubation with cholera
toxin as described in the previous section) to a DE-81 strip. The
toxin had been incubated in the simultaneous presence of 2nCi of
[carbonyl-^C J NAD+ and 2 nCi of [adenine U - ~^c] NAD+ and therefore
the sample should have contained a mixture of unreacted NAD+ and
equal radioactive counts of [narbonyl-^C J nicotinamide and [adenine
14 "i
U- Cl ADP-ribose. After development, the chromatogram was dried and
cut into 1 cm-long segments each of which was counted for radioactivity
as described in Ch. 3.1.2.3. As shown in Fig. 3.1. three peaks of
radioactivity were observed. Since the positions of NAD+ and nicotina¬
mide had already been established visually. the third slow-moving peak
was presumably ADP-ribose. Nicotinamide was detected between R.p values
0.69 - 0.94, NAD+ between 0.38 - 0.63 and ADP-ribose between 0.06-0.31.
Nicotinamide and ADP-ribose were present in approximately equivalent
amounts, about 94% of all applied radioactivity was recovered, and all
three compounds were clearly separated from each other on the DE-81 strip.
3.1.3.2. Recovery of radioactivity from DE-B1 paper
[ Carbonyl-^^C] NAD+ was diluted with water to give an
approximately lu,Ci/ml solution, and increasing volumes up to 50u-l were
placed in a series of vials containing 5 ml of scintillator. An
identical series of aliquots were adsorbed onto pieces of DE-81 paper
and after drying in an oven at 50°C, were also placed in vials as above.
The total volume of aqueous solution in each vial was made up to 50 M-l

















Fig.3.1. Migration of NAD and its hydrolysis products on DE-81 strips.
A mixture was prepared containing 200mM-potassium phosphate,
20rnM-DTT, 1mM-NAD+, 2nCi of [ carbonyl- ' ^cj NAD+, 2nCi of [adenine U-
^c]nAD+, and 118jj,g/ml cholera toxin, pH 7.0. After 3hr at 37 C,
10^1 were applied to a IE-81strip which was developed and analysed for
radioactivity as described in the text (Ch.3.1 .3.1 . )
Reported c.p.m. values are corrected for the total 20ul
assay volume. 'F' indicates the position of the solvent front.
Fig. 3.2. illustrates the quantitative recovery of
[14 i +carbonyl- CI NAD adsorbed onto DE-81 paper
and the method was therefore judged suitable for quantitative assay
determinations without the need for corrections for self-absorption
of counts. The experiment also indicates that the presence of DE-B1
paper in a vial does not per se affect the observed count rate and
therefore no -special precautions to ensure the presence of an exact
amount of paper in each vial were necessary.
3.1.3.3. Breakdown of NAD"1" on DE-B1 paper.
NAD+ was found to be unstable on DE-81 paper at room
temperature, and Fig. 3.3. shows a slow time-dependent release of
[14C] nicotinamide after application of [carbonyl-44C] NAD+ to DE-81
strips which were left for various times before development. After
6 hours about '5% of the applied NAD+ had been broken down.
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Fig.3.2. Recovery of radioactivity from Whatman DE-81 Paper.
Aliquots of an approximately 1P-Ci/ml solution of [carbonyl-
1 4 i +
CJNAD in water were either added directly into scintillation vials
(O—O) or adsorbed onto pieces of DE-81 paper and dried (©■—®). The
total volume of water in each vial was made up to 50^1 with water, 5ml
of toluene-based scintillator was added, and vials were counted for 10
min. All values were single determinations only.
0 2 4 6
Time (hr)
Fig.3.3. Breakdown of NAD+on DE-81 paper.
14 +
1OnCi of [carbonyl- C]NAD were applied to a series of DE-81
paper strips and after the indicated times at room temperature, the
strips were chromatographed and nicotinamide was determined as described





ADP-ribosyltransferases are responsible•for catalysing the
transfer of the ADP-ribose moiety of NAD+ to an acceptor protein, in
the process liberating free nicotinamide and a proton:
„^VCQNH2 ^^vC0NH2






•The NADase activity discussed in Ch. 3.1. may be thought
of as an ADP-ribosylation reaction in which the protein acceptor is
replaced by water and in theory therefore, the assay method described
in Ch. 3.1.2. for NADase activity should also be suitable for the
measurement of ADP-ribosyltransferase activity (assuming that the
transferase is pure and devoid of all NADase activity . However, the
diversity of NAD+-utilising enzymes in the crude rat liver fractions
used in this work, of which only a small proportion are ADP-ribosyl¬
transferases , invalidated the use of any assay method based on the
measurement of nicotinamide production which can serve only as a
measure of the total activities of all enzymes in a solution which
release nicotinamide from NAD+ during catalysis.
For this reason, NAD+ labelled universally with [~^c] in
the adenine ring was chosen as a substrate and after an incubation
with enzyme sample, the amount of [ ~^Cjassociated with TCA-precipitabl
material was determined. In common with all published methods for the
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estimation of ADP-ribose incorporation, the method described here involved
the use of a filtration step during which TCA precipitates were applied
to filters (in this case Whatman GF/C filters) and all non-covalently
r 14 "1
associated I CJ was washed free. Several similar methods to tne one
described here have been reported previous'ly. (Fujimura and Sugimura,
1971; IMishizuka et al, 1971; Haines et al, 1969; Gill, 1972).
3.2.2. Assay Method
3.2.2.1. Incubations and assay media
ADP-ribosyltransferase activities in rat liver fractions
were determined in the appropriate homogenisation buffer (Ch.2.5.1.)
containing various concentrations of NAD+, ATP, DTT, GTP, 50-100 nCi
of[adenine U-^^c]NAD+, cholera toxin and other additions as indicated
in the Results section (Ch. 5.). Assays were usually conducted in a
total volume of 1001-Al and were initiated by the addition of rat liver
fraction. - After incubation at 25°C, 25/S TCA was added to terminate the
reactions and aliquots from each assay were taken for estimation of
14
C ADP-ribose incorporation.
3.2.2.2. Estimation of ADP-ribose incorporation
100 (il of assay mixtures were applied to 2.5 cm diameter
Whatman GF/C glass fiber filter discs, pre-wetted in 5$ TCA and
mounted on a Millipore filtration device. After attaching the top of
the Millipore apparatus the filters were washed with 2 x 20 ml aliquots
of 5% TCA f rom a 20 ml syringe. Excess moisture was removed by forcing
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air through the apparatus twice from the syringe and filters were
removed and dried in an oven at 50°C. The filters were finally
placed in scintillation vials containing 5 ml of toluene-based scintillator
(Ch. 2.7.1.) and counted' for [ ^cjradioactivity in - a Searle Mk. Ill
liquid scintillation spectrometer.
3.2.3. Characterisation of assay method
3.2.3.1. Recovery of radioactivity from Whatman GF/C filters
An approximately 1 p.Ci/ml solution of £ adenine U-^C J NAD"1
was made up in water and increasing volumes up to 50 111 were placed
directly into scintillation vials containing 5 ml of toluene-based
scintillator. An identical series of aliquots were placed on Whatman
GF/C filters, dried at room temperature, and added to scintillation
vials as above. The total volume of aqueous medium in each vial was
made up to 50|il with water, and vials were counted for 10 min. in the
Searle Mk. Ill liquid scintillation spectrometer.
In both cases, a linear relationship was obtained between
amount of ["^cj NAD+ added, and observed d.p.m. (Fig. 3.4.) although
d.p.m. values were always slightly greater when the isotope was adsorbed
onto GF/C filters. A possible reason for this phenomenon is discussed
later (Ch. 3.4.)
3.2.3.2. Recovery of radioactivity in the presence of precipitated protein
In routine assays, radioactivity on GF/C filters was
determined in varying amounts of TCA-precipitated protein and it was
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Fig. 3.4. Recovery of radioactivity from Whatman GF/C filters.
An approximately IJiCi/ml solution of [adenine u-^ 4c]nad+ was
made up in water and increasing volumes were either added directly to
scintillation vials (O—O) or applied to Whatman GF/C filters and dried
(©—-®) . The total volume of water in each vial was made up to 50^1, 5ml
of scintillator were added, and vials were counted for 10min.
to establish that precipitated protein did not
effect on the observed count rate.
8Dyl aliquots of increasing concentrations (up to 2D mg/rnl)
of BSA in water were added to tubes containing 20 yl of an approximately
lyCi/ml solution of [adenine U- ^cj l\IAD+. 10 yd of 25$ TCA were added
and after mixing, 100 yl from each tube were applied to GF/C filters,
dried, and counted in the Searle Mk. Ill as above. As Fig. 3.5. shows,
the presence of precipitated protein over a wide range had no effect
on the observed d.p.m. values.
therefore essential
produce a 'masking'
3.2.3.3. .Efficiency of washing procedure
The sensitivity of the assay method depends on the efficiency
non-covalently attached ! C J is removed from the protein
s in the washing step.
BOyl of ID mg/ml BSA were added to 20yl of an approximately
lyCi/rnl solution of [adenine U-^c]nAD+ followed by 10yl of 25$ TCA.
After mixing, 1D0 yl from each of 5 similar tubes were applied to pre-
wetted GF/C filters and washed with increasing numbers of 2D ml aliquots
of 5$ TCA as described in Ch. 3.2.2.2. The filters were dried, placed in
scintillation vials and counted in the Searle Mk. Ill as above.
with which
p recipitate
As the results in Table 3.1. indicate, the majority of
radioactivity was removed from the filter after the first wash, and
after two washes almost all of the applied counts were removed.
Subsequent washes then had little effect. In routine assays, 2 x 20 ml
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Fig.3.5. Effect of precipitated protein on the recovery of radioactivity
from Whatman GF/C filters.
801X1 of increasing concentrations of BOA in water were added
to 20ixl of a iM-Ci/ml solution of [adenine U-^c3nAD+. 10ixl of 25/&-TCA
were added and 100ixl aliquots were applied to EF/C filters which were
dried, placed in 5ml of scintillator, and counted for 10min.
Table 3.1. Efficiency of washing procedure in ADP-ribcisyltransferase
assay.
80pl of 10 mg/ml BSA were added to 20ul of an approximately
luCi/ml solution of [adenine U-^^cJ NAD+ followed by 10pl of 25%-TCA.
lOOul aliquots were applied to Whatman GF/C filters and washed with
increasing numbers of 20ml-aliauots of 5%-TCA as described in
Ch. 3.2.2. Filters were dried, placed in 5 ml of scintillator and
counted for 10 min. All values were single determinations only.
r 14 "i






3.3. ADENYLATE CYCLASE ASSAY
3.3.1. Introduction
Adenylate cyclase (ATP pyrophosphate-lyase (cyclising)
EC 4.6.1.1.) is an integral component of cellular plasma membranes and
is responsible for the formation of cyclic adenosine 31,5'-monophosphate
(cAMP) from ATP.
ATP &=? cAMP + PPj
Since the discovery of this activity (Rail and Sutherland,
1957) and the subsequent isolation and characterisation of cAMP
(Rail and Sutherland, 1958a), research has continually been hampered by
the lack of simple and efficient methods of assay. Most of the earlier
methods for estimating adenylate cyclase activity (and some more
recent ones) have employed non-radioactive ATP as a substrate, and a
variety of techniques for measuring the small amount of unlabelled cAMP
produced have been reported. For example, cAMP was. originally assayed
by its ability to activate liver glycogen phosphorylase and thus to
stimulate glycogenolysis. Levels of glycogen,by reaction with iodine
(Rail and Sutherland, 1958b) or production of glucose-l-phosphate, by
coupling to NADP+ reduction through phosphoglucomutase and glucose-6-
phosphate dehydrogenase (Brown et al 1963; Scott and Falconer, 1965),
were used as estimates of the amount of cAMP in a sample. A number of
methods then appeared all of which were dependent on the conversion of
cAMP to, and subsequent determination of, some other nucleotide
(Breckenridge, 1964; Goldberg et al, 1969; Hardman et al,1966; Ebashi
et al 1971) . All of these methods were extremely laborious requiring
the preparation of several different purified enzyme systems. They also
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lacked sensitivity, many of the enzymes used being responsive to
variations in the levels of compounds other than cAMP itself (Krebs
etal 1959).'
More recent methods for cAMP determination have concentrated
on measuring the nucleotide directly and have thus achieved a markedly
greater sensitivity. The isolation of cAMP-binding proteins (cAMP-
dependent protein kinases) from skeletal muscle and beef adrenal cortex
enabled the development of saturation binding assays for cAMP (Gilman,
1970; Walton and Garren, 1970; Brown et al 1970; 1971), and a specific
cGMP-binding protein from lobster muscle (Kuo and Greengard, 1970a)
enabled Murad and Gilman (1971) to assay cAMP and cGMP simultaneously.
The ability of cAMP to activate the cAMP-dependent protein kinases has
also been exploited. Thus Kuo and Greengard (1970b) and Wastila et al
(1971) incubated assay samples in the presence of protein kinase end
[tf-^p] ATP' and measured [^pjincorporation into histones and casein
respectively.
The specificity of cAMP-phosphodiesterase, the enzyme
responsible for degradation of the nucleotide, formed the basis of an
enzymatic radioisotopic displacement assay for cAMP (Brooker et al 1968),
and radioimmunoassays for cAMP and cGMP have also been reported (Steiner
et al 1969; 1972; Wehmann et al, 1972).
Some of the above methods, notably the saturation binding
techniques, have provided fairly simple and sensitive adenylate cyclase
assays but again, to a greater or lesser extent, all require the
preparation of other protein/enzyme systems, each fresh preparation
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having to be extensively characterised before use. A high-pressure
liquid chromatographic method for cAMP determination has been described
(Brooker, 1971) but, while eliminating the need for other protein systems,
it required extensive prior purification of samples before chromatography.
Furthermore, all adenylate cyclase assay m'ethods using unlabelled ATP
as substrate suffer from the criticism that the rate of the adenylate
cyclase reaction itself is not being measured. Only the levels of total
cAMP after an incubation are determined and although the two measurements
are unlikely to differ markedly, it is possible that endogenous pools
of cAMP in a tissue could lead to erroneous results, particularly
when attempting to measure low basal activity states of adenylate
cyclase. In order to measure the rate of cAMP production by adenylate
cyclase, it is necessary to use radioactively-labelled ATP as substrate
and determine the amount of radioactive cAMP produced.
There are two major difficulties in assays of this sort.
Firstly, the basal activity of the enzyme is low and only a small
fraction of substrate is converted to product. Secondly, since purifi¬
cation of adenylate cyclase without the loss of regulatory properties
is not yet possible, the enzyme must be assayed in relatively crude
tissue fractions, which contain numerous contaminating ATP-utilising
activities. This necessitates the use of a high concentration of
substrate (0.5-2mM) in order to ensure saturation of all activities,
and since the fractional conversion to cAMP is low, ATP of high specific
radioactivity must be used in a minimal assay volume. Radioactive cAMP
produced must then be separated from a preponderance of radioactive
contaminants and the sensitivity of any assay is therefore dependent
upon the efficiency of cAMP purification. Most of the major possible
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radioactive contaminants resulting from an incubation of a crude












The popular use of^ei- pj ATP as a substrate, stems from the fact
that only phosphorylated contaminants then have to be separated from cAMP,
thereby simplifying the subsequent purification steps.
A major improvement in adenylate cyclase assay techniques
was provided by Krishna et al (1968), who noted that treatment of assay
samples with ZnSO^ /Ba(OH) quantitatively precipitated the vast
majority of adenine-derived compounds leaving cAMP in solution. cGMP
was also precipitated. Adenosine, which was not precipitated,"could
be removed by Dowex-50H+ion-exchange chromatography. Barium ions
however,-are known to catalyse the non-specific formation of cAMP
from ATP (C0ok et al, 1957), a problem which can be overcome by adding
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a slight excess of ZnSO^ to minimise the free Ba++ concentration,
and processing samples rapidly at low temperature (Ebashi et al,1971)
or by prior acid-heat destruction of ATP before the Zn-Ba treatment'
(Nakai and Brooker, 1975)-.
Separation of cAMP by paper chromatographic procedures
(Dousa and Rychlik , 1970; Streeto and Reddy, 1967; Pauk and
Reddy, 1967) and paper chromatography combined with high-voltage paper
electrophoresis (Straub, 1969) has not generally been very successful
and usually involves tedious procedures taking several days to complete.
The most successful adenylate cyclase assays have resulted
from the initial observations of White and Zenser (1971) and Ramachan-
dran (1971) who independently isolated cAMP in a one-step procedure
using columns of neutral alumina. At pH 7.6, the alumina was found
to discriminate between the cyclic nucleotides and most other derivatives
of ATP which are more highly charged at this pH and were retained
on the column. The alumina also discriminated between cAHP and cGMP,
the latter eluting behind cAMP. Thompson et al (1973) reported
several minor modifications to this procedure resulting in greater
reproducibility, lower blanks and enhanced stability of the alumina
columns. However, even with this method, the complete elimination
of radioactivity from reaction blanks was not achieved. Salomon
et al (1974) and later, Wincek and Sweat (1975) were able to achieve
virtually complete elimination of all radioactive contaminants from
cAMP using sequential Dowex-alumina column chromatography, and the
sensitivity of this assay procedure is reflected in its almost
routine use in adenylate cyclase work at the present time. However,
the method does not separate cAMP from neutral contaminants and
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therefore depends heavily on the use as substrate of q> - PjATP
which is both expensive and hazardous to use routinely at the levels
common in adenylate cyclase assay mixtures (up to 10 million cpm.)
For these reasons, in the work reported here, an assay of
as high a sensitivity as possible, and using either [^h] or ["^cJaTP
as substrate, was desired. The method of Keirns et al (1975) involving
the use of [J ATP as substrate and separation of [^hJcAMP by thin-
layer chromatography on polyethyleneimine-impregnated cellulose (PEI—
cellulose), appeared, to separate cAMP from all possible mono- di-
and tri-phosphates as well as neutral contaminants, and was therefore
set up for routine use. Several minor modifications were made to
the method during the course of this work and the procedure is
therefore described in detail in the following sections.
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3.3.2. Assay method
3.3.2.1. Pre-activation of cholera toxin
In some experiments, cholera toxin-was 'preactivated'
essentially as described by Gill (1976b). The toxin solution was
added to a one-tenth volume of activation solution to give final
concentrations of 0.01/5 - 5D5, lOmM-DTT in 50rnM -Tris/HCl, pH 7.4.
After incubation at 25°C or 37°C for 30 mins., one tenth volume of
this solution was added to adenylate cyclase preincubation mixtures
to give the desired final concentration of cholera toxin and where
the final SDS concentration (0.001%) was sufficiently low to have
no effect on adenylate cyclase.
3.3.2.2. Preincubation of adenylate cyclase preparations with cholera toxin
Adenylate cyclase preparations were preincubated with cholera
toxin before assay in the presence of varying concentrations of NAD+,
ATP, DTT, GTP and other additions as indicated in the Results Section
(Ch. 5.). Preincubations were carried out at 25°C or 37°C in a
total volume of 30 - 200p.l and were terminated in one of two ways.
(i) an aliquot of the mixture was removed and transferred
. directly into adenylate cyclase assay medium.
(ii) an excess of the appropriate buffer (Ch. 2.5.1.) at
0°C was added, membranes were precipitated at 1,200g
x 5 min. resuspended in a small volume of buffer, and
aliquots added to adenylate cyclase assay medium.
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3.3.2.3. Adenylate cyclase incubations and assay media.
Adenylate cyclase assays were initiated by the addition
of 15p.l aliquots of preincubation mixtures (Ch. 3.3.2.2.) to lDp.1
of assay medium. After incubation at 25°C pr 37°C, reactions were
terminated by the addition of 5U-1 of 25% TCA, precipitated protein
was removed by centrifugation at l,200g x 10 min, and 10ul of each
supernatant taken for estimation of [] cAMP.
Two different adenylate cyclase assay media were used
during the course of this work.
Medium I:
The final concentrations of components in the 25p.l assay
volume were, 25mM-Tris/HC1, SmM-MgCl^, 5mM-KCl, 5mM-PEP,
0. 5mM-.c AMP, 0.5mM-BMX, ImM-DTT, 0.5 - 2mM-ATP, 0.5-lliCi
of ^8-^hJaTP, 80u,g/ml pyruvate kinase, and 80U'g/ml
adenylate kinase, pH 7.4.
Assay medium was made up by mixing, for each assay, 5ixl
of MgCl -KCl-PEP-cAMP-BMX solution (assay buffer), lul of DTT
•• 3 "1
solution, J^lul of [8- HJATP, lp.l of pyruvate kinase and lul of
adenylate kinase. 10p,l of this mixture were placed in assay tubes
and on addition of 15kH of adenylate cyclase preparation, the final
concentrations indicated above were obtained.
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Medium II:
The final concentrations of components in the 25P1 assay
volume were, 9mM-Hepes, 0.22M-sucrose, 5mM-MgCl , 5mM-PEP,
ImM-DTT, □. ImM-cAMP, □.ImM-BMX, 0.5-lmM-ATP, 80p.M-GTP,
lpCi of [b-^h] ATP, 80p.g/ml pyruvate kinase and 80pg/ml
adenylate kinase, pH 7.4.
Assay medium was made up by mixing, for each assay, 3pl
of PEP, lpl of cAMP-BMX, lpl of DTT, lpl of ATP, lpl of GTP, lpl of
[b-^H J - ATP, lpl of.pyruvate kinase and lpl of adenylate kinase.
10pi of this mixture were placed in assay tubes and on addition of
15pl of adenylate cyclase preparation, the final concentrations
indicated above were obtained.
All solutions in assay medium I were made up in the appropriate
homogenisation buffer (Ch. 2.5.1.) and all solutions in assay medium
II were prepared in Buffer System D (Ch.2.5.1.). The pH was adjusted
to 7.4 with either lM-NaOH or 1M-HC1 using lOpl of 0.2mg/ml phenol red
per ml of solution as an internal indicator. ATP and DTT solutions
were made up fresh prior to each assay and all other solutions were
made up fresh at regular intervals of 2-3 weeks and stored at -20°C
when not in use.
3.3.2.4. Purification off^HlcAMP
[^PljcAMP produced during assay was separated from other
radioactively labelled contaminants by two-solvent descending thin-
layer chromatography (TLC) on polyethyleneimine-impregnated cellulose
(PE I-cellulose) essentially as described by Keirns et al (1974).
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Preparation of TLC plates
A stock solution of 1$-PEI was made up by dissolving 20g
of commercial 50%-PEI in about 700 ml of water, adjusting to pH 6.0
with concentrated HC1, and diluting to 1 litre with distilled water.
20 cm x 50 cm glass plates, used as the support for the thin-layers,
were cleaned before use with 95$ ethanol, rinsed in distilled water,
and dried with a clean towel.
For each plate to be coated, lOg of cellulose micro-
crystalline (Merck) were suspended to a volume of 60 ml in 1% PEI-
solution, and after stirring the suspension for 1 hour the plates
were coated (50 ml of PEI-cellulose/plate) to a layer thickness of
0.3 mm using an automated TLC spreader leaving the top 10 cm of
each plate uncoated. The plates were allowed to dry at room
temperature on a level surface overnight.
After drying, the edges of each layer were trimmed 1 cm
inwards, twelve 1.5 cm-wide channels were cut lengthwise using the
edge of a spatula, and the bottom of each layer was cut in a saw¬
tooth design to ensure even flow of solvent off the ends of the layers.
Plates were wrapped in aluminium foil and stored at toom temperature
for no more than 1 month before use.
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Development of thin layers
10 P-l aliquots from adenylate cyclase assay supernatants
were applied, with drying, 3 cm from the top of each thin layer
(12 samples/plate) . 5P'l of a solution containing lOmM-cAMP and 2-5
nCi of ^adenine U- c]cAMP were applied along with each sample, the
unlabelled cAMP allowing visualisation of cAMP spots under short-wave
fl4 1
ultraviolet light, and the I CI- cAMP enabling calculation of per-cent
recovery of each sample from the thin l'ayer.
A piece of filter paper (20 cm x 15 cm) was wetted with
Solvent I (Methanol: lM-ammonium acetate, 5:2) and placed on top
of each plate overlapping the layer by about 5mm. Polyethylene solvent
troughs were attached to the plates withperspex screw-clips and the
paper wick folded back inside the trough as illustrated in Fig. 3.6.
The plates were placed upright in large chromatography tanks, the
solvent troughs (Capacity: 30 ml) were filled with Solvent I, and
descending development was allowed to proceed in a sealed atmosphere
for 6-8 hours by which time the solvent front had travelled about
20 - 25 cm down the layers.
The plates were removed, solvent troughs detached, and the
layers dried with a hot air blower. cAMP spots were visualised
under short-wave ultraviolet light, a line was scratched about 1 cm
behind the cAMP spots with the edge of a spatula, and the entire area
of the layer behind this line was shaved off and discarded. The plates
were re-wicked as above (the wick overlapping the layers by about 2mm) ,
and descending development was continued for 12 - 16 hours in Solvent II
-86-
A B
Fig.3.6. Apparatus for descending PEI-cellulose thin layer chromatography.
A: Side view.
B: Front view.
1: Glass plate support.
2: Thin layer.
3: Perspex solvent troughs.
4: Filter paper wick.
5: Perspex screw clips.
(n-Butanol: Acetic acid : H^O, 2:1:1). During this stage the solvent
front was allowed to flow off the ends of the layers.
Plates were finally removed, solvent troughs detached, the
layers dried in an oven at 50°C and the positions of the cAMP spots,
seen under short-wave ultraviolet light, were marked with the edge of
a spatula.
3.3.2.5. Recovery of cAMP from thin la'yers and counting conditions
The area of the cAMP spot in each channel was shaved off
with the edge of a spatula and PEI-cellulose scrapings were sucked
directly into scintillation vials using an apparatus connected to a
water pump similar to that originally described by Bjork and Svensson
(1967) and illustrated in Fig. 3.7. Each vial contained 2 ml of 25mM-
MgSO^ acting both as a trap for the cellulose particles (preventing
losses through the outlet tube) and as a solubiliser, eluting cAMP
from the PE I-cellulose particles. The presence of 2 ml of aqueous
medium in each vial, necessitated the use of an unusual scintillation
fluid which was capable of accepting large volumes of water, and the
xylene-triton X-100- based mixture of Fricke (1975), described in
Ch.2.7.1., was found to be suitable. After addition of 10 ml of
scintillator, vials were counted on the double isotope programme of




Fig.3.7. Apparatus for removing PEI-cellulose particles into
scintillation vials.
1: Scintillation vial.
2: 2ml of 25mM-MgS04.
3: Glass plate support.
4: Thin layer.
5: Plastic tubing.
6: To water pump.
7: Rubber seal.
B: Glass tubing.
3.3.3. Characterisation of Assay Method
3.3.3.1. Use of Searle Mk. Ill liquid scintillation spectrometer
All adenylate cyclase assay samples were counted in the
Searle Mk. Ill liquid scintillation spectrometer using the double
isotope programme in the variable quench mode, in which optimum
discriminator settings for each sample are established automatically
prior to commencing counting. Before use the counter was programmed
with sets of quenched and[ "^CJ standards as described in Ch. 2.7.3.
[^h]cAMP and ["^clcAMP standards made up under adenylate cyclase
assay conditions (ie the isotopes adsorbed onto PEI-cellulose
particles in vials before addition of 2 ml of 25mM-Mg50^ and 10ml
of scintillator) were readily recognised by the counter as being[^Hj
fl4 1and I Clstandards. Thus despite the complex nature of the assay
samples the quenfch correction data stored in the counter's memory
were sufficient to enable recognition of the isotopes under cyclase
assay conditions and the inclusion of a new programme specifically
for these samples was unnecessary.
3.3.3.2. Solubilisation ofcAMP from PEI-cellulose particles
In order to ensure consistent detection of all radioactivity
in assay samples, it was necessary to acheive complete solubilisation
of cAMP from PE I-cellulose particles thereby enabling the nucleotide
to be counted free in solution after allowing cellulose particles to
settle. 25mM-MgS0^, as suggested by Keirns et al (1974) was chosen
as the solubilising agent and it's ability to elute cAMP bound to PEI-
was investigated as described below.
Two series of vials were prepared, all containing 50mg. of PEI-cellulose
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particles, [b - ^hJcAMP ( ~ lOOnCi) or ^adenine U-^Cj cAMP (~20 nCi)
were placed directly on the cellulose particles from a 50p.l inicrosyringe
and allowed to dry at room temperature. Increasing volumes (up to 5 ml)
of 25 mM-MgSO^ were added and mixed, followed by 10 ml of scintillator
and all vials were counted for 10 min. in the double-isotope programme
of the Searle Mk. III. Identical series of vials, containing the same
amounts of radioactive cAMP free in solution in the absence of PEI-
cellulose particles, were also prepared for each isotope and counted
as above.
As shown in Fig. 3.8. both [ J and counting efficiencies
decreased linearly with increasing volumes of Mg50^ solution, either
in the presence or absence of PE I-cellulose particles. Efficiencies
in the presence of cellulose were always about 2% lower than those in
the absence of cellulose for both isotopes. The corresponding d-. p.m.
values obtained for these samples are illustrated in Fig. 3.9. When
cAMP was free in solution, addition of a small volume of MgSO^ eluant
(0.5-lml) caused a marked decrease in observed d.p.m. for both isotopes,
the count rate being regained upon further addition of eluant. When
2 - 5 ml of MgSO^ were present in each vial, d.p.m. values did not
vary significantly and were equal to the observed d.p.m. in the absence
of eluant. When either [^hljor ["^cJcAMP was adsorbed to PE I-cellulose
particles, very few counts were detected in the absence of MgSO^.
Addition of as little as 0.5 ml of MgSO^ caused the majority of
counts to be solubilised and for both isotopes, solubilisation was
maximal after addition of 1 ml of MgSO^. Further addition of eluant
had no further effect. For [ ^FljcAMP solubilised from PE I-cellulose













Fig.3.8. Decrease in [ Hi and f C~]c AMP counting efficiency with
increasing volumes of 25mM-Mq50^ solution.
Scintillation vials contained 100nCi of [8- H]cAMP (O,®)"or
1 4
20nCi of [adenine U- C^cAMP (□,!!), either adsorbed to 50rng of PEI-
cellulose particles (©,E3) or free in solution (0,D). The indicated
volumes of 25mM-Mg50^ were added followed by 10ml of scintillator and
vials were counted for 10 min. All values were single determinations c
0 1 2 3 4 5
ml MgSO^/vial
1 14F i g. 3.9. Effect of 25mM-Mq5D on the count rate of f Hi and f C~|cAMP
in the presence and absence of PEI-cellulose.
3Scintillation vials contained 100nCi of [8- H]cAMP (D,®) or
1 4
20nCi of [adenine U- C]cAMP (O , ©), either adsorbed to 50mg of PEI-
cellulose particles (®%E3) or free in solution (0,D). The indicated
volumes of 25mM-MgS0^ were added followed by 10ml of scintillator and
vials were counted for 10min. All values were single determinations only.
ri4 inucleotide free in solution, but for [ CJ cAMP, d.p.m. values
after maximal solubilisation from PEI-cellulose were always significantly
greater than those observed for the nucleotide free in solution. This
observation (similar to that seen with [adenine U-^cj NAD+ on
Whatman GF/C filters: Ch. 3.2.3.1.) is more'clearly illustrated in
the following sections and is discussed in Ch. 3.4.
3.3.3.3. Recovery of [^h] and ["^cjcAMP from PE I-cellulose Particle s
The results presented above indicated that 2 ml of 25mM-Mg504
per 10 ml of scintillator was able to elute cAMP quantitatively from
PEI-cellulose particles while at the same time giving acceptable
counting efficiencies of 22% and 55% for [^h] and [ respectively.
The validity of this conclusion was tested by adsorbing increasing
amounts of either [8 - ] cAMP or [adenine U-^^C ]cAMP to 50 mg of
PE I-cellulose particles in scintillation vials and adding 2 ml of 25rnM-
MgSO^ and 10 ml of scintillator as above. An identical series of vials
for each isotope containing the radioactive cAMP free in solution was
also prepared, and all vials were counted on the double isotope
programme of the Searle Mk. Ill for 10 min.
Fig. 3.10. shows that for [ ^hJ cAMP, identical d.p.m. values
were recorded whether the nucleotide was free in. solution, or whether
initially adsorbed on PEI-cellulose particles and subsequently eluted
r 14 1
with 2 ml of 25 mM-MgSO^i Although CJcAMP, as noted above, produced
higher count rates after adsorption and elution from PEI-cellulose
(fig. 3;11.), under both conditions there was a linear increase in
d.p.m. values with increasing amounts of isotope added.
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3
Fig.3.10. Recovery of £ HlcAMP from PE I-cellulose particles.
Scintillation vials contained increasing volumes of 10uCi/ml
3
£8- H^cAMP either free in solution (O O) or adsorbed to 50mg of PEI- •
cellulose particles (© ®) . ^ml of 25mM-MgS0 were added followed by 10ml
of scintillator and vials were counted for 10min.
pl[ C]cAMP/vial
1 4
Fig . 3.1 1 . Recovery of f L'lcAMP from PEI -cellulose particles.
Scintillation vials contained increasing volumes of [adenine U-
1 4
C]cAMP either free in solution (O—©) or adsorbed to 50mg of PEI-
cellulose particles (©•—-©). 2ml of ZSmM-MgSD^ were added followed by
10ml of scintillator and vials were counted for 10rnin.
3.3.3.4. Effect "of PE I-cellulose particles on [^HJ andl ^Cjcountinq
characteristics.
The experiments described above were conducted with a
constant amount (50 mg) of PEI-cellulose particles in each vial.
Although possible, it would be extremely laborious to ensure that*
in routine assays, all vials contained exactly the same amount of
cellulose particles. The effect of varying the content of PEI-
cellulose over a wide range was therefore studied.
Series of vials were prepared containing either [ 8-^H j cAMP
(~100 nCi) or [adenine U-^^CJcAMP (^ 20 nCi) adsorbed to increasing
amounts (0-100 mg) of PEI-cellulose particles in scintillation vials.
2 ml of 25 mM-MgSO^ were added followed by 10 ml of scintillator and
vials were counted for 10 min. in the double isotope programme of the
SearleMk. III.
Counting efficiencies for [ ] and [^cJcAMP were found to
vary in a similar fashion (Fig. 3.12.) with each displaying a curious
peak at 20 mg of cellulose per vial. The corresponding d.p.m. values
(Fig. 3.13) indicated that the amount of PEI-cellulose present had
little effect on [J cAMP counting and the recorded d.p.m. were
similar at all amounts of cellulose-tested. The counting characteristics
f 14 1of I CI cAMP however varied in a complex fashion with PEI-cellulose
quantities. As little as 10 mg of cellulose per vial was sufficient
to cause the apparent increase in count-rate noted earlier and from
20-100 mg of cellulose per vial,d.p.m. values decreased gradually at
a rate of about 40 d.p.m. mg of cellulose added. These observations
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mg PEI-cellulose/vial
Fig.3.12• Effect of PEI-cellulose particles on the counting efficiencies
□ f f3Hl and |"^E*1cAMP.
Scintillation vials contained 10OnCi of £8- H]cAMP (O—O) or
10nCi of [adenine U-^CjcAMP adsorbed to the indicated amounts of
PEI-cellulose particles. 2ml of 25mM-MgSO^ were added followed by 10ml of
scintillator and vials were counted for 10min.
0 20 40 60 80 100
mg PEI—cellulose/vial
Fig.3.13. Effect of PEI-cellulose particles on the count rate of
f3Hl and f^ClcAMP.
3
Scintillation vials contained 100nCi of [8- H]cAMP (O—O) or
1 4
10nCi of [adenine U- CjcAMP (©—@) adsorbed to the indicated amounts
of PEI-cellulose particles. 2ml of 25mM-MgS0^ were added followed by
10ml of scintillator and vials were counted for 10min.
3.3.3.5. Simultaneous determination of [^H ] and ["^cjcAMP.
The counting conditions determined above for [ J and [~^c]
counting in separate vials were tested for their suitability in
measuring both isotopes simultaneously in the same vial. Solutions
of the two isotopes were mixed in equal amounts to give a solution
which was approximately 5nCi/10W in [ J cAMP and 1 nCi/lOpl
in [~^C J cAMP. Increasing volumes of this mixture (0-100pl) were
adsorbed onto 50 mg of PE I-cellulose particles in scintillation
vials, 2ml. Df " 2 5rnM-Mg50^ were added followed by 10ml. of scintillator,
and vials were counted for 1Omin.
Fig. 3.14 shows that, for both isotopes, a linear increase
in d.p.m. values was'obtained with increasing volume of double-isotope
mixture added and the conditions were therefore considered to be
suitable for the simultaneous determination of [^h] and [ ^cjcAMP
in adenylate cyclase assay samples.
3.3.3.6. Migration of cAMP on PE I-cellulose TLC plates
In routine work, adenylate cyclase assay samples were applied
r 14 i
to TLC plates along with I adenine U- CI cAMP and unlabelled carrier
cAMP, and the position of cAMP after development of the chromatograms
was determined by visualisation of the carrier under short-wave
ultraviolet light. To ensure that this was a valid procedure a
mixture of [ "^H J cAMP (~ 2 50 nCi) and cj cAMP (~ 50 nCi) were
applied to a TLC plate along with 5pd of 10 mM-cAMP and after
development in Solvent I as described in Ch. 3.2.2.4., 1 cm- long
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Fi g. 3.1 4. Simultaneous counting of f^Hl and f^FlcAMP under adenylate
cyclase assay conditions.
Scintillation vials contained increasing amounts of both
[B-3H]cAMP and [adenine U-^C]cAMP adsorbed to 50mg of PEI-cellulose
particles. 2ml of 25mM-Mg50^ were added followed by 10ml of
scintillator and vials were counted for 10min,
and counted as described in Ch. 3.2.2.5. After development in
Solvent II, the position of cAMP under ultraviolet light was noted
and the remainder of the chromatogram was cut out and counted as
above. (Fig. 3.15. )
Both [J and [^CJ cAMP comigrated with unlabelled
carrier cAMP in the complete two-solvent system. In solvent I,
cAMP was visualised between values 0.49-0.58. The Rf value
of cAMP in Solvent II could not be calculated since in this system,
/
the solvent front is allowed to flow off the end of the layer overnight.
The total d.p.m. recovered from the plate was 788,031 for [ J and
T14 1
83,949 for | C I and since a duplicate aliquot of the mixture applied
to the plate adsorbed directly onto PEI-cellulose in a scintillation
vial and counted as described in Ch. 3.2.2.5. gave 804,739 and 87,746 d.p.m.
for [J and [~^c] respectively, the total recovery of counts from
theplate was 98$ for [ J and 96$ for [ ~^C J cAMP.
ATPA similar experiment in which an aliquot of £ 8- H ]
was applied to a TLCplate and developed in Solvent I only, indicated




















Fig.3.15. Migration of f^Hl and [^ClcAMP with unlabelled cAMP on
PEI-cellulose thin layers.
3 14
[B- H^cAMP (25QnCi) and [adenine U- C]]cAMP (50nCi) were
applied to a TLC plate along with 5P-1 of 10mM-cAMP as described in
Ch.3.3.2.4. After development in both solvents, 1cm-long segments of
3 14
the layer were cut out and counted for [ Hj and [ C].
0: origin.
E: end of layer.
511: start of solvent II.
1 and 2: positions of unlabelled cAMP after development in solvents
I and II respectively.
0 4 8 12 16 20
Distance (cm)
Fig.3.16, Migration of ATP in solvent I on PEI-cellulose thin layers.
3
50nCi of [8- H]ATP in a volume of 10p.1 containing 5mM-
unlabelled ATP was applied to a PEI-cellulose thin layer and
developed in solvent I as described in Ch. 3.3.2.4. After drying,




The NADase assay method described in Ch. 3.1. was both rapid
and easily performed and DE-81 paper chromatography provided a clear
separation of both hydrolysis products of NAD+ (nicotinamide and
ADP-ribose) from each other and from unreacted NAD"1 . The data in
Fig. 3.1. indicate that NADase activities could theoretically be
r 14 1 + r 14 i +
measured with either I carbonyl- CI NAD or [adenine U - CI NAD
f14 1 f14 T
by determining production of I CI nicotinamide or I CI ADP-ribose
respectively. This was in fact confirmed experimentally (results
not shown) and estimation of ADP-ribose production could be facilitated
by increasing the concentration of formic acid in the developing
solvent from 0.12M to 0.3M which resulted in NAD+ and nicotinamide
both migrating near the solvent front leaving ADP-ribose with an R.p
of about 0.3 - 0.4. For routine work however, the less expensive
14 i +
carbonyl - CI isotope of NAD was employed.
[ ~^C ] counting characteristics were not altered when NAD+
was adsorbed to DE-81 paper (Fig. 3.2.) and the only potential draw¬
back of the method was the instability of NAD+ on the paper (Fig. 3.3.)
In practise, however, this was not a serious disadvantage since, in
most experiments, all samples were chromatographed simultaneously
immediately after application to the strips. In assays with large
humbers of samples however, when strips were chromatographed in
batches of 20-40, corrections for non-specific breakdown on DE-81
paper were made by including a duplicate blank assay for each batch.
This procedure was justified by the linearity of NAD+ breakdown with
time in Fig. 3.3. and NADase activities of enzyme samples were identical
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after appropriate blank subtraction, between samples chromatographed
immediately and samples chromatographed several hours after
application to the strips.
The ADP-ribosyltransferase assay method described in Ch. 3.2.
was also easily performed and efficient removal of non-covalently
attached [ ~^C ] material from protein - [ ~^C j ADP-ribose complexes
was achieved with 2 x 20 ml washes of the sample on GF/C filters,
(fig. 3.6.) As the results in Fig. 3.6. indicate, assay sensitivity
(blank approaching zero) was related to the number of washing steps
performed, but since little increase in sensitivity was obtained with
more than 2 washes, and since physical damage to the filters
sometimes occurred after repeated washing, filters were routinely washed
with 2 x 20 ml aliquots of 5% TCA in the work reported here.
Unlike the counting characteristics of [ ^C ] NAD+ on DE-81
chromatography paper, adsorption of [ ~^C JNAD+ on GF/C filters
results in an apparently more than quantitative recovery of d.p.m.
from the filters (Fig. 3.4.) This was most likely an artifact of
the counting method employed. During computation of d.p.m. values
by the Searle Nik. Ill, several quantities are taken into account,
including the number of counts appearing in the tritium channel and
the resulting calculated channels ratio. In the presence of GF/C
filters, counts in the tritium channel were always higher, leading
to a decrease in the channels ratio. Apparently therefore, the
r 14 i
emission spectrum of I Cl adsorbed to GF/C filters has been distorted
slightly causing a greater proportion of counts to appear in the
tritium channel. Because of this, the counter will automatically
set new discriminator and attenuation levels and since all of these
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factors are accounted for in calculating the d.p.tn. values, this
may result in the apparent observed increase in count-rate. Since
f 14 1
d.p.m. increased linearly with amount of I CI added to the filters
(Fig. 3.4.) this is not a- serious complication in itself but it
does emphasise the importance of preparing standard vials under
identical conditions to those prevalent in the experimental vials.
Only then can a standard vial be used for direct calculation of number
of d.p.m. added to each assay in an experiment.
The presence of precipitated protein, even in large amounts,
had no effect on the observed count rate of [NAD+ on GF/C filters
(Fig. 3.5.).and the method was therefore suitable for estimating
1*14 1
j C IADP-ribose incorporation into proteins under conditions where
the amount of protein applied to filters is not necessarily constant.
The adenylate cyclase assay method described in Ch. 3.3.
involved the use of £ 8 - H J ATP as substrate with subsequent
purification of [8-^hJcAMP on PEI-cellulose thin layer chromatograms.
Previous attempts to purify c AMP by TLC methods were not always
successful and the systems used were often not well characterised.
Bar and Hechter (1969 ) described purification of cAMP on PE I-cellulose
thin layers but because only a one-dimensional run with one solvent
was used, the authors were forced to employ [ - ^pJ- ATP as substrate
in order to minimise radioactive contamination. Dinghe et al (1969)
using silica gel TLC reported separation of cAMP from only ATP, ADP,
5'-AMP and adenosine. Similarly Upton (1970) who used the tendency
of borate ions to form complexes with the 2', 3'-cis dial grouping
an simple sugars, developed a method for cAMP purification on
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tetraborate-impregnated silica gel thin layers, but again separation
of cAMP from only a small number of contaminants was reported.
Shimizu et al (1969) also used silica gel TLC and described separation
of cAMP from a larger number of compounds but separation from guanine
and hypoxanthinewas not achieved. The method was suitable for work
on brain tissue which lacks the enzyme adenine deaminase, but
would be of limited use with other tissues containing this activity
such as rat liver. Woods and Waitzman (1970) have also described
purification of cAMP by TLC on a silicic acid-glass microfibre
matrix.
A major reason for adopting the PEI-cellulose TLC method of
Keirns et al (1974) in this work, was the extensive characterisation
of the system carried out by these workers, who demonstrated separation
of cAMP from virtually all possible contaminants arising in an
adenylate cyclase assay. Development of the layers with Solvent I
(Methanol : lM-ammonium acetate, 5 : 2), left the highly charged
polyanionic- species ATP, ADP, ETP, GDP (and although, not described,
probably also ITP and IDP) at or near the origin owing to their high
affinity for the polycationic PE I matrix. 2'-AMP, 2'-deoxy-AMP,
3' -AMP, 2 ' -GMP, 2 tleoxy 5'-GMP, 3'-GMP, 5'-GMP and IMP were also
significantly retarded and migrated with a lower R^. than cAMP. All
of these major contaminants were therefore discarded by removing this
part of the layer after Solvent I development.
The neutral contaminants adenosine, 2 ' - deoxyadenosine,
hypoxanthine, adenine, inosine, guanine, guanosine, 2'-deoxyguanosine,
and xa'nthosine, which all migrated with similar or slightly greater
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R^. values to that of cAMP in Solvent I were carried well ahead of
cAMP in Solvent II (nButanol : Acetic acid: H^D, 2:1:1) which also
served to separate cAMP from such closely related compounds as
2'-deoxy cAMP, 21,3'—cAMP, cGMP, and 2,'3' - cGMP. The only other
possible major contaminant not described, xanthine, probably
migrates in a similar fashion to adenine and guanine as a result of
its structural similarity to these compounds.
Since cAMP was therefore show'n to be separated efficiently
from all major contaminants, characterisation of the separation system
was not repeated here and it was only considered necessary to check
the migration of £ J ATP in Solvent I and of cAMP in Solvents I and
II. As shown in Fig. 3.16[ ^H ] ATP remained at the origin during
Solvent I development and cAMP, [ H j cAMP and [~^cj cAMP all co-
migrated in the complete two-solvent system (Fig. 3.15).
However, it was essential to characterise fully the counting
conditions for[ ] and [ "^cJcAMP after removal of samples from the
TLC plates. Elution of both isotopes of cAMP from PEI-cellulose
particles was complete when 1 - 2 ml of 25mM-Mg5D^ were added to the
particles in a vial and gently shaken for a few seconds before addition
of scintillator' (Fig. 3.9.). The low affinity of cAMP for PEI-
cellulose was therefore of great advantage and the use of more
complicated and tedious elution methods (Randerath, 1967) was unnece¬
ssary. A small volume of MgSO^, although probably sufficient to
solubilise cAMP produced a cloudy precipitate on addition of 10 ml
of scintillator and the loss of counts noted with radioactive cAMP
.free in solution under this condition (Fig. 3.9.), was probably due
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to a proportion of the cAMP being out of solution in the heterogeneous
mixture. Addition of more MgSO^ caused the mixture to become clear
again and on addition of 3 - 5 ml, a semi-solid gel state was obtained
There was therefore an optimum aqueous volume of 1 - 3 ml of MgSO^
solution per 10 ml of scintillator and in routine assays, 2ml was
employed.
With 2 ml of 25mM-Mg50^ per 10 ml of scintillator, 'recovery
of [^H ]cAMP from PEI-cellulose was quantitative but recovery of
[~^C JcAMP was apparently more than quantitative (figs. 3.10 and 3.11
respectively). This is a completely analogous phenomenon to that note
[14 I +C J NAD on GF/C filters and can be explained in the
r 14 1
same way as discussed previously. Since the only purpose of I C J -
cAMP in this system was to monitor recoveries from the TLC plates, the
absolute d.p.m. values were not of great importance. It was sufficien
merely that d.p.m. increased linearly with increasing amounts of
[~^C JcAMP initially adsorbed to PEI-cellulose and as Fig. 3.11. shows
this relationship was obtained. However, it was essential that for
r 14 1
each experiment, an aliquot of the I CJcAMP solution applied to the
TLC plates along with each assay sample, was adsorbed to PEI-cellulose
particles in a vial and then eluted and counted as for all other
samples. This standard vial could then be used as a true estimate of
100% recovery to which all other experimental samples could be related
ri4 T
[ C I cAMP counting characteristics varied also with the
relative amount of PEI-cellulose particles present (Fig. 3.13.)' The
'increase' in count-rate observed initially by adding cellulose was
progressively reduced on addition of more cellulose between 20 - lOQmg
per vial. This corresponds to a decrease in count-rate, relative to
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the peak rate at 20 mg/vial, of about 0.15$ per mg of cellulose
added, and was a potentially more serious complication since it would
be extremely difficult and tedious to ensure that all vials in an
experiment contained exactly the same amount of PEI-cellulose particles.
However by cutting out an equal area of TLC, plate for each sample in
an experiment, the amount of cellulose in each vial did not vary by
more than a few milligrams and was usually about 15-20 mg per vial.
In this region count rate is independent of the amount of PE I-cellulose
and should any particular vial contain significantly more cellulose,
a reduction in count-rate of 0.15$ per mg of cellulose would only
cause a decrease of 7-14 d.p.m for each additional mg of cellulose,
14
(5,000 - 10,000 d.p.m. of C cAMP were routinely applied to TLC
x T 14 T
plates;. Errors due to the complex counting characteristics of I CI
cAMP were therfore considered to be insignificant and with appropriate
standards and adequate precautions, its use as a monitor of TLC
recoveries was judged to be valid. [1 cAMP counting characteristics
were not altered significantly in the presence of varying amounts of
PE I-cellulose particles (Fig. 3.13.)
The method therefore appeared to be suitable for quantitative
adenylate cyclase assay determinations and had several distinct advantages
over other existing methods. The PEI-cellulose layers were themselves
inexpensive and easily prepared, and the ability to analyse 12 samples
per TLC plate enabled many aamples to be handled without great technical
difficulty. Pre-washing of the thin layers as described by Randerath (1967),
a long and tedious procedute for the large plates used in this assay,
was found to be unnecessary. Presumably, washing would be of greater
importance when samples were to be eluted and estimated by U.V. absorption
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ATP can
when impurities on the layers may cause interference.
A major advantage of the method is that[8-^hj-
be used as substrate since, although the number of possible contaminan
is maximal with this isotope, the purification system is sufficiently
sophisticated to eliminate all of the major charged and neutral
contaminants. The use of [^h] ATP, rather than[o< - ^p]aTP makes the
method both considerably less expensive and much less hazardous to
use routinely. The long half-life of[^hjover that of[ pjis also
advantageous since samples can be left for long periods if necessary
before counting,and corrections for decay of any particular batch
of ATP during use are unnecessary. •
As. noted earlier the sensitivity of a radioactive adenylate
cyclase assay is increased by incubating with high specific radio¬
activity ATP in as small a volume as possible. Since a maximum of
ID ii.1 is required for application to TLC plates, assays can easily
be carried out in very small volumes (25ul or less) and aliquots
taken directly for analysis in a concentrated form, without the need
for dilution and the errors involved therein, before application to
columns etc.
Assay sensitivity is proportional to the levels of d.p.m.
in the blanks and sensitivity is therefore maximal as the blank
approaches zero. Using [ q< - ^p} ATP as substrate with purification
of cAMP by sequential Dowex-alumina chromatography, assay blanks
equivalent to only 0.0002/6 of the total [^P ] substrate added were
reported (Salomon et al, 1974). In the method described here blank
values varied from 0.0025 to 0.01/6 of the total Jsubstrate added
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and although the technique was th'erefore at least 10 times less
sensitive than the method of Salomon and coworkers, it was considered
to be adequate for this work, where low basal activities of adenylate
cyclase were compared with the usually much greater activities
after cholera toxin treatment.
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Chapter 4. Purification of cholera toxin
4.1. Introduction
Finkelstein and LoSpalluto (1969) were the first workers
to report the production of purified cholera toxin. After growing
the highly toxigenic 569B Inaba strain of V.cholerae in multi-litre
fermenter cultures on a synthetic medium supplemented with casamino
acids (syncase medium), cholera toxin was isolated from the culture
filtrate by ammonium sulphate fractionation, DEAE-cellulose column
chromatography, and gel filtration on columns of Agarose A-5m and
Sephadex G-75. The final gel filtration step consisted of two
columns linked in series and served to separate whole cholera toxin
from choleragenoid. The same workers then reported several modifications
to the method which enabled an improvement in yield (Finkelstein
and Lo5palluto, 1970) and which included the substitution of several
ultrafiltration steps in place of the ammonium sulphate and DEAE-
cellulose .chromatographic steps in the original method. The toxin
isolated by this method was homogeneous as judged by gel filtration,
immunoelectrophoresis, ultracentrifugation, ion-exchange chromatography,
and immunologic criteria (Finkelstein and LoSpalluto, 1969).
It is of interest to note that the purification of cholera
toxin was facilitated by the anomalous behaviour of the toxin on
gel filtration media. On Agarose A-5m for example, the toxin behaved
as if it had a molecular weight of less than 20,000 daltons and this
property enabled an easy separation of toxin from all other proteins
of similar molecular weight. The same property was also of great
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use in the purification scheme described in this report (see
Ch. 4.2.3.).
The quality and yield of the cholera toxin obtained by
the purification method of Finkelstein and LoSpalluto is reflected
in the almost universal use of toxin prepared in this way in cholera
research. However the method involves the use of several large scale
column chromatographic steps including a double gel filtration step
on Sephadex G-75, during which excessive dilution of toxin fractions
will occur. For this reason the method is best suited to the
purification of cholera toxin from large amounts of starting material.
Since the amount of material available for this work was limited, a
simpler purification scheme with fewer stages was desirable. As
described below, it proved possible to isolate cholera toxin which
was homogeneous as judged by 5D5-polyacryiamide gel electrophoresis,
with a three-step purification method involving ammonium sulphate
fractionation, ion-exchange chromatography on DEAE-cellulose, and
gel filtration on Ultrogel AcA-44.
4.2. Results
The results presented below are taken from a representative
example of a toxin purification. Results obtained in all other
purifications were similar although there were some variations between
different batches of crude starting material (see Ch. 4.3.).
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4.2.1. Ammonium sulphate fractionation.
A preliminary experiment was conducted on a small scale
to determine the optimum conditions for precipitation of cholera
toxin by ammonium sulphate from culture filtrates of V. cholerae.
I
1 ml of the crude toxin supernatant obtained as described in Ch.2.1.
was made 30$ of room temperature saturation in ammonium sulphate
and after 2D min. of stirring, precipitated protein was recovered
by centrifugation and resuspended in 0.5 ml of 50mM-Tris/HCl, pH 7.4.
Ammonium sulphate was then added to the supernatant to a final
concentration of 40$ of room temperature saturation and the procedure
was repeated. In this way, resuspended precipitates from 0-30$,
30-40$, 40-50$, 50-60$. 60-70$, 70-90$, and supernatant from the
final fractionation step were obtained and all were tested for
antigenicity against cholera anti-serum as described in Ch. 2.2.1.
Cholera toxin was detected
40-50$ and 50-60$ f ractiona
was therefore indicated for
large-scale purifications,
precipitated in the 0-30$ f
step could be omitted and a
decrease the puritiy of the
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in the precipitates from the30-40$,
tions and a 30-60$ ammonium sulphate cut
the precipitation of cholera toxin in
However since the amount of protein
ractionation was almost negligible this
direct 0-60$ fractionation did not
final cholera toxin product.
4.2.2. DEAE-cellulose chromatography
Conditions for the elution of cholera toxin from DEAE-
cellulose were established initially on a small scale by the
application of 1 ml of crude toxin supernatant to a small column
of DEAE-cellulose in a Pasteur pipette equilibrated in 50mM-Tris/HCl,
pH 7.4. The column was eluted with 3 x 1 ml portions of the same
buffer containing 5,10,50,100,250, and 500 mM-NaCl and 1 ml fractions
were collected, all of which were tested for antigenicity against
cholera anti-serum as described in Ch. 2.2.1. Cholera toxin appeared
in three of the column fractions corresponding to elution with SOmM
(two fractions) and 100 mM (one fraction) NaCl, and for large scale
purifications, a linear 0-100mM-NaCl gradient was therefore employed.
The results of a large-scale elution from DEAE-cellulose
of the toxin-containing fraction from ammonium sulphate treatment,
are shown in Fig. 4.1. which illustrates the fortuitous phenomenon
that the majority of the contaminating proteins in the preparation tend
to adhere tightly to DEAE-cellulose at pH 7.4 and are only eluted
with a 200mM-NaCl wash after elution with the gradient. In contrast,
cholera toxin eluted in a low, broad peak near the beginning of the
gradient and these fractions were pooled and concentrated as described
in Ch. 2.1.2.
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Figure 4.1. Elution of cholera toxin from DEAE-cellulose
Cholera toxin-containing fractions after ammonium sulphate
fractionation were dialysed against 50mM-Tris/HC1, pH 7.4 and applied
to a colonn (2.5 cm x 7 cm) of DEAE - cellulose equilibrated in the
same buffer. Elution was performed at a flow rate of 20. ml/hr
with a linear 0 - 100 mM-NaCi gradient and 3 ml-fractions were collected.
The arrow indicates the end of the linear NaCl gradient and the
commencement of a 200rnM-l\laCl wash. Cholera toxin (shaded bar)
was detected in the column fractions as described in Ch. 2.2.1.
Fraction number
4.2.3. Gel filtration on Ultroqel AcA-44
Prior to use, a column (2cm x 92 cm) of Ultrogel AcA-44
(molecular weight range: 12,000-130,000) was set up, equilibrated
in O.IM-Tris/ HC1, O.lM-NaCl, pH 7.4, and characterised for molecular
weight determinations as summarised in Figs. 4.2. to 4.4.
For determination of the included and excluded volumes a
mixture of blue dextran and DNP-lysine was passed through the column
and as Fig. 4.2. shows, the void volume (VD) was calculated to be
87.4 ml while DNP-lysine eluted in a total excluded volume of 273.6ml.
The latter value agrees well with the total column volume (V )
calculated from the dimensions of the column, which was 289 ml.
The column was then calibrated with a mixture of three
standard proteins; bovine serum albumin (68,000 daltons), ovalbumin
(43,000 daltons), and soya bean trypsin inhibitor (21,000 daltons).
The results in Fig. 4.3. illustrate that the three proteins were
eluted as three distinct peaks with elution volumes (Ve) of 120, 142.5,
and 172.5 ml respectively. The small peak of A2BQ-absorbing material
eluted in the void volume was presumably due to contaminants in the
standard protein preparations. Using these data, a linear relation¬
ship was obtained between log of molecular weight and elution volume
(as a percentage of the total column volume) and the standard curve
shown in Fig. 4.4. was useful for the determination of molecular
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Figure 4.2. Elution of a mixture of Blue Dextran and DNP-Lysine
from UltroqelAcA - 44.
A few milligrams of Blue Dextran were dissolved in O.IM-Tris/
HC1, O.lM-NaCl, pH 7.4 and filtered. DNP-lysine was then added to
the solution until a bright green colour was obtained and 2 ml of the
/
mixture were applied to a 2 cm x 92 cm column of Ultrogel AcA-44 equilibrat
in the same buffer. Elution was carried out overnight at a flow rate
of 5.B cm/hr and 3.8 ml - fractions were collected. The absorbance




0 20 40 60 80
Fraction number
Figure 4.3. Calibration of Ultrogel AcA-44 column with molecular
weight standards.
5 ml of a solution in □.lM-Tris/HCl, O.lM-NaCl, pH 7.4
containing 10 mg each of bovine serum albumin (1), ovalbumin (2), and
soya bean trypsin inhibitor (3) were applied to a 2 cm x 92 cm column
Ultrogel AcA-44 equilibrated in the same buffer. , Elution was carried
out overnight at a flow rate of 5.8 cm/hr and 2.5 ml fractions were
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Figure 4.4. Molecular weight standardisation of Ultroqel AcA-44 column
Experimental details are as described in the legend to Fig. 4.3.
The molecular weights of the standard proteins are plotted as a function
of their elution volumes from Ultrogel AcA-44 (Ve) expressed as a
percentage of the total column volume (Vc).
When the pooled cholera toxin-containing fractions from
DEAE-cellulose chromatography (Fig. 4.1.) were applied to and eluted
from the gel filtration column, the results shown in Fig. 4.5. were
obtained. Three major peaks of protein were evident:
(i) a large, sharp peak eluting in the void volume which
presumably represents proteins with molecular weights
greater than about 80,000 daltons.
(ii) a smaller peak with a shoulder eluting between 114 and
190 ml, corresponding to proteins of molecular weights
20,000 to 70,000 daltons.
(i.ii) the smallest and broadest peak eluting between 209
and 285 ml, representing proteins with molecular weights
of less than 20,000 daltons.
Cholera toxin, with a molecular weight of 82,000 daltons
would be expected to elute with or immediately after the void volume,
but in fact the toxin was detected in column fractions 50 to 90 in
the very broad peak of apparent molecular weight less than 20,000.
Thus in an analogous manner to the elution characteristics of cholera
toxin from Agarose A-5m and Sephadex G-75 (Finkelstein and LoSpalluto,
1969), the toxin has also behaved anomalously on Ultrogel AcA-44
indicating that some degree of affinity probably exists between cholera
toxin and the agarose matrix. The usefulness of this property for
purification purposes is also illustrated in Fig. 4.5. where it can
be seen that, had the toxin behaved as would have been expected from
a consideration of its molecular weight, it would undoubtedly have
been associated with several major contaminants and would not have
been obtained in a purified state.
-108-
Figure 4.5. Elution of pooled toxin-containing fractions after
DEAE-cellulose'chromatography from Ultroqel AcA-44.
Cholera toxin fractions from DEAE-cellulose chromatography
(Fig. 4.1.) were pooled and dialysed against O.IM-Tris/HC1, O.lM-NaCl,
pH 7.4. After freeze-drying and resuspending in a small volume of
the same buffer, the fractions were applied to a 2 cm x 92 cm column
of Ultrogel AcA-44 and elution was carried out overnight at a flow
rate of 5.B cm/hr. 3.8ml - fractions were collected which were
analysed for protein by recording the absorbance at 280 nm. Cholera
toxin (shaded bar) was detected as described in Ch. 2.2.1.
Fraction number
4.2.4. Criteria of' purity
Since the exact amount of cholera toxin in the culture
filtrates of V. cholerae was not known, it was not possible to
calculate the recovery of toxin after each step in the purification.
However in a typical preparation, 70 mg of crude starting material
I
yielded about 1 mg of purified toxin product. This is likely to
represent a high recovery of cholera toxin during purification since
the latter was undoubtedly only a minor component of the culture
filtrate. This is illustrated in Figs. 4.6. and 4.7. which show scans
of SDS-polyacrylamide gels of the culture filtrate and of the purified
toxin respectively. In Fig. 4.7. subunits A and B of the purified
toxin migrated with mobilities of 0.55 and 0.87 corresponding to
molecular weights of 21,000 and less than 12,000 respectively (see
Fig. 2.1.). These values are typical of those for the toxin subunits
determined in this system (van Heyningen, 1976a). In Fig. 4.6. the
corresponding peaks (marked A and B) constitute only a small fraction
of the total protein in the culture filtrate. Similarly on native
polyacrylamide gels, pure cholera toxin migrated with a mobility of
0.05 (Fig. 4.9.) and the corresponding peak on a gel of the culture
filtrate (Fig. 4.8.) appeared only as a small shoulder on a major
slow-moving peak.
Since a study of the detailed structure of cholera toxin
was not the prime concern of the present report, the purity of the
final product was not investigated in other analytical systems. The
toxin pppeared to be homogeneous on both SDS and native polyacrylamide
gels (Figs. 4.7. and 4.9.) and migrated in an identical fashion to
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Figure 4.6. 5D5-Polyacrylamide gel electrophoresis of
V. cholerae culture filtrate.
50Ul of V. cholerae culture filtrate (containing 150pg
of protein)'were electrophoresed on 10/S-polyacrylamide SD5 gels as
described in Ch. 2.3.1. After staining and destaining, the gel
was scanned spectrophotometrically at 570nm. The positions of the
cholera toxin subunits (A and B) were determined from Fig. 4.7.
BPB indicates the position of the bromophenol blue marker dye.
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Figure 4.7. 5DS-Polyacrylamide gel electrophoresis of cholera toxin
purified from V. cholerae culture filtrates.
Experimental details were exactly as described in the legend
to Fig. 4.6. except that 50 p,l of purified cholera toxin (containing
50Mg of protein) were subjected to 5D5 gel electrophoresis.
Figure 4.8. Native polyacrylamide gel electrophoresis of V. cholerae
culture filtrates.
ma*'
501X1 of V. cholerae culture filtrate (containing 150ixg
of protein) were electrophoresed on native polyacrylamide gels as
described in Ch. 2.3.2. After staining and destaining the gel was
scanned spectrophotometrically at 570 nm. The position of cholera
toxin was determined from the data in Fig. 4.9. BPB indicates the
position of the bromophenol blue marker dye.
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Figure 4.9. Native polyacrylamide gel electrophoresis of
cholera toxin purified .from V. cholerae culture
filtrates.
Experimental details were exactly as described in the
legend to Fig. 4.8. except that 50 p.1 of purified cholera toxin
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cholera toxin obtained from Dr. R.A. Finkelstein (results not shown.)
These observations were taken as an indication that the above
purification method resulted in the production of apparently pure
cholera toxin, indistinguishable from a known samp-le of highly purified
material, and the toxin was therefore considered to be suitable for




It is clear from the above results that cholera toxin was
only a minor component in the culture filtrate of V. cholerae obtained
from the Wellcome Research Laboratories. Since the conditions employed
for the growth of V. cholerae and the methods of preparation of the
culture filtrates were not known, it is not possible to evaluate the
extent to which these conditions were optimal. However cholera toxin
was readily detectable in the crude material by Ouchterlcny
immunodiffusion and from about lOOmg of starting protein, 1 to 2 mg
of toxin were obtained in a purified form, which was sufficient for
several months of experimentation. It should be noted however that
different batches of culture filtrate varied considerably especially with
respect to protease contamination. In the material used for the
purification described above, such contamination was not detectable
but in some batches, it was not possible to isolate purified cholera
toxin by the above method, a problem which was eliminated by including
O.lmM-PMSF in the buffers used throughout the purification procedure.
Analysis of the toxin purified from these batches by SDS-polyacrylamide
gel electrophoresis after various times of incubation at 37°C prior to
electrophoresis, showed no evidence of toxin destruction and the proteases
were therefore separated from the toxin at some stage in the purification.
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The purification scheme described here is a significant
simplification of the procedure of Finkelstein and LoSpalluto,(1970)
and can in fact be simplified further by the complete omission of
the ammonium sulphate fractionation step. The small amount of material
removed from the toxin in this step was subsequently found to be
separated from cholera toxin in any case, by DEAE-cellulose chroma¬
tography and thus, a two-step procedure consisting of ion-exchange
chromatography on DEAE-cellulose followed by gel filtration on
Ultrogel AcA-44 was sufficient to obtain purified cholera toxin which
was homogeneous on 5D5 and native polyacrylamide gels. By far the
most effective step in the purification scheme was DEAE-cellulose
chromatography in which it was possible to separate more than 75%
of contaminating proteins from the toxin (Fig. 4.1.). However were
it not for the anomalous behaviour of cholera toxin on Uitrogel AcA-44,
this would have been of little use in the subsequent gel filtration
step since there was still significant contamination by proteins with
similar molecular weights to that of the toxin. However since cholera
toxin eluted from Ultrogel AcA-44 with the characteristics of a protein
with a molecular weight of less than 20,000 daltons, it was efficiently
separated from these remaining contaminants (Fig. 4.5.)
Although the purified toxin behaved as a homogeneous protein
on SDS and native polyacrylamide gels with identical migration
characteristics to those of highly purified material from Dr. R.A.
Finkelstein, some of the results presented in Ch. 5.2. indicated that
the toxin was not homogeneous and appeared to contain several fragments
of cholera toxin as well as some contaminating NADase activity distinct
from the toxin and from fragments of the toxin. Presumably, in the
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method of Finkslstein and LoSpalluto (1970) these contaminants may
be resolved from the intact toxin in their final double gel filtration
step.
It seems likely that studies on the mechanism of action
of cholera toxin may indicate alternative simplifications for cholera
toxin purification methods and for example, the involvement of I\IAD+
in toxin action (see Chs. 5.and 6.) has resulted in the demonstration
that cholera toxin will bind reversibly to columns of Sepharose
covalently linked to NAD+(Antoni et_al_, 1978) and affinity chroma¬
tography on such columns may be of considerable use in purification
procedures. Similar properties have been described for diphtheria
toxin (Montanaro and Sperti, 1967) and-have been used to purify the
toxin on NAD+ - Sepharose columns)Cukor et al, 1974).
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Chapter 5. Results
5• 1 • Characterisation pf rat- liver adenylate cyclase and
activation by cholera toxin.
Production of cAMP from ATP in rat liver homogenates was
linear with time over the ranges tested both at 25°C and at 37°C
(Figs. 5.1. and 5.2. respectively). The specific activity of
■?
adenylate cyclase under these conditions was 44 and 86 pmoles cAMP
min mg protein respectively. With a 20 min. assay time at 37°C,
cAMP production also increased linearly with homogenate protein
concentration up to at least 357 pg protein per 25 Pi assay volume
(Fig. 5.3.). These data were taken as an indication that the
adenylate cyclase assay described in Ch. 3.3. was suitable for
determining the activity of this enzyme in rat liver homogenates,
and subsequent experiments were conducted within the ranges of time
and protein concentration determined above.
When rat liver homogenates were incubated with cholera
toxin for 10 min. at 25°C in the presence'of MAD+, ATP, DTT and GTP,
adenylate cyclase activity upon subsequent assay was elevated to
a maximum of about three-fold over basal levels. As shown in Fig. 5.4.
activation was detectable with only Q.01 p.g/ml cholera toxin and was
maximal with 1 Pg/ml. Further addition of toxin at concentrations
up to lOpg/ml had no further effect on adenylate cyclase activity.
In contradiction to earlier reports in the pigeon erythrocyte
system (Gill, 1976b), activation of adenylate cyclase in rat

























Fig.5.1 . Time course of cAMP production by rat liver homoqenate at 25 C.
A rat liver homogenate was prepared in Buffer System B as
described in Ch.2.5. and 15p.l aliquots were added to 1 Dial of assay
medium I (Ch.3.3.2.3) containing 25,000pmoles of ATP and 0.6pCi of
[8-^H]ATP. After the indicated times at 25°C, 10(i.l of 25%-TCA were
added, precipitated protein was removed by centrifugation, and 5U-1 of
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Fig. 5.2. Time course of cAMP production by rat liver homoqenate at 37 C.
A rat liver hornogenate was prepared in Buffer System A as
described in Ch.2.5. and 1 5P1 aliquots were added to 1 Dpi of assay
medium I (Ch.3.3.2.3) containing 25,00Dpmoles of ATP and 1PCi of
[8-^3ATP. After the indicated times at 37°C, 5P1 of 50%-TCA were added,
precipitated protein was removed by centrifugation, and 5pl of each
3























0 100 200 300 400
pg Protein/assay
Fig.5.3. Production of cAMP at 37 C by rat liver homoqenat'e as a
function of homoqenate protein concentration.
A rat liver homogenate was prepared in Buffer System B as
described in Ch.2.5. and increasing volumes up to 1 5|il were added to
10til of assay medium I (Ch.3.3.2.3) containing 14,500pmoles of ATP and
0.6uCi of PS- H^ATP. The total volume of each assay was made up to 25nl
with buffer. After 20min at 37°C, 1Oul of 25%-TCA were added, precipitated
protein was removed by centrif ugation, and 10p-1 of each- supernatant
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Fig.5.4. Activation of adenylate cyclase by cholera toxin in rat liver.
A rat liver was prepared in Buffer System D as described in
Ch.2.5. arid 140|il aliquots were incubated in a total volume of 200^1
with 2mM-ATP, 2mM-DTT, 1 mM-NAD+, 200UM-GTP, and the indicated final
concentrations of cholera toxin. After 10min. at 25 C, an excess of cold
buffer was added, membranes were precipitated by centrifugation and
resuspended in 50^1 of buffer. 15^1 aliquots were added to 1Onl of
assay medium II (Ch.3.3.2.3) and after 10min at 25°C, 5|il of 25%-TCA
were added, precipitated protein was removed by centrifugation, and
10M>1 aliquots taken for estimation of [ H3cAMP. Error bars indicate
• •
the range of duplicate determinations.
cytosol. This is clearly evident from the results shown in Fig. 5.5.
in which crude rat liver membranes were washed several times to
remove all traces of cytosol, and then incubated in adenylate
cyclase assay medium, supplemented with lmM-NAD+, in the presence
and absence of cholera toxin. At all points on the subsequent time
course, production of cAMP was markedly greater in the presence of
toxin and activation over basal adenylate cyclase activity was 2• 3-
fold and 3.3-fo.ld after 5 min. and 3D min. of assay respectively.
However, the maximum toxin-stimulated specific activity (125 pmoles
cAMP min. mg protein) was achieved after only 10 min. of assay,
and the progressive increase in the extent of cyclase activation
over the 30 min. assay period was due to the much greater instability
of the unstimulated enzyme, which produced cAMP linearly with time
during only the first few minutes of assay. This contrasts with
the results obtained in rat liver homogenate where cAMP production
was linear with time up to at least 15 min. (Fig. 5.1.). Although
the reasons for this were not investigated thoroughly, it may be
related to the fact that cytosol was found to contain a factor (s)
which elevated basal adenylate cyclase activity two-fold (results
not shown), a finding which has already been reported for fat cell
adenylate cyclase (Ganguly and Greenough, 1975). It seems possible
that such stimulatory factors may also contribute to the stability
of the cyclase during prolonged incubations. In contrast to the
basal activity of the enzyme, toxin-stimulated activity in the
absence of cytosol was not unstable to long incubation times (Fig.5.5.)
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Fig.5.5. Time courses of cAMP production in crude rat liver membranes
in the presence and absence of cholera toxin.
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 1Opl aliquots were added to 1 Opl of assay medium
II (Ch.3.3.2.3) supplemented with NAD+ to a final concentration of 1mM.
5Pl of preactivated cholera toxin ( Final concentration: 2Pg/ml) (@—®) or
5Pl of activation solution for controls (O—O) were added and after the
indicated times at 25°C, 5Ul of 25^-TCA were added, precipitated protein
was removed by centrifugation, and 1 Dpi of each supernatant taken for
estimation of [ H^jcAMP. All values were single determinations only.
5.2. The NADase activity of cholera toxin
5.2.1. Demonstration of activity
Cholera toxin purified as described in Ch. 2.1. was assayed
for NACase activity using the assay medium originally described by
Moss et al (1976b ). As shown in Fig. 5.6. production of nicotinamide
from NAD+ increased linearly with cholera toxin concentration over
the range tested (up to 500u.g/ml), and the specific activity of the
toxin under these conditions was 3.2. nmoles nicotinamide min. mg
toxin. From a comparison of Figs. 5.4. and 5.6. it is immediately
apparent that extremely large amounts of cholera toxin are required
to demonstrate hydrolysis of NAD+ in relation to the amounts required
for activation of adenylate cyclase in rat liver homogenates. For
example in the NADase assay, activity was not readily detectable
at toxin concentrations less than 100ug/ml, while adenylate cyclase
activation was maximal with lUg/ml toxin.
Although cytosolic factors, as described in the previous
section, did not appear to be essential for the action of cholera
toxin in rat liver membranes, the importance of such factors reported
in other tissues, such as pigeon erythrocytes (Gill, 1976b ), prompted
the suggestion that a possible role for these factors may be to facilitate
the action of cholera toxin by enhancing its activity towards NAD+ in an
enzymic reaction. However, as shown in Fig. 5.7., the NADase activity
of the toxin was essentially unchanged when measured in the presence
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Fig. 5. 6. Hydrolysis of NAD by purified cholera toxin.
Assays were conducted in a total volume of 25P-1 containing
200mM-potassium phosphate, 20mM-DTT, 1.5mM-NAD+, 4nCi of [carbonyl-
14C]f\IAD+, and the indicated concentrations of cholera toxin, pH 7.D.
After 90rnin at 37°C, 10l.il aliquots were taken for estimation of [^C]-
nicotinamide. All values were single determinations only.
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Fig.5.7. Effect of cytosol on the NADase activity of cholera toxin.
Assays were conducted in a total volume of 25P-1 containing
1OOmM-potassium phosphate, 10mM-DTT, 1mM-NAD , 5nCi of [carbonyl- C]-
NAD+, the indicated concentrations of cholera toxin, and either 12.5M-1
of pigeon erythrocyte cytosol (©——#) or buffer for controls (O—O) . After
4hr at 37°C, 25(-tl of 2 5%-TCA were added, precipitated protein was removed
by centrifugation, and 25IA1 of each supernatant taken for estimation of
[^C]nicotinamide. All values were the means of duplicate determinations.
decrease in activity in the presence of cytosol probably reflects
some degree of isotope dilution by endogenous NAD+ in the preparation
but it is quite clear that even if these endogenous levels were
accounted for in the calculation of results, the NADase activity
of the toxin would not be significantly elevated above that seen
in the absence of. cytosol.
5.2.2. The effect of phosphate ions and ionic strength on the
NADase activity of cholera toxin
Moss et al (1976 b) and Moss and Vaughan (1977) reported
that phosphate buffers stimulated the NADase activity of cholera
toxin and an almost six-fold enhancement of activity was observed
by increasing the potassium phosphate concentration from lOOmM to
400rnM. In an attempt to repeat this work, assays were conducted in
the presence and absence of cholera toxin in increasing concentrations
of potassium phosphate up to 5D0 mM. In order to ensure that assays
in the absence of phosphate were maintained at the correct pH, all
solutions were prepared in lOmM-Tris/HCl and adjusted to pH 7.0 with
concentrated NaOH.
By increasing the potassium phosphate concentration from
zero to 500mM there was an apparent 2.3-fold increase in the NADase
activity of cholera toxin (Fig. 5.8.). However since there was an
almost equivalent increase in the amount of NAD' hydrolysed in the
absence of cholera toxin, NAD+ hydrolysis due to the toxin itself
increased only slightly with increasing potassium phosphate concentration
(from 4.7 nmoles nicotinamide min. mg in the absence of phosphate
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Fig.5.8. Effect of potassium phosphate on the hydrolysis of NAD+
in the presence and absence of cholera toxin.
Assays were conducted in a total volume of 40^1 containing
10mM-Tris/HCl,pH 7.0, 2mM-NAD+, 20mM-DTT, 50nCi of [carbonyl-1 4C]l\IAD+,
the indicated ionic strength supplied as potassium phosphate, and
either 5;xg of cholera toxin (©—©) or buffer for controls (O—O) . After
30min at 37°C, 1 Qui aliquots were taken for estimation of [14c]~
*
nicotinamide. All values were single determinations only.
to 7.3 nmoles nicotinamide min. mg at 500mM-potassium phosphate).
A similar experiment testing equivalent ionic strengths
supplied as NaC.l gave similar results but with several minor differences
(Fig. 5.9.). Below an ionic strength of 0.2, NaCl had little effect
on NAD+ hydrolysis either in the presence or absence of cholera toxin
and the specific activity of the toxin under these conditions was 6.7
nmoles nicotinamide min. mg . However when the ionic strength
was increased from 0.2 to 1.0, there was a ten-fold increase in NAD+
hydrolysis under both conditions leading to an apparent ten-fold
increase in the specific activity of the toxin, which was about 77
nmoles nicotinamide min. ^ mg ^ at lM-NaCl. For reasons discussed
in Ch. 6. little significance was attached to this latter result
and in subsequent work, NADase assays were conducted either in phosphate
buffers of low ionic strength (less than 0.2) or in buffers such as
sodium acetate, Tris/Hd, or Hepes/NaOH which did not promote non¬
specific hydrolysis of NAD+.
5.2.3. The effect of arqinine on the NADase activity of cholera
toxin.
The stimulatory effect of arginine on the NADase activity
of cholera toxin described by Moss and Vaughan (1977), could not be
observed in this work. Arginine at concentrations up to IDOmM
consistently had no effect on the amount of NAD+ hydrolysed either
by cholera toxin purified as described in Ch. 2.1. (Table 5.1.), or
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Fig.5.9. Effect of NaCl on the hydrolysis of NAD+ in the presence &.
absence of cholera toxin.
Assays were conducted in a total volume of 4Q(J>1 containing
10mM-Tris/HCl,pH 7.0, 2mM-NAD+, 20mM-DTT, 50nCi of [carbonyl-"'^C]NAD+,
the indicated ionic strength supplied as NaCl, and either 5U»g of
cholera toxin (©—©) or buffer for controls (O—O) . After 30min at 37 C,
10(11 aliquots were taken for estimation of [^^nicotinamide. All
values were single determinations only.
Table 5.1. Effect of arqinine on the NADase activity of cholera
toxin purified from V. choleras culture filtrates
as described in Ch. 2.1.
Assays were conducted in a total volume of 20j.il containing
200rnM-potassium phosphate, 20mM~DTT, 2mM-NAD , 4 nCi of ^Carbonyl- c]
NAD+, 60 jig/ml cholera toxin, and the indicated concentrations of
L-arginine. pH 7.0. After 105 min. at 37°C, 10 Hi aliquot^ were taken
for estimation of [ J nicotinamide. All values were single determin¬
ations only.
Arginine concentration (mM) NADase activity







Table 5.2. Effect of arqinine en the NADase activity of purified
cholera toxin obtained from Dr. R. Rappaport.
Assays were conducted in a total volume of 40q,l containing
lOmM-Hepes, □.25M-sucrose, 5rnM-MgCl2, 20mM-DTT, 2mM-NAD+, 50 nCi of
[carbonyl - J - NAD+, 25 lig/ml cholera toxin, and the indicated
concentrations of L-arginine, pH 7.4. After 90 min. at 37°C, 10 ul
of 25% - TCA were added and 10 Ul aliquots taken for estimation of
[14 1C Inicotinamide. All values were single determinations only.
Arginine concentration (rnM) NADase activity





5.2.4. NAD+ Hydrolysis by crude culture filtrates of V. cholerae
Crude culture filtrates of V. cholerae were found to
catalyse NAD^ hydrolysis with a specific activity of almost 600 nmoles
nicotinamide min. mg ^ (Fig. 5.10.), which was therefore about 200
times more active than purified cholera toxin (see Fig. 5.6.).
Furthermore, as shown in Table 5.3., the majority of this activity
could be separated from the toxin during purification. After ammonium
sulphate fractionation the highest NADase specific activity was
found in the supernatant which contained no cholera toxin as judged
by 5D5 gel electrophoresis and Ouchterlony immunodiffusion. Similarly
after DEAE-cellulose column chromatography, a pool of the fractions
which did not contain cholera toxin, was enriched in NADase activity.
The small amount of activity remaining in the toxin-containing fractions
copurified with the toxin again in the final gel filtration step.
Since crude culture filtrates of V. cholerae therefore
contained a very highly active NADase distinct from choleis toxin, it
was important to establish whether the NADase activity associated with
purified toxin preparations was a property of the toxin itself, or
whether it was due to residual contamination by a small amount of the
NADase in the culture filtrate. The relative activities of the purified
toxin NADase and of the NADase eluted from DEAE-cellulose (hereafter
referred to as 'non-toxin NADase'), can be seen clearly from the time
courses of Fig. 5.11. The non-toxin NADase, with a specific activity
(measured after 30 min. of assay)of about 2,600 nmoles nicotinamide
min. ^ mg \ was at least 150 times more active than the purified





























Fig.5.10. Hydrolysis of NAD by crude culture filtrates of V. cholerae.
Assays were conducted in a total volume of 1 5M-1 containing
200mM-sodium acetate, 20mM-DTT, 3.3mM-NAD^, 10nCi of [carbonyl-'' 4C]~
NAD+, and the indicated concentrations of culture filtrate protein,
pH 6.2. After 50min at 37 C, 1Dul aliquots were taken for estimation
of [14C]nicotinamide. All values were the means of duplicate
• o
determinations.
Table 5.3. Purification of cholera toxin from V, choleras culture
filtrate - separation from NADase activity.
NADase activities were determined in a total volume of 20|il
containing 200mM-potassium phosphate, 2Dmlvl-bTT, 2mM-NAD+ and 10 r.Ci
of [ carbonyl-^C ]NAD+, pH 7.0. After 3D min. at 37°C, IOij.I aliquots
were taken for estimation of nicotinamide. All values were the
means of duplicate determinations and all other techniques were performed
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Fig.5.11. Hydrolysis of NAD by purified cholera toxin and by the
non-toxin NADase eluted from DEAE-cellulose.
Assays were conducted in a total volume of 20ul containing
200mM-potassium phosphate, 20mM-DTT, 2mM-NAD^ , 10nCi of [carbonyl-^C]-
NAD+, and either 0.75Ug of purified cholera toxin (O—O) or □.□Bug of
non-toxin NADase (@——0) , pH 7.D. After the indicated times at 37°C, 10Ul
1 4
aliquots were taken for estimation of [ [^nicotinamide. All values
were ingle determinations only.
Table 5.4. Effect of INH on the NADase activity of purified cholera
toxin and of non-toxin NADase.
Assays were conducted in a total volume of 20ul containing
200 mM-potassium phosphate, 20mM-DTT, 2mM-NAD-+, 4nCi of [ carbonyl- ^cj
NAD+, and the indicated concentrations of INH, pH 7.0. Assays were
initiated by the addition of either purified cholera toxin (7t-ig protein)
or non-toxin NADase (0.08ug protein) and after 90 min. at 37°C, lOdl
r 14 -i
aliquots were taken for estimation of I CI nicotinamide. Values
were the means of duplicate determinations except where indicated
othe rwise.
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to inhibition by iso-nicotinic acid hydrazide (II\IH), an analogue
of nicotinamide, and were therefore similar to most other bacterial
NADases (seeCh.6.)
The NADase activity of the purified toxin was not stimulated
after treatment with dilute mixtures of SDS and DTT, a procedure
which enhances the ability of cholera toxin to activate adenylate
cyclase in broken cell systems (Gill, 1976 b ; van Heyningen, 1977 t> ) .
Instead, this activity and the activity of the non-toxin NADase, were
both inhibited markedly after 5D5-DTT treatment (Table 5.5.). Conflicting
effects were also observed in experiments in which the toxin was
preincubated with an excess of antibodies raised against whole toxin
in rabbits (see van Heyningen, 1976 a). This treatment, which inhibits
the action of cholera toxin in disrupted cell systems (van Heyningen,
1976 b), had no effect on the NADase activity of either purified toxin
or of crude culture filtrates of V. cholerae (Table 5.6.). It should
be noted that the antitoxin used in this experiment was the purified
IgG fraction from crude rabbit antiserum (the crude antiserum itself
contained a highly active NADase contaminant which was removed after
the purification steps described in Ch. 2.2.2.).
From the quantities of this material and of the purified
toxin added to the preincubation mixtures, and assuming molecular
weights of 84,000 daltons and 160,000 daltons for cholera toxin and
IgG respectively, it can be calculated that IgG was present in an
approximately 20-fold molar excess over cholera toxin in this experiment.
Although it is unlikely that all of the protein in the IgG fraction was
antitoxin antibody, it is probable that sufficient antibody was present
to neutralise all of the cholera toxin during preincubation.
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Table 5.5. Effect of preincubation with 5D5 and DTT on the NADase
activity of purified cholera toxin and of non-toxin
NADase.
Purified cholera toxin or non-toxin NADase were added to a
1/10 volume of either 50mM-Tris/HCl, pH 7.4 or the same buffer containing
SDS and DTT to give final concentrations of 0.1% 5D5, ImM-DTT in a
total volume of 50pl. After 10 min. at 37°C, 5pl aliquots (5.4Pg
purified toxin or O.lpg non-toxin NADase) were transferred to 15pl of
assay medium to give final concentrations of 200mM-potassium phosphate,
20mM-DTT, 2mM-NAD+, and 10 nCi of [carbonyl-14C ] NAD+, pH 7.0. After
90 min. (purified toxin) or 30 min (non-toxin NADase) at 37°C, lOu.l
aliquots were taken for estimation of nicotinamide. Values were










8.6 - 0.3 (SEM)







Tab1s 5.6. Effect of cho]era antitoxin on the NADase activity of
purified t.oxin and of V. choleras culture filtrates.
251A1 of anti-cholera toxin IgG (350Ug protein), prepared
as described in Ch. 2.2.2. were mixed with an equal volume of either
culture filtrate (0.75u-g protein) o r purifie d toxin (15ug protein) and
incubated at 37°C for 10 min. Control incubations contained the
buffer in which the antitoxin was prepared. After 10 min. 10^1
aliquots were transferred to 10ul of assay medium to give final concen¬
trations of 200 mM-scdium acetate, 20rnM-DTT, 2.5mM-NAD+, and lOnCi of
[Carbonyl-^C NAD4], pH 6.2. After 60 min (Culture filtrate) or 120 min
(purified toxin) at 37°C, 5ul of 25% -TCA were added, precipitated
protein was removed by centrifugation, and lOul of each supernatant
taken for estimation■of [ j - nicotinamide. Values were the means
of duplicate (culture filtrate) or triplicate (purified toxin) determinations.
Preparation Preincubation NADase activity
conditions (nmoles nicotinamide min--5" mg_J".
culture filtrate - antitoxin 467 - 16
+ antitoxin 429 - 48
Purified toxin - antitoxin
+ antitoxin
8. B - 0.9 (SEM)
9.4 - 0.7 (SEM)
5.2.5. Separation of NADase and adenylate cyclase activating
activity of cholera toxin by polyacrylamide gel electrophoresis
The results presented in the previous section suggested that
the NADase activity in purified cholera toxin preparations may not he a
property of the toxin itself, but may be due to a contaminant not
entirely removed during purification. In order to test this hypothesis
directly, samples of crude culture filtrates and of purified cholera
toxin were electrophoresed on native polyacrylamide gels which were
sliced and eluted as described in Ch. 2.3.3. The eluates, after
freeze-drying and resuspension in 30pl of water, were analysed for
NADase activity, adenylate cyclase activating activity, and antigenicity
against rabbit antiserum. The results are shown in Figs. 5.12.A and B
for crude and. purified toxin respectively.
Antigenic material was detected in both gels at mobility
0.05 to 0.15 where there was the expected comigrating peak of adenylate
cyclase activating activity. Surprisingly the crude toxin displayed a
major peak of cyclase activating material, distinct from cholera toxin,
at mobility 0.45, and although this material was less evident in the
purified toxin, it was replaced by several smaller peaks of activity
notably at mobilities 0.20, 0.27, and 0.32. The peak at 0.27 was also
present, but to a lesser extent, in crude cholera toxin.
In both gels there was one major peak of NADase activity at
mobility 0.55 with a smaller peak at 0.27. An area of very low NADase
activity co-migrating with cholera toxin in the crude preparation, was
not evident after purification.
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Figure 5.12. Separation of NADase activity from adenylate cyclase
activating activity of cholera toxin on native
polyacrylamide gels.
50 pi of either V. cholerae culture filtrate (A) or cholera
toxin purified therefrom (B), containing 150 tig and 50 Ug of protein
respectively, were electrophoresed on native polyacrylamide gels which
were sliced and eluted as described in Ch. 2.3.3. After freeze-drying
and resuspension in 30 pi of water, 5 pi were taken for Ouchterlony
immuno-diffusion against rabbit antitoxin as described in Ch. 2.2.1.,
5Pl for NADase assay (O O), and 10 Pi for adenylate cyclase
activating assay (© ©) .
NADase activities were determined in a total volume of 15pl
containing 200mM-sodium acetate, 20mM-DTT, 2mM-NAD+, and 10 nCi of
[carbonyl - 14c] NAD+, pH 6.2. After 50 min. at 37°C , 10 pi aliquots
f 14 T
were taken for estimation of I C I- nicotinamide.
Adenylate cyclase activating assays were carried out by adding
10 Pi of each gel slice eluate to 15pl of rat liver homogenate prepared
in Buffer System B as described in Ch.2.5., in the presence of 2.5mM-
NAD+, 2.5 mM-ATP, 2.5 mM-DTT, and 2.5mM-INH. After 20 min. at 37°C,
15 Pi aliquots were transferred to lOpl of assay medium I (Ch. 3.3.2.3.)
containing 14,500 pmoles of ATP and 0.6pCi of ^8 - j ATP, and
adenylate cyclase was assayed for 20 min at 37°C. Reactions were
terminated by adding lOpl of 25$ - TCA, precipitated protein was removed
by centrifugation, and lOpl of each supernatant taken for estimation
of [3H ] cAMP.
Figure 5.12. cont.
All assays were single determinations only. Horizontal
bars indicate the mobilities at whifch cholera toxin was detected by
□uchterlony Immunodiffusion.
nrnolescAMPmingp otein nmolesicotinamideproduced/50min/3Qpleluates
Thus although the purified cholera toxin was homogeneous
as judged by the presence of one band after staining a corresponding
gel for protein (see gel scan of purified toxin in Fig. 4. 9), the
enzymatic analysis described here emphasises the extent of heterogeneity
in the preparation and supports the hypothesis chat the NADase activity
of purified cholera toxin is due to a contaminant enzyme, present in
small amounts, but of very high activity.
/
5.2.6. Kinetics of NAD+ hydrolysis by different preparations of
cholera toxin.
■s
In an attempt to determine whether the NADase activity of
several different cholera toxin preparations was due to the same
contaminant, kinetic rate parameters for the reactions were investigated.
Initial rates of NAD"1 hydrolysis in the presence of increasing concentra¬
tions of NAD+ (0.2mM to 1.0 mM) were determined and the results were
analysed using the Direct Linear Plot of Eisenthal and Cornish-Bowden
(1974 ), and a later modification of the same method (Cornish-Bowden
and Eisenthal, 1978 ). Analysis of kinetic data on these plots is
explained in Appendix II.
As shown in Fig. 5.13. the NADase activity in crude culture
filtrates of V. cholerae exhibited a Km for NAD+ of 0.24 mM, and a
V of 3.15 dmoles nicotinamide min. mq . Purified cholera toxin
max
derived from this material displayed a very similar Km value (0.20mM)
with a Vmax which was only 1/150 of that of the crude material (Fig.
5.14). This is in agreement with the results of the previous experiment
where the NADase activity of purified cholera toxin was accounted for
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Fig.5.13. Kinetic analysis of the NADase reaction catalysed by
crude culture filtrates of V. cholerae.
Assays were conducted in a total volume of 40p.l containing
14
1OmM-potassiurn phosphate, 20mM-DTT, 120nCi of [carbonyl- C]NAD ,
0.3lPg of culture filtrate protein, and the indicated concentrations
of NAD+, pH 7.D. After 5min at 37°C, 1 Ctrl of 25%-TCA were added and
10d-1 aliquots taken for estimation of C''^C]nicotinamide. All values
were single determinations only.
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Fig. 5.14. Kinetic analysis of the NADase reaction catalysed by
cholera toxin purified from crude culture filtrates of V. cholerae.
Assays were conducted in a total volume of 401^1 containing 10rnM-
14 +
potassium phosphate, 20mM-DTT, 1OOnCi of fcarbonyl- CJNAD , 1.9Ug
of cholera toxin, and the indicated concentrations of NAD+, pH 7.0.
After 60min at 37°C, 10Ul of 25/S-TCA were added and 1 Dul aliquots
taken for estimation of [ ^C]nicotinamide. All values were single
determinations only.
mobility as the major peak of NADase activity in the crude toxin,
and provides further evidence to support the hypothesis that both
activities are due to the same enzyme.
However, when a similar kinetic experiment was conducted
with a sample of purified toxin obtained from Dr. R. Rappaport, a
much higher value (2.5mM) was calculated (Fig. 5.15), and the Vmax
of this preparation (10.5 nmoles nicotinamide min. ^ mg "*") was about
half that of the toxin purified from crude culture filtrates in this
laboratory. Furthermore, a sample of purified cholera toxin obtained
from Dr. R.A. Finkelstein had a similar K value of 2.1 mM, and in
m
this preparation the Vmax was ten-fold lower again at only 1.1 nmoles
nicotinamide min. mg (Fig. 5.16.)
Despite these differences in the Km values between cholera
toxin purified in this laboratory and the other two preparations
described above, and despite the fact that in the former preparation,
no detectable NADase activity was associated with the toxin itself
(Fig. 5.12.B.), this material and the purified toxin from Dr. R.A .
Finkelstein activated adenylate cyclase in rat liver membranes to the
same extent when added in equal concentrations (Fig. 5.17.)
Since it was not clear from the above results whether or
not cholera toxin was capable of hydrolysing NAD+, and since NADase
activity did not appear to correlate with the efficiency of adenylate
cyclase activation by the toxin, it was considered that the continued
study of this activity could easily result in the formulation of erroneous
conclusions, and the role of NAD+ in toxin action was therefore studied
directly in crude preparations of adenylate cyclase.
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Fig. 5.1 5 . Kinetic analysis of the NADase reaction catalysed by
cholera toxin obtained from Dr. R. Rappaport.
Assays were conducted in a total volume of 4Qui containing
1OmM-potassium phosphate, 20mM-DTT, 1OOnCi of [carbonyl-1^C]NADh,
4.6p-g of cholera toxin, and the indicated concentrations of I\1AD+,
pH 7.0. After 60min at 37°C, 1Oul of 25^-TCA were added and 1Opl
aliquots taken for estimation of ^(^nicotinamide. All values were
the means of duplicate determinations.
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Fig.5.16. Kinetic analysis of the NADase reaction catalysed by cholera
toxin obtained from Dr. R.A.Finkelstein.
- Assays were conducted in a total volume of 40^1 containing
10mM-potassium phosphate, 2DmM-DTT, 10OnCi of [carbonyl-^C]NAD+, 10p.g
of cholera toxin, and the indicated concentrations of NAD+, pH 7.0.
After 60min at 37 C, 10P'l of 25%-TCA were added and 1 Oul aliquots taken

















0 5 6 7
.jjg/ml Cholera toxin
Fig.5.17. Activation of rat liver adenylate cyclase by two different-
preparations of cholera toxin.
A rat liver homcgenate was prepared in Buffer System D as
described in Ch.2.5. and aliquots incubated in a total volume of 4QU1
with 5mM-ATP, 5mM-DTT, 2mM-NAD+, and either cholera toxin purified in
this laboratory (O——O) , or purified and obtained from Dr. R . A . Finkelstein
(©-—©). After 15min at 37°C, an excess of cold buffer was added, membranes
were precipitated by centrifugation, resuspended in 401^1 of buffer, and
15111 aliquots added to 1 0|xl of assay medium II ( Ch . 3 . 3 . 2 . 3 ) . After 1 Omin
at 37°C, 5P.1 of 25%-TCA were added, precipitated protein was removed by
3
centrifugation, and 5^1 of each supernatant taken for estimation of [ H]-
cAMP. All values were single determinations only.
5.3. The role of NAD in the activation of adenylate cyclase
in particulate fractions of rat liver by cholera toxin.
5.3.1. Dependence of cholera toxin action on the presence of NAD+.
When crude rat liver membranes were incubated in adenylate
cyclase assay medium in the presence of cholera toxin, no activation
of adenylate cyclase occurred unless NAD+ was also present (Fig. 5.18.)
However, lOU-M-NAD"* was completely ineffective in supporting cyclase
+
activation, 100P-M-NAD supported some activation only after a 10 min.
incubation time, and maximum toxin action was observed with lmM-l\lAD+
when cyclase activation first became apparent after 6 min. of assay and
was maximal (2.5-fold) after 8 to ID min. Addition of 5mM-NAD+ did
not result in any greater cyclase activation and indeed reduced the
maximum adenylate cyclase specific activity attained.
Thus, although there was an obligatory requirement for NAD+
in cholera toxin action, the results in Fig. 5.18. were not entirely
consistent with the hypothesis that NAD+ is a substrate in a toxin-
catalysed reaction since if this were the case, the extent of cyclase
activation would be expected to increase linearly with substrate (NAD+)
concentration until the latter achieved saturating concentrations. These
results however indicate that there is a definite 'threshold' concentration
of NAD+ below which adenylate cyclase activation by cholera toxin cannot
be supported. Nevertheless, in crude membrane preparations of the type
employed here, there may be a number of factors which could interfere
in a directly linear response of toxin action with NAD+ concentration.
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Fig.5.1B. Effect of NAD+ on adenylate cyclase activation by cholera toxin,
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 10(11 aliquots were incubated in a total volume of
25U-1 in assay medium II ( Ch . 3. 3. 2 . 3 ), Assays contained preactivated cholera
toxin at a final concentration of 2ug/ml in the presence of 0 (€> ©) ,
(00 <^(iM (D—O), -fnM (A—A), snd^SmM (B—3) !\!AD+. Basal activity (O—O) was
I
determined by substituting activation solution for cholera toxin. After
the indicated times at 25°C, 5(il of 25%-TCA were added, precipitated protein
was removed by centrifugation, and 10(11 of each supernatant taken for
estimation of [ H]cAMP. All values were single determinations only.
A major source of potential interference was recognised when rat
liver fractions were assayed for endogenous NADase activity as
described in the following■section.
5.3.2. NAD+ Hydrolysis by rat liver preparations.
As shown in Fig. 5.19., rat liver homogenates were extremely
effective in catalysing the release of nicotinamide from NAD+. When
portions of homogenate were incubated in the presence of 2mM-NAD+,
50^ of the NAD+ was hydrolysed after only 5 min. and after about
20 min, all added NAD+ was destroyed. Although the release of nico¬
tinamide from NAD+ can be accomplished by more than one type of enzyme
(see Ch. 6.), the activities are referred to here collectively as
endogenous rat liver- NADase.
Almost all of the endogenous NADase activity was associated
with the crude membrane fraction and was found at a very high level
in a purified plasma membrane fraction prepared earlier (Table 5.7.)
This activity, by catalysing the rapid destruction of NAD+, may be
responsible for the failure of low concentrations of NAD+ to support
adenylate cyclase activation by cholera toxin, and in order to study the
mechanism of the toxin's action in the absence of such interference,
several attempts were made to selectively inhibit the activity of
these enzymes.
Fig. 5.20. illustrates the effects of temperature and of
INH on the endogenous NADases. Like most enzymic reactions, NAD+
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Fig.5.19. Hydrolysis of NAD by rat liver homoqenates,
A rat liver homogenate was prepared in Buffer System B as
described in Ch.2.5. and 30U-1 aliquots were incubated in a total volume
+ . r 14-+
of 50(^1 containing 2mM-NAD and 2bnCi of Lcarbonyl- CJNAD . After the
indicated times at 37°C, 50ixl of 5^-TCA were added, precipitated protein
was removed by centrifugation, and 1Onl of each supernatant taken for
r1 4 nestimation of |_ CJnicotinamide. Error bars indicate the range of
*
duplicate determinations.
Table 5.7. NADase activity In subcellular fractions of rat liver.
Crude membranes and cytosol fractions (prepared in Buffer
System B) and purified plasma membranes from rat liver were prepared
as described in Ch. 2.5. 30ul aliquots of each fraction were
incubated in a total volume of 50ul with 2mM-NAD+ and 25 nCi o.f
[carbonyl-"'"^cj NAD+. After 10 min (crude membranes and cytosol) or
5 min. (plasma membranes) at 37°C, 50lil of 5%-TCA were added, precipitated
protein was removed by centrifugation, and 10ul of each supernatant




(n moles nicotinamide min mg )
Crude memb'ranes 40.0 - 1.1 (SEM)
Cytosol 6.4 - 0.4 (SEM)
























0 1 10 100 500
Temperature INH concentration
(°C) (mM)
Fig.5.2D. Effect of temperature and of INH on rat liver NADases.
Crude rat liver membranes were prepared in Buffer System B as
described in Ch.2.5. and 1Oul aliquots were incubated in a total volume of
50^1 with 2mM-NAD and 25nCi of [carbonyl-^^C]NAD , equilibrated at the
indicated temperatures. Assays were also conducted at 37°C only^in the
presence of increasing concentrations of INH. After 5min, 50plof 57°-TCA
were added, precipitated protein was removed by centrifugation, and 10p.1
1 4
of each supernatant taken for estimation of [ C^nicotinamide. Error bars
indicate the range of duplicate determinations.
of that at 37°C. At the latter temperature some inhibition was
observed with INH, but only when high concentrations were employed.
Maximal inhibition (about 60%) was achieved with lOOmM-INH and
addition of 500mM-INH produced no further effect. It therefore
appears that some of the activities contributing to total NAD+
hydrolysis are sensitive to INH at high concentrations, but that
the remainder of the activities are of the ' INH-insensitive ' type
(see Ch. 6.).
Methylxanthines and Imidazole derivatives have been reported
to inhibit NADase and poly (ADPrribose) polymerase activities (Gill, 1972;
Levi et al, 1978).
However, as shown in Fig. 5.21., isobutyl-
methylxanthine (BMX), at concentrations approaching the limits of
its solubility in water, had only a slight inhibitory effect on the
endogenous rat liver NADases. Similarly, Green and Dobrjansky (1971a,b.)
have reported the inactivation of NADases from mammalian species by
incubation at pH 8.0 with their substrate, NAD+, but again this
treatment was only partially effective in inhibiting endogenous rat
liver NADase activities. As shown in Fig. 5.22. maximal inhibition
(about 50%) was observed after preincubation with lmM-NAD+ for 10 min.
at 0°C, and higher NAD+ concentrations were without further effect.
Like INH therefore, preincubation with NAD+ affected only a certain
proportion of the total NAD+-utilising activities, and since a
combination of NAD+-preincubation and subsequent assay in the presence
of lOOmM-INH only resulted in the same degree of inhibition (results
not shown), both treatments apparently affected the same activities.
A similar experiment involving preincubation with nicotinamide was
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Fig. 5.21 . Effect of BMX on rat liver IMADases.
Crude rat liver membranes were prepared in Buffer 5ystem B as
described in Ch.2.5. except that the pH was increased to B.C. 20(il
aliquots were incubated in a total volume of BDp.1 with 1.25mM-NAD+, 25nCi
of [carbonyl-^^C]NAD+, and the indicated concentrations of BMX. After 5min
at 37°C, 20U1 of 5^-TCA were added, precipitated protein was removed by
centrifugation, and 10lil of each supernatant taken for estimation of

























Fig.5.22. Effect of preincubation with NAD on rat livsr NADase;
Crude rat liver membranes were prepared in Buffer System B as
described in Ch.2.5. except that the pH was increased to 8.0, and 50ixl
aliquots were incubated in a total volume of 1001X1 with the indicated
concentrations of NAD+. After 1Omin at 0DC, an excess of cold 1OmM-
Tris/HCl, pH 8.0 was added, membranes were precipitated by centrifugation,
and after a further wash and centrifugation, were finally resuspended
in 100ixl of 10mM-Tris/HCl, pH 8.0. 30|xl aliquots of each suspension
were incubated in a total volume of 50M>1 with 2mM-NAD"< and 25nCi of
[carbonyl-''^C^NAD^ After 20min at 37°C, 50ixl of 5/&-TCA were added,
precipitated protein was removed by centrifugation, and 10p.1 of each
supernatant taken for estimation of [\^C]nicotinamide. Error bars
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Fig.5.23. Effect of preincubation with nicotinamide on rat liver NflPases.
Experimental details were exactly as described in the legend
to Fig.5.22. except that 2D0p>l aliquots of homogenate were preincubated
in a total volume of 4D0P-1 with the indicated concentrations of
o
nicotinamide at 25 C. Error bars indicate the range of duplicate
determinations.
The direct use of nicotinamide in the assay medium was
initially avoided because of its reported inhibitory effect on the
action of cholera toxin (Gill and Meren, 1978). However in the
experiments reported in the following section, where adenylate cyclase
activation by cholera toxin was studied in relation to the incorporation
of ADP-ribose into rat liver membrane proteins, the use of nicotinamide
proved extremely useful in investigating the mechanism of toxin
action.
A procedure was also devised which enabled almost complete
separation of adenylate cyclase from endogenous NADase activities and
results obtained with this system are reported in Ch. 5.5.
5.4. Activation of adenylate cyclase and incorporation of ADP-
Ribose in rat liver hornoqenates and membrane preparations.
Fig.5 . 24 . A shows an extended time course of adenylate cyclase
activation by cholera toxin in rat liver homogenates. In this
experiment, aliquots of homogenate were incubated with or without
cholera toxin in the presence of (\!AD+, ATP, DTT and GTP for increasing
times up to 45 min. Membranes were then isolated by centrifugation,
resuspended, and assayed for cyclase activity. Activation of the
enzyme was apparent after 2 min. of preincubation with toxin, was
maximal after 15 min, and remained in an activated state over the
entire 45 min. period. The slight decrease in activity towards the
end of the time course is probably due to the instability of adenylate
cyclase after incubation for prolonged periods. In the absence of
cholera toxin, basal adenylate cyclase activity also increased during
-126-
Fig.5.24. Time courses of -adenylate cyclase activity and of ADP-ribose
incorporation in rat liver homoqenates in the presence and
absence of cholera toxin.
. A rat liver homogenate•was prepared in Buffer System B as
described in CH.2.5. and 40lil aliquots were incubated in a total volume
of 60|il with 5mM-ATP, 5mM-DTT, 1 mM-l\]AD+, 1OOliM-GTP, 50nCi of [adenine U-
^ ^ -j.
C3NAD , and either 10p.g/ml cholera toxin (©—■©) or buffer for controls
(O—O). After the indicated times at 25°C, an excess of cold buffer was
added, membranes were precipitated by centrifugation, and resuspended in
401-11 of buffer. 15|il of each suspension were added to 10|il of assay
medium II (Ch.3.3.2.3) and adenylate cyclase was assayed for 1Omin at
25°C. 25P-1 of 5%-TCA were added to the remainders of the preincubation
1 4
mixtures and 501H aliquots were taken for estimation of [ C]ADP-ribose
incorporation. All values were single determinations only.
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the first few minutes of incubation, an observation which may be
related to the presence of GTP in the preincubation mixtures.
Aliauots of the same preincubation mixtures were also
assayed for ADP-ribose incorporation and the results are shown in
Fig. 5.24.B. During the first 10 min'. when adenylate cyclase was
undergoing rapid activation, there was little difference in the
amount of ADP-ribose incorporated in the presence or absence of
cholera toxin, and incorporation was in fact slightly less in the
presence of toxin. Incorporation of ADP-ribose in the absence of
cholera toxin continued to increase up to 30 min. after which time
the net amount of incorporation began to decease. With cholera toxin
on the other hand, incorporation of ADP-ribose began to decrease
much sooner and never attained the high levels seen in the absence
of toxin after 3D min. After 45 min. the amount of ADP-ribose
incorporated was again comparable under both conditions. The great
majority of the endogenous ADP-ribosyltransferase activity was located
in the membrane fraction (Fig. 5.25.) Cytosol contained very little
activity, an observation which could be accounted for either by a
lack of transferase enzymes or by a lack of the appropriate substrates.
However, addition of membranes and cytosol in equal volumes did not
result in an increase in the amount of ADP-ribose incorporated and
indeed there was a surprising, but significant, inhibition of incorp¬
oration on addition of cytosol to membranes. Cholera toxin had little
effect on the amount of ADP-ribose incorporated under all three
conditions.
-127-
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Fig.5.25. ADP-ribose incorporation in membrane and cytosol fractions
□f rat liver and the effect of cholera toxin.
Crude rat liver membranes and cytoscl were prepared in Buffer
System B as described in Ch.2.5. and 30ul of either preparation or 30p-l
of a mixture of equivalent amounts of each, were incubated in a total
volume of 50!Xl with 2mM-ATP, 2mM-DTT, 100pM-NAD+, 100nCi of [adenine U-
1 4 n -f
CJNAD , 200P-M-GTP, and either 10p.g/ml cholera toxin(shaded bars) or
buffer for controls (clear bars). After 10min at 25°C, 15Ul .of 25%-TCA
1 4
were added and 50lil of each suspension taken for estimation of C cD-
ADP-ribose incorporation. Error bars indicate the range of duplicate
determinations.
Since no toxin-specific ADP-ribosylation could be detected
in the crude system described above, the possibility that the toxin
was an ADP-ribosyltransferase was investigated indirectly by studying
the effects of nicotinamide on the action of cholera toxin. In the
preliminary experiment shown in Fig. 5.26, aliquots of crude membranes
were incubated with or without cholera toxin in the presence of
increasing concentrations of nicotinamide up to lOmM. Membranes
were then washed free of nicotinamide and toxin, and adenylate cyclase
activity was determined. Nicotinamide had no effect on the basal
activity of adenylate cyclase over the range of concentrations tested,
but in the presence of cholera toxin, the compound had two distinct
effects. At low concentrations (up to ImM) the toxin was apparently
able to activate adenylate cyclase to a greater extent, and only with
lDmM-nicotinamide was the action of toxin inhibited.
As noted earlier from the results in Fig. 5.18, the action
of cholera toxin in rat liver membranes was not supported unless
the NAD+ concentration was at fairly high levels. When the ability
of NAD+ to support toxin action was studied at a variety of nicotinamide
concentrations, the results shown in Figs. 5.27 and 5.28 were obtained.
In these experiments, time courses of adenylate cyclase activity
were conducted in the presence of cholera toxin with the NAD+ and
nicotinamide concentrations indicated in the figures and the membrane
preparation was the same as that used in the experiment of Fig.5.18.
When the NAD"* concentration was lOOuM (Fig.5.27), cholera
toxin increased adenylate cyclase activity almost 2-fold after a
10 min. incubation in the absence of nicotinamide. lOpM-nicotinamide
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Fig.5.26. Effect of nicotinamide on adenylate cyclase activation
by cholera toxin.
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 100M.1 aliquots were incubated in a total volume
of 2001x1 with 5mM-ATP, 5mM-DTT, 200P-M-GTP, 500|xM-NAD+, the indicated
concentrations of nicotinamide, and either 9|Xg/ml of preactivated cholera
toxin (©—@) or activation solution for controls (O—O) . After 5min at
■25°C, an excess of cold buffer was added, membranes were precipitated by
centrifugation, and resuspended in 1 DDp-l of buffer. 1 5|Xl aliquots were
added to 1Oul of assay medium II (Ch.3.3.2.3), and adenylate cyclase was
assayed for 1Omin at 25°C. 5ixl of 25%-TCA were added, precipitated
protein was removed by centrifugation, and 10p.1 of each supernatant taken
estimation of [^H]cAMP. Error bars indicate the range of duplicates.
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Fig.5.27. Effect of nicotinamide on adenylate cyclase activation by
cholera toxin in the presence of 1D0uM-NAD+.
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 1Opd aliquots were incubated in a total volume
of 25p.l in assay medium II (Ch.3.3.2.3) supplemented with 100pM-NAD+.
Preactivated cholera toxin was added to a final concentration of 2Hg/ml
and time courses were conducted in the presence of □ (©—-©) , 10p.M (□—Q) ,
100P.M (BHD) , 1 mM (A~A), 10mM (AHk) , and 25mM (O—nicotinamide.
Control incubations contained activation solution in place of cholera toxin
(O—©< . After the indicated times at 25°C, 5Hi of 25%-TCA were added,
precipitated protein was removed by centrifugatmon, and 1 Dlil of each





















Fig.5.2B. Effect of nicotinamide on adenylate cyclase activation by
cholera toxin in the presence of ImM-NADt
Experimental details were exactly as described in the legend
Fig.5.27. except that the NAD+ concentration was raised to 1mM. Time
courses were conducted in the presence of 0' (©—©) , 10UM (O-O), 100U-M
(Hi), 1mM (A-A), and 10mM (A—A) nicotinamide. Control incubations
contained activation solution in place of cholera toxin (O—O) .
the final extent of cyclase activation was increased significantly.
The presence of ImM-nicotinamide provided optimal conditions for
cyclase activation and after 10 min. the cholera toxin-stimulated
activity was 3-fold above basal levels. Further addition of nico¬
tinamide to a concentration of lOmM reduced'the extent of activation
seen after 10 min, and with 25mM-nicotinamide this was reduced still
further. It should be noted however that with high concentrations
of nicotinamide (ImM and above), a more rapid activation of adenylate
cyclase was possible and after a 2 min. incubation time, toxin-
stimulated cyclase activity increased with increasing nicotinamide
concentration.
When the NAD+ concentration was ImM (the concentration at
which maximum toxin, action was supported: see Fig. 5.IB), the
pattern of nicotinamide effects was rather different (Fig. 5.28).
Addition of nicotinamide in increasing concentrations up to 10mM
caused a progressive inhibition of adenylate cyclase activation
attained after a 10 min. incubation time with cholera toxin. Again,
however, with high nicotinamide concentrations, initial activation
of the enzyme was more rapid.
The complex effects of nicotinamide on the kinetics and
extent of adenylate cyclase activation by cholera toxin are illustrated
more clearly in Fig. 5.29 where cyclase activities after 2 min.
and after 10 min. have been plotted as a function of nicotinamide
concentration for the two different NAD+ concentrations employed.


























Fig. 5.29. Effect of nicotinamide on adenylate cyclase activation by
cholera toxin at two different NAD+ concentrations.
Experimental data are taken from Figs.5.27. and 5.2B.
Adenylate cyclase activities after 2min (0,0) and 1Omin (©,13) of
incubation with cholera toxin in the presence of 100[iM (O , ©) and
1 mM (D,S) NAD"1, are plotted as a function of nicotinamide
concentration. A and B represent basal adenylate cyclase activity
after 1Omin and 2min of incubation respectively.
(i) With 100PM-NAD+ and a 10 min. incubation time, toxin-
stimulation of adenylate cyclase is seen in the absence of nico-
\
tinamide but the extent of activation can be increased signficantly
by adding nicotinamide up to a concentration of ImM. Higher
concentrations result in progressive inhibition of toxin action.
With a 2 min. incubation time, addition of nicotinamide causes an
initial reduction in the rate of cAMP accumulation but between ImM and
25mM-nicotinamide, a progressively more rapid activation of 'adenylate
cyclase occurs.
(ii) With lmM-NAD+ and a 10 min. incubation time, cholera toxin
action is maximal in the absence of nicotinamide, but the extent of
cyclase activation is less than is seen with 100pM-NAD+ and lmM-
nicotinamide. Addition of nicotinamide then progressively inhibits
the action of cholera toxin but again the initial rate of cyclase
activation observed after a 2 min. incubation time increases with
increasing nicotinamide concentration.
Identical incubations to those described above were also
conducted in which [adenine U-^^cJnAD"1" was included in the assay medium
and ADP-ribose incorporation after 2,5, and 10 min. was determined in
the presence and absence of cholera toxin. The results are shown in
Figs. 5.30 and 5.31 for the experiments with 100pM-NAD+, and lmM-NAD+
respectively. With 100pM-NAD+, ADP-ribose incorporation under all
conditions was maximal after 5 min. of incubation, and after 10 min.
some of the incorporated ADP-ribose was apparently removed. Addition
of nicotinamide caused a progressive inhibition of incorporation with 50%
inhibition occurring with about lOOpM-nicotinamide. Maximal inhibition
(94%) was achieved with lOmM
-130
Fig.5.30. Effect of nicotinamide on ADP-ribose incorporation with
10OuM-NAP"1" in the presence and absence of cholera toxin.
Crude rat liver membranes were prepared inBuffer System D as
described in Ch.2.5. and 25|xl aliquots were incubated in a total volume
of 50p>l with 1mM-ATP, 1 mM-DTT, 100|xM-NAD+, 80p.M-GTP, 75nCi of [adenine-
14 +
U- C]l\IAD , and either 2|Xg/ml of preactivated cholera toxin (B), or
activation solution for controls (A). Time courses were conducted at
25°C in the presence of 0 (O—O) , 10(xM (©—©), 100|xM (□—□) , 1 mM (&-£!!),
1 OmM (A—A), and 2bmM (A—A) nicotinamide. Reactions were terminated by
the addition of 10pl of 25%-TCA and 50^1 of each suspension were taken
i-14 -i
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Fig.5.31. Effect of nicotinamide on ADF-ribose incorporation with
ImM-NAD* in the presence and absence of cholera toxin.
Experimental details were exactly as described in the legend
to Fig.5.3D. except that the NAD+ concentration was 1mM. Time courses
were conducted in the presence of □ (O-—O) , 1 OpM (•——•), 1 OOpM (□—Q) ,
1 mM (B8—JIS), 10rnM (A*—A), arid 25mM (A—A) nicotinamide, in the presence
(B) and absence (A) of cholera toxin.
to 25mM-nicotinamide. The pattern of ADP-ribose incorporation in
the presence of cholera toxin was essentially identical and there
was no detectable toxin-specific ADP-ribosylation under any conditions.
With lmM-NAD+ (Fig. 5.31.), ADP-ribose incorporation was
always about ID-fold greater than with lOOpM-NAD""" and the time course
of incorporation was also different from that seen with 10DpM-NAD+.
The amount of incorporation increased throughout the 10 min. incubation
period with no indication of any net removal of ADP-ribose already
incorporated. Again nicotinamide caused a progressive inhibition
of ADP-ribose incorporation but the concentrations required to achieve
the same degree of inhibition were greater. For example 50% inhibition
was not observed until the nicotinamide concentration was almost ImM
and maximal inhibition, with lDmM to 25mM-nicotinamide, was 89%.
Again the extent of incorporation in the presence of cholera toxin was
identical under all conditions.
From the above results therefore it is apparent that maximum
adenylate cyclase activation by choleia toxin is supported in the
simultaneous presence of 100pM-NAD+ and ImM-nicotinamide and that
activation under these conditions is greater than with lmM-NAD+ alone.
Despite this, a toxin-specific ADP-ribosylation was still not detectable.
Therefore an experiment was conducted using the optimal conditions of
NAD+ and nicotinamide in the presence of 20mM-thymidine. The latter
compound is an inhibitor of the enzyme poly (ADP-ribose) polymerase
which is likely to be present in the crude membrane preparations used
in these experiments (see Ch. 6.). The results are shown in Fig. 5.32.
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Fig.5.32. ADP-ribosylatlon catalysed by cholera toxin.
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 25pl aliquots were incubated in a total volume of
50pl of 1mM-ATP, ImM-DTT, 1 D0liM-NAD+, 80HM-GTP, 20mM-thymidine, 1 mM-
nicotinamide, lOCnCi of [adenine U- C]l\IAD , and the indicated
concentrations of preactivated cholera toxin. After 5min at 25°C, 1Opl
of 25^-lCA were added and 5DP'l of each suspension taken for estimation of
• 14
[ C]ADP-ribose incorporation. All values were single determinations only.
lmM-nicotinamide (Fig. 5. 3D. ) was inhibited by a further 80/S by
20mM-thymidine, reducing the rate of ADP-ribose incorporation to
barely detectable levels (.6 to 7 pmoles ADP-ribose incorporated
per 5 min. incubation time). Addition of cholera toxin to these
maximally inhibited preparations resulted in a small, but quite distinct,
increase in incorporation of ADP-ribose with increasing concentrations
of cholera toxin. The maximum amount of ADP-ribose incorporated
by the toxin (at a concentration of 9Pg/ml) was about 4 pmoles per
5 min. assay period, and with 2 Pg/ml -cholera toxin (the concentration
employed in all of the experiments described above), toxin-specific
ADP-ribosylation only amounted to about 0.3 pmoles per 5 min. If
these results represent a genuine toxin-specific ADP-ribosylation
then the specific activity of the toxin was about 750 prnoles AADP-ribose
-1 -1
incorporated min mg at 1,2 and 5 Mg/ml toxin, and 1,900 pmoles
ADP-ribose min. ^ mg ^ at 9fg/ml toxin.
It has been noted earlier that maximum adenylate cyclase
activation in rat liver membranes occurs with about lP-g/ml cholera
toxin (Fig. 5.4.) However, when a similar experiment was performed
in the presence of 100|aM [\IAD+, lmM-nicotinamide, and 20mM-thymidine,
the results presented in Fig. 5.33. were obtained. O.lli-g/ml caused a
1.5-fold stimulation of activity and lp-g/ml toxin produced almost
2-fold activation. However in contrast to earlier results (fig. 5.4.)
adenylate cyclase activity continued to increase markedly with
increasing toxin concentration and the enzyme was activated 3.5-fold
with lOPg/ml toxin and over 4-fold with 20Ug/ml toxin. It therefore
appears that the conditions established above which enabled the
observation of a detectable toxin-specific ADP-ribosylation also enabled
the toxin to activate adenylate cyclase to a greater extent over a much
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Fig.5.33. Enhanced activity of cholera toxin in the presence of
nicotinamide and thymidine.
Crude rat liver membranes were prepared in Buffer System D as
described in Ch.2.5. and 10P1 aliquots were incubated in a total volume of
25pl in assay medium II (Ch.3.3.2.3) supplemented with 1mM-nicotinamide,
20mM-thymidine, and the indicated concentrations of preactivated cholera
toxin. After 1Omin at 25°C, 5pl of 25^-TCA were added, precipitated protein
was removed by centrifugation, and 1 Dpi of each supernatant taken for
estimation of [ H^cAMP. Error bars indicate the range of duplicate
determinations.
5.5. The action of cholera toxin on solubilised adenylate cyclase
As described in Ch. 5.3.2. it was not possible to inhibit
endogenous rat liver NADases to a sufficient extent to enable
investigation of toxin action in the absence of interfering activities.
However a method was devised to separate adenylate cyclase from
these activities based on the relative ease of solubilisation of
'the former with the non-ionic detergent Lubrol-PX, which is -effective
in the range 0.01 to 0.1$ (v/v). In contrast, endogenous NADase
activity was found to be extremely resistant to solubilisation with
this detergent (Fig. 5.34.) NADase activity first appeared in the
supernatant after solubilisation with 0.1% Lubrol-PX but this
represented only about 5% of the total activity present in the membranes.
Even with 1% Lubrol-PX the majority of NADase activity remained
membrane-bound. It is interesting to note that on addition of very
low concentrations of detergent (0.001$), there was a significant
increase in the specific activity of membrane-bound NADases. This
could be due to a direct stimulatory effect of Lubrol=PX on the
enzymes or to an 'unmasking' of previously buried active sites on
the membrane surfaces.
An adenylate cyclase preparation solubilised with 0.25$
Lubrol-PX catalysed NAD+ hydrolysis with a specific activity of
about 3 nmoles nicotinamide min. ^mg ^ (Fig.5.35) which was about
5$ of the activity in the parent membrane preparation. However,
solubilised adenylate cyclase presented several new problems in
itself, not least of which was the instability of the enzyme after
activation by cholera toxin (Fig. 5.36.). Cholera toxin caused a
2-fold stimulation of activity which was maximal after a 2 min.
-133-
Fig.5.34. Solubilisatlon of endogenous rat liver NADases with Lubrol-PX.
Crude rat liver membranes were prepared in Buffer System B as
described in Ch.2.5. and 7ml aliquots were mixed with an equal volume of
Lubrol-PX in the same buffer to give the indicated final concentrations.
After mixing and centrifugation at 100,000g x 3Qmin, the supernatants
were removed and the pellets resuspended in an equal volume of buffer.
30|xl aliquots of the supernatant (O—O) and particulate fractions (@—©)
were incubated in a total volume of 50^1 with 5mM-NAD+ and 50nCi of
14 "I-
[carbonyl- C]l\lAD . After 5min (particulate preparations) or 15min
(supernatants) at 25 C, 50(^1 of 5%~TCA were added, precipitated protein
was removed by centrifugation, and 10p.1 of each supernatant taken for
1 4
estimation of [ ^nicotinamide. All values were single determinations
only.
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Fig.5.35. Hydrolysis of NAD+ in rat liver homoqenates solubilised
with 0.25?o-Lubrol-PX.
A rat liver homogenate was prepared in Buffer System B and
solubilised with 0.25^-Lubrol-PX as described in Ch.2.5. 30(il aliquots-
were incubated in a total volume of 50(il with 2mM-NAD+ and 25nCi of
[carbonyl-^C]NADl After the indicated times at 25°C, 50(11 of 5%-TCA
were added, precipitated protein was removed by centrifugation, and 10(il
1 4
of each supernatant taken for estimation of [ C]nicotinamide. All values
were single determinations only.
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Fig.5.36. Activation of Lubrol-solubilised adenylate cyclase by cholera toxin.
A rat liver was prepared in Buffer System B and solubilised with
□ . 25%-Lubrol-PX as described in Ch.2.5. 1 50|Xl aliquots were incubated in a
total volume of 200lxl with 1mM-ATP, 1mM-DTT, ImM-NAD"1", and either 10p.g/ml
cholera toxin (©—©) or buffer for controls (O—O) . After the indicated times
at 25 C, 15ixl aliquots were transferred to tubes containing 10|Xl of assay
medium I (Ch.3.3.2.3) to give a final ATP concentration of 1mM. After a
further incubation at 25°C for 5min, 10ixl of 25%-TCA were added,
precipitated protein was removed by centrifugation, and 5|Xl of each
supernatant taken for estimation of [ H]cAMP. All values were single
determinations only.
preincubation time but on longer incubations with toxin, the
stimulated activity decayed rapidly and within 6 min. had. fallen
below the activity of the unstimulated, control enzyme. Similar
results have been reported previously (van Heyningen, 1976b ).
Short incubation times (2 min.) were therefore employed in all
future work on this system.
Activation of solubilised adenylate cyclase by cholera
toxin was completely analogous to activation of the membrane-bound
enzyme. 0.01 Vig/ml toxin caused some activation } activation was
maximal with lPg/ml, and addition of more toxin up to a concentratio
of 50Pg/ml.had no further effect (Fig. 5.37.) Maximal activation
was about 3-fold over basal levels. However estimations of ADP-
ribose incorporation in an identical series of incubations produced
the surprising result that addition of cholera toxin caused marked
inhibition of ADP-ribose incorporation. In the presence of 10pg/ml
toxin, when adenylate cyclase" was already maximally activated, ADP-
ribose incorporation was less than 10% of that in the absence of
toxin. 50p<g/ml toxin caused only a further slight reduction in
ADP-ribose incorporation.
The action of cholera toxin as an inhibitor of endogenous
ADP-ribosyltransferases is clearly illustrated in Fig. 5.38. which
shows time courses of ADP-ribose incorporation in the presence of
several different concentrations of cholera toxin. At all points
on the time courses, the rate of ADP-ribose incorporation decreased
with increasing toxin concentration with 50% inhibition occurring
at about O.lPg/ml toxin. Although cyclase activation was maximal
a-fter 2 min. of incubation with toxin, the toxin-induced inhibition
of ADP-ribosyltransferases was maintained for at least 10 min.
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Fig.5.37. Activation of adenylate cyclase and inhibition of ADP-ribose
incorporation by cholera toxin in soiubilised rat liver
homoqenate.
A rat liver homogenate was prepared in Buffer System B and
solubilised with □. 25?o-Lubrol-PX as described in Ch.2.5. 50pl aliquots
were incubated in a total volume of 1 OOpl with 5mM-ATP, 5mM-BTT, 200pM-
NAD+, 50nCi of [adenine U-'' ^C]NAD+, and the ind icated concentrations of
cholera toxin. After 2min at 25°C, 1 5pl aliquots were transferred to
tubes containing 1 Dpi of assay medium II (Ch.3.3.2.3) to'give a final
ATP concentration of 5mM, and adenylate cyclase activities were
determined after a 5min assay at 25°C. 50pl of 5$-TCA were added to
the remainders of the preincubation mixtures and 1ODpl of each
14
suspension were taken for estimation of [ C]ADP-ribose incorporation.
All values were single determinations only.
(O—O) : Adenylate cyclase activities.
(®——©) : ADP-ribose incorporation.
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F i g. 5. 3 8 . Effect of cholera toxin on ADP-ribosylation in solubilised
rat liver homoqenate.
A rat liver homogenate was prepared in Buffer System B and
solubilised with 0.25/£-Lubrol-PX as described in Ch.2.5. 50pl aliquots were
incubated in a total volume of 1OOpd with 2mM-ATP, 5mM-DTT, 200PM-NAD ,
100p>M-GTP, 50nCi of [adenine U-^C^NAD*, and cholera toxin at final
concentrations of □ (O—O) , 0.01 (#—@) , 0.1 (□—□), and 1 (B—IS) l^g/ml.
After the indicated times at 25°C, 10pl of 25/&-TCA were added and EOpl of
14 n
each suspension taken for estimation of [ CjADP-riboee incorporation.
All values were single determinations only.
Chapter 6. Discussion
6.1. The NADase activity of cholera toxin.
6.1.1. NAD+ hydrolysis by purified preparations of cholera toxin.
As outlined in Ch. 1.10,I\IAD+ was initially implicated in
the mechanism of action of cholera toxin by Gill (1975) who showed
that pigeon erythrocyte lysates, when depleted of endogenous NAD+,
became refractory to cholera toxin and that on readdition of exogenous
NAD+, toxin sensitivity was restored. On the basis of these observations
Gill suggested that one possible mechanism of toxin action could be
the transfer of the ADP-ribose moiety, of NAD^ to an intracellular
acceptor protein, possibly a part of the adenylate cyclase complex
itself. Such a mechanism would be analogous to the already established
action of diptheria toxin. Once inside a cell, diphtheria toxin uses
endogenous supplies of NAD+ as a substrate for the ADP-ribosylation
of elongation factor-2 (EF-2), an event which inhibits the translocation
of nascent polypeptide chains from the acceptor to the donor sites
on ribosomes, thereby inhibiting protein synthesis (see Collier, 1975).
Possible analogies with diphtheria toxin can also be
suggested from the similarities in the structures of the two toxins
despite the fact that, superficially, there appear to be few points
of comparison. Unlike cholera toxin, diphtheria toxin does not possess
a complicated subunit structure and consists only of one 62,000 dalton
polypeptide. However the toxin is readily cleaved proteolytically to
produce a species known as 'nicked' toxin which consists of two distinct
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polypeptide chains held together covalently by one disulphide bridge,
□n reduction with thiol reagents the two fragments, termed A and B
(of molecular weights 24,000 daltons and 30,000 daltons respectively),
are released. Fragment A alone has been shown to be the enzymically
active species (Gill and Dinius, 1971; Gill and Pappenheimer, 1971;
Collier and Traugh, 1969 ), and since this fragment is not toxic
towards intact cells, fragment B is presumed to be responsible for
the binding of toxin to cell surfaces and possibly also for assisting
fragment A in its passage through the'cell membrane to its intracellular
site of action. Since the enzymic activity of diphtheria toxin is
only manifested after the proteolytic and reductive generation of
fragment A (Collier and Traugh, 1969), this process presumably occurs
in vivo and could perhaps be catalysed by host cell proteases at some
stage after the initial toxin binding event. Thus the two functional
domains of diphtheria toxin are entirely analogous to the A and B
subunits of cholera toxin, although in the case of diphtheria toxin,
much less is known about the specific ceil surface receptor recognised
by the B fragment of the toxin.
The possibility that subunit A of cholera toxin is also an
enzyme possessing an ADP-ribosyltransferase activity was supported
by the observations of Moss et al (1976b) who found that cholera toxin
was capable of hydrolysing NAD+ to nicotinamide and ADP-ribose. The
results presented in Fig. 5.6. confirm this observation and, also in
agreement with these workers, high concentrations of cholera toxin and
long incubation times were necessary before a detectable NADase activity
could be demonstrated. Pigeon erythrocyte cytosol had no effect on
the NADase activity of cholera toxin (Fig. 5.7.) thereby ruling out
-136-
the possibility that the cytosolic factors implicated in the mechanism
of toxin action (Gill, 1975; 1976b) were not involved in the enhancement
of an enzymic activity of cholera toxin towards NAD+. As shown in
Fig. 5.5. a requirement for cytosolic factors in toxin action was not,
in any case, observed in the rat liver system, a result which is in
agreement with those of Martin et al (1977) who demonstrated activation
of adenylate cyclase by cholera toxin in purified rat liver plasma
membranes. However some of the results discussed later suggest the
existence of cytosolic factors which, "although not essential requirements
for toxin action, may at least assist the toxin in adenylate cyclase
activation.
The discrepancy between the concentrations of cholera toxin
required for cyclase activation and those required to demonstrate an
NADase activity does not necessarily argue against an enzymic mechanism
of toxin action involving NAD+ as a substrate. Diphtheria toxin is
known to catalyse three different reactions:
1. H^D + NAD+^—ADP-ribose + nicotinamide + H +
2. Diphtheria toxin + NAD~^=;Diphtheria toxin - ADP-ribose +
nicotinamide + H+
3. EF-2 + NAD EF-2-ADP-ribose + nicotinamide + H+
Only reaction 3, the ADP-ribosylation of EF-2, is considered
to be of physiological importance, the other two reactions (NAD+
hydrolysis and self-ADP-ribosylation) being merely unphysiological
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manifestations of the true activity which are catalysed at a much
slower rate. NAD+ hydrolysis by diphtheria toxin has been calculated
to proceed at a rate which is about 2 x 10^ times less than that of
EF-2 ADP-ribosylation under conditions of saturating NAD+ (Kandel
et al, 1974). However it is essential, when using high concentrations
of toxins, to establish that any observed effect is a true property
of the toxin under study and that it is not due to small amounts of
contaminating proteins, the activities of which would not normally
be detectable at physiological concentrations of the toxin. The
problems of purity in -toxin preparations and the possibilities of
contaminating activities, even in apparently highly purified
preparations, have been discussed recently by Wadstrom (1978) and
it is interesting to note the case of at least one other bacterial
toxin to which an enzymic activity was wrongly assigned. The strepto¬
lysin 0 from Streptococcus pyogenes was initially thought to possess
an intrinsic NADase activity but subsequent studies demonstrated that
this activity was in fact due to a contaminant and could be separated
from the toxin by iso-electric focussing(Alouf and Raynaud, 1970;
1973; Shany et al,1973; Smyth and Fehrenbach, 1974).
In the case of diphtheria toxin there is good evidence
to suggest that NADase activity is a genuine property of the toxin
and indeed this activity, by allowing kinetic and inhibitor studies
to be conducted in simple, well defined buffer systems (Kandel
et al, 1974), has been useful in elucidating the detailed mechanism
of the toxin's action. In a similar way, the demonstration of a
cholera toxin-associated NADase activity provided opportunities for
studying the action of cholera toxin in a simplified system.
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However some of the results presented in Ch. 5.2. were not consistent
with the supposition that NADase activity was a genuine reflection
of the toxin's true activity and emphasised the need for caution
in extrapolating from results obtained in studies of this activity
to the mechanism of toxin action on adenylate cyclase. Before
discussing these results, it is important to consider some aspects
of the stability of NAD+ in different buffer systems.
6.1.2. Effects of ionic strength on the stability of NAD+
Stimulation of the NADase activity of cholera toxin in
phosphate buffers as reported by Moss et al (1976b) and Moss and
Vaughan (1977), was not confirmed in this work. The results in
Fig. 5.8. indicate that the increased rate of NAD+ hydrolysis by
cholera toxin with increasing potassium phosphate concentrations
is not due to a direct stimulatory effect of phosphate on the toxin's
activity, but to a non-specific effect on the stability of NAD+.
Also in contrast to the results of Moss and coworkers, the NADase
activity of the toxin used in this study was independent of buffer
composition and activities were comparable, after appropriate blank
subtraction, in 50mM-Tris/HC1, 200mM-sodium acetate, or various
concentrations of potassium phosphate. As Fig. 5.9. shows, the non¬
specific effect on NAD+ hydrolysis was not unique to phosphate,and
NaCl in high concentrations also resulted in a high degree of non¬
specific NAD+ hydrolysis.
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These results are in agreement with previous reports on
the stability of NAD+ in various buffer systems at different pH
values. Colowick et al (1951) noted that with phosphate buffers,
+ o
the cleavage rate of NAD- at 100 C increased dramatically at pH
values of 6 and above and when several buffers were tested, all
at 0.1M concentration and pH 7.5, only phosphate and citrate increased
the rate of NAD+ destruction. Lowry et al (1961) confirmed these
observations and described 3.5-fold and 7-fold increases in the
cleavage rate of NAD+ at pH 6.2 and 6.B respectively by 0.lM-phosphate,
whether at 25 , 38 or 60°C. These workers also described enhanced
cleavage of NAD+ in the presence of NaCl and several other salts.
It should he noted that the buffer systems employed by
Moss and coworkers -routinely contained 0.2M to □.4M-potassium
phosphate at pH 7.0,under which conditions the non-specific cleavage
rate of NAD+ is high. Although no references were made to the
problems of high blank values in this system, the use of 0.4M-
phosphate in the work described here resulted in blank values which
were only slightly lower, and often greater, than the values obtained
in the presence of cholera toxin. Since the non-specific effects
of NaCl on the stability of NAD+ were even more marked (in Fig. 5.9.
for example, almost 25$ of all available NAD+ was destroyed by lM-NaCl
in the absence of cholera toxin), the apparent ten-fold increase
in the activity of toxin on increasing the NaCl concentration from
zero to 1M, was not considered to be of any real significance.
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6.1.3. NAD+ hydrolysis by culture filtrates of V. chclerae
The fact that cholera toxin appeared to be capable of
hydrolysing NAD+ raised the possibility of monitoring toxin purification
enzymically, thereby improving significantly on the qualitative
techniques of Ouchterlony immunodiffusion and SDS gel electro¬
phoresis used previously. However, as shown in Fig. 5.10. crude
culture filtrates of V. cholerae possessed an NADase activity which
was almost 200 times greater than that' of the purified toxin.
Furthermore, NADase activity purified separately from cholera toxin
and the non-toxin NADase eluted from DEAE-cellulose was again about
200 times more active than the toxin finally obtained in this
purification. It should be emphasised that all preparations of
cholera toxin purified during the course of this work (which all
appeared to be homogeneous on polyacrylamide gel electrophoresis),
displayed different specific activities of NADase, depending
presumably on the efficiency of removal of the non-toxin NADase in
different purifications. However since all preparations displayed
at least some degree of NADase activity, the possibility of a toxin-
associated NADase was not ruled out by this observation alone.
Nevertheless the results do emphasise the importance of purity in
toxin preparations when using high concentrations of the toxin. From
the results in Fig. 5.11. it can be calculated that all of the NADase
activity observed in the purified toxin (0.75Pg of protein per
assay), could be accounted for by only 4.7 ng of non-toxin NADase
contaminant. 50ug of the same preparation could therefore con~tain
0.3lig of non-toxin NADase and thus, even with large loadings on SD5-
polyacrylamide gels, the proposed contaminaiit would not be visible.
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6.1.4. Arguments against the significance of NADase activity
in relation to the action of cholera toxin on adenylate
cyclase.
If NAD+ hydrolysis by purified preparations of cholera
toxin was a useful indication of the activity of toxin with respect
to adenylate cyclase activation, treatments which alter cyclase
activation by the toxin would be expected to alter the NADase
activity in the same way. However this was not found to be the
case. Preincubation, of cholera toxin in a dilute solution of SD5
and DTT enhances the subsequent ability of the toxin to activate
adenylate cyclase in broken cell preparations (Gill, 1976b; van
Heyningen, 1977b). This is presumed to be due to the release of
active peptide A^ from the intact toxin molecule during the SDS-
DTT treatment. Such a treatment might therefore be expected to
enhance the toxin's NADase activity but on the contrary, preincubation
with 5DS and DTT markedly inhibited the NADase reaction catalysed
both by purified cholera toxin and by the non-toxin NADase (Table 5.5.)
Similarly, preincubation with antitoxin, a procedure which prevents
toxin action on subsequent addition to an adenylate cyclase preparation,
had no effect on the NADase activity of either culture filtrates of
V. cholerae or of purified cholera toxin (Table 5.6.).
Direct evidence that the NADase activity of purified cholera
toxin was not a genuine property of the toxin was derived from the
results presented in Fig. 5.12. In this experiment cholera toxin,
in both crude and purified preparations, comigrated on polyacrylamide
gels with an expected peak of adenylate cyclase activating activity
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but in 'the purified material this did not coincide with any detectable
NADase activity. It appears therefore that the cholera toxin purified
in this work possesses an RIADase activity which can be wholly accounted
for by a contaminating enzyme present in small amounts. Although it
remains possible that a more sensitive assay method may have detected
a toxin-associated NADase activity, this alone cannot account for the
differences between these results and those of Moss et al (1976b)
who, using similar assay procedures, demonstrated NADase activity in
one slice from a polyacrylamide gel of'purified cholera toxin in a
comigrating position with the stained protein band. The mobility of
their toxin on the gel was similar to that observed here, but no
other peaks of NADase activity were detected. Adenylate cyclase
activating activities of the gel slice fractions were not reported.
It is also possible that a specific toxin-associated NADase
activity may have been detected had the assays been conducted in the
presence of agents which have been reported to enhance the NADase
activity of the toxin. Moss and Vaughan (1977) have described marked
enhancement of this activity in the presence of arginine, a phenomenon
which was explained by suggesting that arginine, by acting as a more
efficient acceptor of ADP-ribose than water, encouraged the cleavage
of NAD+ by cholera toxin. Direct evidence for this suggestion was
also presented when a compound with the characteristics of an ADP-
ribose-argiiiine adduct was isolated from incubation mixtures containing
cholera toxin, NAD+ and arginine. However as shown in Tables 5.1. and
5.2., the NADase activity of cholera toxin purified in this laboratory,
as well as a sample of purified toxin given by Dr. R. Rappaport, was
consistently unaffected by arginine. At present, no satisfactory
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explanation for this major discrepancy with the results of Moss and
coworkers can be put forward.
It is interesting to note that more than one species of
adenylate cyclase activating material was observed in both crude and
purified toxin preparations (Fig. 5.12.) The crude toxin (culture
filtrate) displayed one major peak distinct from the toxin itself at
mobility 0.45. It seems probable that this represents free subunit
A of the toxin since a similar gel of the purified subunit, stained
for protein, displayed one band in this position (results not shown).
After purification much of this material was removed but was replaced
with several other smaller peaks of activity and in fact, the purified
toxin was more heterogeneouswith respect to adenylate cyclase
activating species than was the crude material. The most likely
explanation for this phenomenon is the proteolytic generation of
fragments of active subunit A during purification. The problems of
proteases in some batches of crude toxin have already been referred
to in Ch. 4. and a recent report by Gill and Rappaport (1979) has
implicated the possible importance of extracellular V. cholerae
proteases in the production of the 'nicked' A^ and A^ peptides of
cholera toxin. In this report also, similar experiments to the one
described above were reported in which active cyclase stimulating
material was only observed in association with intact subunit A or
with peptide A^ on 5D5-polyacrylamide gels. No other peaks of activity
analogous to those in Fig. 5.12.B. were detected. This may simply
reflect a greater purity of the toxin preparation used by these workers
but since their experiments were conducted on 5D5 gels, the presence
of fragments differing by only a few hundred daltons cannot be excluded.
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Such fragments would migrate in essentially the same position as
intact subunit A on SDS gels but the loss of only one or a few amino
acids may result in markedly different migration characteristics on
native polyacrylamide gels where overall charge, as well as size
and shape, contributes to the observed mobility. Thus the various
peaks of activity present in Fig. 5.12.B do not necessarily represent
very small fragments of subunit A but may differ from this, and from
each other, in only several amino acids. On the other hand, significantly
smaller fragments are not excluded either. Matuo et al (1976) reported
the generation of active fragments of cholera toxin by proteases
present in Sarcoma 180 cell membranes, and the smallest fragment which
still retained activity was reported to have a molecular weight of
only 1,400 daltons i.e. about ten amino acids in length. Although
it is difficult to reconcile an enzymic mechanism of toxin action
with the retention of activity by such a small fragment, it is interesting
to note that recent studies on the amino acid sequence of peptide A^
of cholera toxin have revealed a small area of sequence homology
with the q/ subunit of thyrotropin stimulating hormone (T5H), and that
this same sequence is remarkahly similar to the nonapeptide neurohypo¬
physeal hormones oxytocin and vasopressin (see Kohn et al, 1978).
It will be of obvious interest to determine the amino acid sequence of
the active 1,400 dalton fragment since this may not activate adenylate
cyclase in the same way as intact peptide A^. The selective advantages
of a toxin which could still activate pathogenic processes (perhaps
by a different non-enzymic mechanism) even if severely degraded by
intracellular proteases, are obvious. Furthermore, if small fragments
of cholera toxin generated intracellularly were capable of binding
directly to adenylate cyclase, some of the results of Cuatrecasas and
coworkers described in Ch.1.10. could also be more readily explained.
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The major conclusion to be drawn from the above experiment
is that the adenylate cyclase activating activity of the cholera toxin
purified in this laboratory was not associated with an NADase
activity and that the small amount of the latter activity in these
preparations was due to a contaminant enzyme. The possible role of a
highly active NADase secreted extracellularly by V. cholerae is
obscure and to the author's knowledge, the enzyme has not been
described previously. NADases are widely distributed in nature and
have been described in several microorganisms. In general, procaryotic
NADases are soluble enzymes which are resistant to inhibition by
nicotinamide and by other pyridine compounds (including INH) and
which are often accompanied by heat-labile inhibitor proteins (Everse
and Kaplan, 196B). The major NADase of V. cholerae was also resistant
to inhibition by INH (Table 5.4.) and thus resembles most other
bacterial NADases, but since the enzyme was active without a requirement
for heat treatment, it apparently is not accompanied by a heat labile
inhibitor protein. In a recent report (Fernandes et al, 1979),
membrane-bound NADases have been described in the inner and outer
membranes of V. cholerae. In the inner membrane most of the NADase
activity was associated with a 29,000 dalton protein while in the
outer membrane the major NADase had a molecular weight of 22,000.
The inner membrane NADase was also capable of ADP-ribosylating a
44,000 dalton protein also in the inner membrane and antibodies
against subunit A of purified cholera toxin inhibited this ADP-ribo-
sylation. The authors suggested that these activities may represent
the membrane-bound precursors of cholera toxin and that ADP-ribosylation
of the 44,000 dalton protein in the inner membrane may be of importance
in cellular regulation. It is interesting to note that although
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antibodies against subunit A of purified toxin inhibited the ADP-
ribosyltransferase activity of the putative inner membrane-bound
precursor of toxin, it had no effect on the NADase.activity. In the
same way, activation of-adenylate cyclase by chole-ra toxin, which
may involve an ADP-ribosyltransferase activity, is inhibited by
cholera antitoxin, but NADase activity was unaffected by antitoxin
treatment (Table 5.6.). These results lend support to the hypothesis
that the inner and outer membrane NADases of V. cholerae are
associated with the precursors of cholera toxin and suggest that
NADase activity, if a genuine property of the purified toxin, occurs
independently of the putative ADP-ribosyltransferase activity and
may be catalysed at a different site. Since the NADases described
in these studies were membrane-bound, they are probably unrelated
to the major NADase described in this work which was a soluble enzyme,
secreted extracellularly by V. cholerae.
Kinetic studies with different preparations of purified
cholera toxin did not fully support the conc-lusion drawn from the
results in Fig. 5.12. that cholera toxin is devoid of an NADase
activity. As shown in Figs. 5.13. and 5.14., the NADase activity
in culture filtrates of V. cholerae and in the toxin purified
therefrom, exhibited the same kinetic affinity for NAD+ (0.2mM),
confirming that both activities are due to the same enzyme. However
kinetic analyses of the reactions catalysed by purified cholera
toxin given by Dr. R. Rappaport and Dr. R.A. Finkelstein both
displayed ten-fold greater Km values for NAD+ (Figs. 5.15. and
5.16.). Even this latter value of 2mM is considerably less than
that of 3.8 rnM initially reported by Moss et al (1976b), although
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the use of low concentrations of phosphate (lOmM) and analysis of
the data by the statistically more accurate Direct Linear method in
the work described here, may account for this difference. Despite
the wide variations in the kinetic parameters of the NADase reactions
catalysed by different toxin preparations, the two most widely
differing samples (the toxin purified in this laboratory and the toxin
from Dr. R.A. Finkelstein) produced virtually identical effects on
rat liver adenylate cyclase when added in equal concentrations
(Fig. 5.17.)•
The above results indicate that the study of the NADase
activity of cholera toxin is of questionable value in investigating
the mechanism of toxin action. Although it cannot be concluded with
certainty that cholera toxin does not possess an NADase activity,
these results and those of Fernandes et al (1979) suggest that this
activity is at least independent of the activity responsible for
adenylate cyclase activation. Thus the only artifical system which
may be expected to yield valuable information on the mechanism of
cholera toxin action would be one which is directed specifically
towards the ADP-ribosyltransferase activity of the toxin. The system
initially reported by Moss and Vaughan (1977) in which the toxin-
catalysed ADP-ribosylation of arginine was described, has recently
been modified by Mekalanos et al(1979a,b) who have studied the detailed
molecular mechanisms involved in the transfer of the ADP-ribose
moiety of NAD+ to guanidine groups on artifical acceptor molecules
catalysed by cholera toxin.
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Studies with this artificial system are likely to provide
useful information on the mechanism of cholera toxin action.
In this work however, it was decided to study the role of
NAD+ as a putative substrate for toxin-cafalysed ADP-ribosylation
under conditions in which adenylate cyclase activation is observed
i.e. in crude cellular systems with physiologically meaningful
concentrations of toxin and of reactants. In particular, attempts
were made to demonstrate toxin-specific ADP-ribosylation of rat liver
membrane proteins as was reported in pigeon erythrocyte membranes
concurrently with the execution of this work (Gill and Meren, 1978;
Cassel and Pfeuffer, 1978). In this way it was hoped to establish
that the mechanism of toxin action in complex membranes was at least
similar to its action on the relatively simple pigeon erythrocyte
system.
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6.2. The role of NAD in the activation of adenylate cyclase
by cholera toxin.
6.2.1. Requirement for NAD+ in toxin action and interference by
endogenous rat liver enzymes.
The l\IAD+ requirement for cyclase activation by cholera
'toxin first reported by Gill (1975) in pigeon erythrocyte lysates,
and later verified in many tissues including rat liver plasma
membranes (Martin et al, 1977), was also confirmed here (Fig. 5.18.)
However, while Martin and coworkers noted a continually increasing
extent of cyclase activation with increasing NAD+ concentrations up
to at least 5mM, Fig. 5.18. indicates that maximum toxin action in
crude rat liver membranes was observed with ImM-NAD , and 5mM-NAD+
was less effective. These results are similar to those of Flores
et al (1976) who also observed a maximum effect of cholera toxin in
rat liver homogenates with lmM-NAD+. These differences may reflect
some property of the crude systems used by the latter authors and in
this work, as opposed to the purified plasma membranes employed by
Martin and coworkers. As shown in Fig. 5.18., the extent of cyclase
activation was not directly proportional to the NAD+ concentration
as might be expected if NAD+ was the substrate for a toxin-catalysed
reaction, but this is undoubtedly related to the high levels of
contaminating NADases in the crude membrane preparation (Fig. 5.19.)-.
Since cholera toxin action was not supported at low NAD+ concentrations,
it may be postulated that under these conditions the toxin is unable
to compete effectively for substrate with the endogenous NADase
activities and that the latter enzymes may exhibit a higher affinity
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for NAD+ than does the toxin. Mammalian NADases in general tend to
possess hiqh affinities for NAD+ and K values of l6u>M for bovine
. m
erythrocyte NADase (Pekala and Anderson, 1978), 56p.M for calf-spleen
NADase (Schuber and Travo, 1976), and lOOl^M for soluble seminal fluid
NADase (Yuan and Anderson, 1971) have been reported. Although these
values are certainly much lower than that for the NADase activity of
cholera toxin, for the reasons discussed in the previous section it
is not possible to make any meaningful comparisons until the Km value
for NAD+ in the toxin-associated ADP-ribosyltransferase activity
has been determined.
It should be emphasised that the endogenous rat liver activities
referred to collectively here as 'NADase', probably represent a
variety of enzymes which catalyse the release of nicotinamide from
NAD+ and in crude rat liver membranes there are likely to be two
major activities contributing to total NAD+ destruction:
(i) P°ly (ADP-ribose) polymerase
(ii) microsomal NADase
Poly (ADP-ribose) is a polymer cf repeating ADP-ribose
residues linked ribosyl (1 -» 2) ribose with adenosine at the growing
end which has been found covalently attached to histones (Nishizuka
et al, 1968; Otake et al, 1969), and which has been implicated in the
control of DNA synthesis and gene expression (Burzio and Koide, 1970;
1971; Lehmann et al, 1974; Rickwood et al,1977).
However the exact function of this curious polymer remains obscure.
The enzyme responsible for its synthesis, poly (ADP-ribose) poly¬
merase, has been reported to exhibit a Km value for NAD+ of 0.25mM
both in nuclei (Nakazawa et al, 1968 ) and in soluble extracts of tissue
homogenates (Gill, 1972). Since the crude rat liver membrane preparations
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employed in the work described here undoubtedly contained nuclear
material, poly (ADP-ribose) polymerase is likely to be an important
competitor for NAD+ in this system. However, since purified plasma
membranes (which should be devoid of this enzyme) still displayed
high levels of NAD+ - utilising activities (Table 5.7.), the membrane-
bound microsomal NADases probably represent the major pathway for
NAD+ destruction. NADases have been reported previously to co-purify
along with plasma membranes as well as with microsomal fractions'
(Bock et al, 1971). Since the endogenous NAD+-utilising activities
could therefore not be separated from adenylate cyclase simply by
purifying the plasma membrane fraction, several attempts were made to
selectively inhibit these activities leaving the action of cholera
toxin unaffected.
NADases from different species exhibit curious differences
in their susceptibility to inhibition by INH. For example the enzymes
from homogenates of beef spleen and brain are inhibited by more than
50% with 0.75mM-INH, while in the corresponding tissues from rat and
mouse, NADases are relatively unaffected by 25mM-INH. In general,
NADases from ruminants and birds are 'INH-sensitive' while those from
all other species are 1INH-insensitive' (Zatman et al, 1954). The
results in Fig. 5.20. indicate that INH in high concentrations did
have an inhibitory effect on rat liver NADases and maximal inhibition
(about 60%) was observed with 100mM-INH. Although this appears to
be a significant inhibition, the remaining activity was still at a
high level and continued to interfere with the action of cholera toxin.
Similarly, other inhibitory techniques tested were either totally
ineffective (preincubation with nicotinamide) or only partially
-152-
effective (preincubation with NAD+; treatment with methylxanthines)
as inhibitors of the endogenous rat liver NADases.
It is evident therefore that the major problem encountered
by Gill and Meren (1978) in attempting to 'demonstrate cholera toxin-
specific ADP-ribosylation in pigeon erythrocyte membranes was exactly
reversed in the rat liver membrane system. In the former case,
endogenous NAD+ in the pigeon erythrocyte lysate diluted high specific
radioactivity [^p] NAD+ added exogenously, thereby rendering the
small amount of ADP-ribose incorporated by the toxin undetectable.
In rat liver membranes it was not possible to add low concentrations
of highly radioactive l\IAD+ since such low concentrations (lOpM) were
insufficient to support cholera toxin action, being metabolised
preferentially through the endogenous l\IAD+-utilising pathways. Although
it proved possible to effectively separate adenylate cyclase from these
activities, based on the selective solubilisation of the former with
Lubrol-PX, new difficulties arose from the use of solubilised prep¬
arations, .the major problem being the instability of adenylate cyclase
after solubilisation. Nevertheless, some interesting results were
obtained with this system and these are discussed later (Ch. 6.3.),
but because of the problems of cyclase stability, studies were
continued mainly with the particulate crude membrane preparation.
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6.2.2. Incorporation of ADP-ribose into rat liver proteins.
When adenylate cyclase activity in rat liver homogenate
was determined after various times of incubation with or without
cholera toxin, in conjunction with estimations of ADP-ribose incorp¬
oration, the results shown in Fig. 5.24. were obtained. 1 mM-NAD+
was employed in this experiment which was therefore sufficient to
support maximum cholera toxin action and after 15 min. of incubation
with toxin, the cyclase was activated' maximally by about two-r'fold.
Despite this clear activation, no toxin-specific incorporation of
ADP-ribose was evident and indeed, at later time points, ADP-ribose
incorporation in the presence of toxin was significantly inhibited.
Time courses of ADP-ribose incorporation in crude extracts of mammalian
tissues characteristically show the pattern illustrated in this figure,
namely an initial rapid burst of incorporation, followed by a decrease
in the rate of incorporation, and then an overall decline in the net
amount of ADP-ribose incorporated. This probably reflects alterations
in the relative rates of synthesis and degradation of protein-ADP-
ribose complexes. In particular, mammalian nuclei contain two enzymes
which are responsible for the degradation of poly (ADP-ribose) polymers
a nucleolar phosphodiesterase which hydrolyses pyrophosphate bonds
at the terminal poly (ADP-ribose) residue and which may also hydrolyse
NAD+ ( Futai and Mizuno, 1967; Futai et al,
1968), and a soluble poly(ADP-ribose) glycohydrolase which catalyses
hydrolysis of the ribosyl-ribose bonds (Ueda et al, 1972; Miwa and
Sugimura, 1971). After the first ten to fifteen minutes of incubation
in the above experiment, NAD+ levels will be severely depleted as a
result of the action of endogenous microsomal NADase activities (Fig.5.
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and since substrate concentration will therefore become limiting,
the rate of ADP-ribose incorporation will decrease and eventually
cease altogether, leaving visible only the rate of degradation of
protein -ADP-ribose complexes.
A comparison of Figs. 5.24.B. and 5.19. indicate that the
majority ofthe MAD+-utilising activities in rat liver homogenates are
probably of the NADase type. Total NAD+ destruction after ID min.
in Fig. 5.19. amounted to about 70 nmoles of nicotinamide released
per assay after the initial addition of 2mM-NAD+, while in the presence
of lmM-NAD+ in the above experiment, only about 250 pmoles of ADP-ribose
were incorporated into protein after the same time. Although these
two experiments were conducted under slightly different conditions
and at different incubation temperatures, it is clear that ADP-ribo-
syltransferase activites constitute only a small fraction of the total
NAD+ - utilising activities in rat liver homogenates.
The apparent inhibition of ADP-ribose incorporation by cholera
toxin at all time points, and especially after 10 min. of incubation,
is discussed later when the same effect was observed, but to a greater
extent, in solubilised rat liver homogenates. It is evident at this
stage that if cholera toxin catalyses an ADP-ribosylation, then the
techniques employed in the above experiment were not sufficiently
sensitive to detect this process.
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6.2.3. Effects of nicotinamide and thymidine on the action of
cholera toxin.
Nicotinamide, an effective inhibitor of NADases and ADP-
ribosyltransferases from most eucaryotic species (Zatman et al, 1953;
1954; Gill, 1972; Pekala and Anderson, 1978), was found to exhibit
selective effects between the activities of endogenous NAD+-utilising
enzymes and of cholera toxin in rat liver membranes. As Fig. 5.26.
shows, a preliminary experiment indicated that nicotinamide could
inhibit the action of cholera toxin but only when present in high
concentrations.At lower concentrations (up to ImM) the compound appeared
to result in enhancement of adenylate cyclase activation by the toxin.
A more detailed study of the effects of nicotinamide confirmed this
finding and three major conclusions can be drawn from the results
summarised in Figs. 5.27 to 5.29.
(i) the action of cholera toxin on adenylate cyclase in crude
rat liver membranes can be supported with low concentrations of NAD+
provided that nicotinamide is also present, and indeed with a
combination of 100M.M-NAD+ and ImM-nicotinamide, toxin action is greater
than with lmM-NAD+ alone. At concentrations of nicotinamide greater
than ImM, inhibition of toxin action begins to occur. In contrast,
when the NAD+ concentration is high, low concentrations of nicotinamide
do not enhance the action of cholera toxin and a slow progressive
inhibition occurs on the addition of this compound.
(ii) High concentrations of nicotinamide, although reducing the
maximal extent of cyclase activation observed after a 1C min. incubation
time, result in an initial rapid burst of adenylate cyclase activation
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after 2 min. when an effect of cholera toxin is not normally evident.
This effect is seen with both low (lOOpM) and high (ImM) concentrations
of NAD+.
(iii) Even with high concentrations of- nicotinamide (10 mM to
25mM), cholera toxin action is not completely inhibited and significant
cyclase activation still occurs. This result is not in agreement with
those of Fig. 5.26. where lOmM-nicotinamide was found to completely
inhibit toxin action. No definite explanation can be offered for this
discrepancy but since the above results were reproducible in several
different experiments, they are probably more reliable than the prelimina
results of Fig. 5.26.
ADP-ribose incorporation assays conducted under exactly the
same conditions as the above adenylate cyclase assays (Figs. 5.30. and
5.31.) showed nicotinamide to be an effective inhibitor of endogenous
ADP-ribosyltransferase enzymes but again, even with maximal inhibition
(about 90%. at lOmM to 25mM-nicotinamide) there was no' detectable toxin
specific ADP-ribosylation. This was also true for the conditions
(100p.M-NAD+ and ImM-nicotinamide) under which cholera toxin action was
maximal.
Thus the use of nicotinamide alone did not enable the
observation of the putative cholera toxin-catalysed ADP-ribosylation
possibly because the effect of the toxin, which is likely to be very
small even under optimal conditions, would be even smaller when
partially inhibited by high concentrations of nicotinamide. However
when thymidine (20mM) was included in assays under optimal cyclase
activating conditions of lOOU-M-NAD and ImM-nicotinamide, the background
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rate of ADP-ribose incorporation was almost completely abolished.
Since thymidine is an effective inhibitor of poly (ADP-ribose)
polymerase (Tanuma et al,1978; 1979; Clark et al, 1971; Preiss
et al, 1971) it seems likely that the majority of endogenous ADP-
ribosylation is due to this enzyme. However, thymidine had no effect
on the action of cholera toxin (Fig. 5.33.) and therefore these
conditions supported maximum toxin action with the minimum of inter¬
ference from endogenous NAD+-utilising enzymes. High concentrations
of nicotinamide alone can also reduce endogenous ADP-ribosylation
to comparable levels (see Figs. 5.30. and 5.31.) but only at the
expense of a loss in toxin activity and although 20mM-thymidine alone
would probably be sufficient to completely inhibit poly (ADP-ribose)
polymerase, it is unlikely to have an extensive inhibitory effect on
the microsomal NADases which constitute the greatest proportion of
endogenous l\lAD+-uti.lising activities. Thus optimal conditions for
cholera toxin action can only be obtained with a combination of an
optimal NAD:nicotinamide ratio and sufficient thymidine to inhibit
poly (ADP-ribose) polymerase by almost 100$. Under these conditions
a cholera toxin-specific incorporation of ADP--ribose into rat liver
membrane proteins was observed (Fig. 5.32.)
With cholera toxin at a concentration of 2 tig/ml (the
concentration employed in all of the experiments discussed above),
only about 0.3 pmoles of ADP-ribose were incorporated by the toxin
after a 5 min. incubation time and it is therefore not surprising
that all previous attempts to demonstrate this activity of the toxin
(against a background of tens or hundreds of pmoles of ADP-ribose being
incorporated), were unsuccessful. However by increasing the toxin
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concentration up- to 9Pg/ml the amount of ADP-ribose incorporated by
the toxin was increased significantly. Since maximum adenylate
cyclase activation has previously been shown to occur with only lUg/ml
cholera toxin (Fig. 5.4.), this would not be expected if all ADP-
ribosylations were relevant to the process of cyclase stimulation-.
However in the presence of 100pM-NAD+, ImM-nicotinamide, and 20mM-
thymidine, maximum cyclase activation was no longer observed with
lUg/ml cholera toxin but continued to increase dramatically with toxin
concentrations up to 20Pg/ml (Fig. 5.33.). Thus under these conditions
cholera toxin was a considerably more effective stimulator of adenylate
cyclase and it therefore seems likely that at least some of the ADP-
ribosylations observed with high toxin concentrations are of relevance
to cyclase activation.
However there was still no direct proportionality between
the amount of ADP-ribose incorporated and the extent of adenylate
cyclase activation. While lpg/ml cholera toxin catalysed the incorp¬
oration of-0.2pmoles of ADP-ribose with a two-fold increase in cyclase
activity, 9Pg/ml toxin catalysed the incorporation of almost 4 pmoles o1
ADP-ribose with only an approximate 3.5-fold stimulation of adenylate
cyclase. Other results by Gill and Meren (1978) and Gill (1979) have
indicated a similar situation in pigeon erythrocyte lysates where more
than one protein was specifically ADP-ribosylated by the toxin. As
yet, the possible significance of these 'extra' ADP-ribosylations
is not understood.
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6.2.4. Model of cholera toxin action in rat liver membranes.
The results discussed above can be integrated into the
scheme outlined in Fig. -6.1. which summarises the factors involved
in the action of cholera toxin in crude rat liver membranes. A
similar situation may be found to exist in most complex tissues which
contain endogenous NAD+ - utilising activities, although it should
be remembered that in intact cells, compartmentation of cellular
functions may eliminate or modulate some of these processes.
In the crude membrane preparation with no additions, endo¬
genous l\IAD+-utilising activities are uninhibited and since they are
likely to be present in a large excess over cholera toxin, and since
they may exhibit a .higher affinity for NAD+ than does the toxin, small
amounts of NAD+ added exogenously are metabolised preferentially by
these enzymes. Only when high concentrations of l\IAD+ are employed
(ImM), when the endogenous enzymes are presumably approaching saturation
point, is there sufficient NAD+ available to support the activation
of adenylate cyclase by cholera toxin. ImM-nicotinamide inhibits
endogenous ADP-ribosyltransferase activities by about 75% and although
the effect of nicotinamide on the microsomal NADase activities was not
studied in detail, preliminary experiments indicated that these enzymes
were almost completely inhibited under these conditions. Thus in the
presence of ImM-nicotinamide, low concentrations of NAD+ are effective
in supporting cholera toxin action, and the inhibition of toxin action
at high nicotinamide concentrations may reflect end product inhibition
of a toxin-catalysed ADP-ribosylation. However, since cholera toxin
is relatively resistant to inhibition by nicotinamide, the immediate
almost 100% inhibition of all endogenous NAD+-utilising enzymes, which
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Figure 6.1. Competition for NAD between cholera toxin and
endogenous enzymes in rat liver membrane fractions.
NIC : Nicotinamide
Preferential pathways for NAD+ - utilisation
in the absence of inhibitory factors.
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probably occurs .on addition of high nicotinamide concentrations, may
be responsible for the initial rapid burst of toxin action observed
under these conditions. When optimal adenylate cyclase activating
conditions are employed, with nicotinamide in a ten-fold molar excess
over l\IAD+, addition of 20mM-thymidine causres almost 100% inhibition
of the remaining poly (ADP-ribose) polymerase activity, and thus
cholera toxin becomes one of the few NAD+-utilising enzymes in the
preparation which is not inhibited, the result being abnormally high
levels of cyclase activation in conjunction with a detectable toxin-
specific ADP-ribosyltransferase activity.
The results in Fig. 5.IB. suggested that high concentrations
of NAD+ in this system (e.g. 5mM) inhibit the action of cholera toxin.
Despite reports that NAD+ itself at this concentration inhibits basal
adenylate cyclase activity by about 50% (Martin et al, 1977), corrections
for this phenomenon would not fully account for the extent of inhibition
observed and it seems possible that this result may represent substrate
inhibition, of cholera toxin. This suggestion is supported by the
observation that with 100[iM-NAD+, addition of ImM-nicotinamide
"J" 1
produced enhancement of toxin action, presumably by making NAD
available to the toxin through inhibition of endogenous activities
(Fig. 5.27). With lmM-NAD+ however,the same addition of nicotinamide
did not result in enhancement of toxin action but caused significant
inhibition (Fig. 5.28). Although it is possible that cholera toxin
may be more susceptible to inhibition by nicotinamide in the presence
of high NAD+ concentrations, it is perhaps more likely that the
inhibition of endogenous activities by ImM-nicotinamide in the presence
of lmM-NAD+ makes such a large excess of NAD+ available for the toxin
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that the result is the same as that seen with 5mM-NAD+
alone, namely substrate inhibition.
6.2.5. Nature of the substrate for cholera toxin-catalysed
ADP-ribosylation.
Having demonstrated that specific ADP-ribosylation by
cholera toxin could be observed in crude rat liver membranes, several
attempts were made to identify the substrate(s) for toxin action in
order to investigate the possibility that the same 42,000 dalton
acceptor protein labelled by cholera toxin and £ ^P j NAD+ in pigeon
erythrocytes (Gill and Meren, 1978; Cassel and Pfeuffer, 1978),
was also the target for toxin action in rat liver membranes. These
experiments involved incubations with cholera toxin and [adenine U -
NAD+ in crude membrane preparations followed by solubilisation of
the membranes and application to 5D5 or native polyacrylamide gels,
which were sliced and counted for radioactivity as described in
Ch. 2.3.4.- However these attempts were unsuccessful owing to the
fact that so few radioactive counts were incorporated into protein
by the toxin. For example, from about l^lCi of [ adenine U-^C] NAD+
added to an assay, only several hundred counts were specifically
incorporated as ADP-ribose by cholera toxin, and although this was
reproducible in the assays described in the previous section, it was
too little to be detected with certainty after application to and
elution from slices of polyacrylamide gels. The use of [~^pJnAD+,
as described by other workers, should enable these experiments to
be performed more readily.
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However it seems likely that the major target protein of
42,000 daltons may be the cholera toxin substrate in rat liver also
since this has been a common feature of toxin action in all systems
studied to date, namely pigeon erythrocytes (Gill and Meren, 1978;
Cassel and Pfeuffer, 1978; Gill, 1979), fat cell ghosts (Malbon
and Gill, 1979), mouse 549 lymphoma cells, turkey erythrocytes, and
human erythrocytes (Kaslow et al, 1979). The latter authors, in
attempting to demonstrate cholera toxin-specific ADP-ribosylatio'n
in turkey erythrocyte membranes, also encountered the difficulties









conclusions to be made.
by partially purifying solubilised fractions of the membran
incubation with cholera toxin and [*^p] NAD+. This possibi
previously been attempted in this work when solubilised rat
membranes were subjected to ion-exchange chromatography on
cellulose or gel filtration on Sepharose-6B, and each fract
for ADP-ribose accepting activity in the presence and absen
cholera toxin. Again however the "observed effects with £ad
14 1 +U- C I NAD as substrate were too small to allow any defini
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6.3. Other activities of cholera toxin.
Several observations on the mechanism of action of
cholera toxin suggest that ADP-ribosylation of an adenylate cyclase-
associated GTP-binding protein may not be the only action of the
toxin, or at least that the consequent inhibition of the GTPase
activity of this protein may not be the only manifestation of the
toxin-catalysed ADP-ribosylation. For example, fluoride stimulation
of adenylate cyclase, a process which is modulated by cholera toxin
(see Ch.1.12.), is not itself dependent on guanylnucleotides (Ross
et al, 1977). The fact that cholera toxin appears to ADP-ribosylate
more than one protein (Gill and Meren, 1978; Gill, 1979) also
suggests other, as yet unknown, actions of the toxin, although it
remains possible that the majority of these ADP-ribosylations are
of no physiological significance and simply reflect the occurrence
.of several intracellular proteins with similar sequences to the
true toxin substrate.
However some of the results presented in this report
indicate the existence of at least one other effect of cholera toxin
which can be directly related to the proposed mechanism of the toxin's
action. This activity came to light as a result of studies on
solubilised preparations of rat liver homogenates. As shown in Fig.
5.34. endogenous NADase activities in rat liver homogenatss were
extremely resistant to solubilisation with Lubrol-PX, a property
which is shared by other mammalian NADases (Pekala and Anderson,
1978). Adenylate cyclase on the other hand could be readily solubilised
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with 0.25% Lubrol-PX and the resultant preparation, which was
relatively free of NADase activity (compare Figs. 5.19. and 5.35.),
appeared to be suitable for studying cholera toxin action in the
absence of interfering activities. However, although the solubilised
adenylate cyclase was capable of being activated by cholera toxin
(Fig. 5.36.), the stimulated enzyme was unstable and rapidly decayed
to levels below that of the unstimulated control cyclase. When
this preparation was incubated with increasing concentrations of
cholera toxin for the optimal time of'2 min., and estimations were
made of adenylate cyclase activity and of ADP-ribose incorporation,
the surprising result shown in Fig. 5.37. was obtained. While adenylate
cyclase was stimulated to a maximum of about three-fold over basal
levels, the amount of ADP-ribose incorporation decreased markedly
with increasing toxin concentrations. It therefore appears that
cholera toxin has inhibited, to a large extent, the activity of
endogenous ADP-ribosyltransferases. Confirmation of this conclusion
is illustrated in Fig. 5.38. However it is important to note that
ADP-ribose incorporation was not completely abolished even at SO^g/ml
cholera toxin, and the interesting possibility is therefore raised
that the residual rate of ADP-ribosylation which cannot be inhibited
by cholera toxin may in fact be due to the toxin itself.
The above results can be compared with those in Fig. 5.24.B.
where an inhibition of background ADP-ribosylation by cholera toxin
was also seen in particulate homogenates although in this case, the
effect was not marked until after 10 min. of incubation with toxin.
It is interesting to relate these results to the earlier observation
(Fig. 5.25.) that the endogenous ADP-ribosyltransferases were located
almost exclusively in the membrane fraction. Cytosol contained neither
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the enzymes nor the substrates but on addition of cytosol to the
membranes there was a significant decrease in the rate of endogenous
ADP-ribosylation, suggesting that cytosol may contain some ADP-
ribosyltransferase-inhibiting factor. Furthermore, although cholera
toxin had little effect on the rate of ADP-ribosylation either in
the membranes or in the membranes plus cytosol, there may have been
a further small decrease in the amount of ADP-ribose incorporated
in the latter condition on addition of cholera toxin. Although the
difference here is too small to be assigned any real significance,
when combined with the above observations, the results suggest that
cytosol contains an ADP-ribosyltransferase-inhibiting factor which
is more effective in the presence of cholera toxin. Alternatively,
cytosol may contain enzymes (such as the poly (ADP-ribose) glycohydrolase
referred to earlier) which degrade protein-ADP-ribose complexes and
cholera toxin may exert a direct stimulatory effect on these enzymes.
All of the solubilised preparations used in the above
experiments were derived from homogenates i.e. membranes soiubilised
in the presence of cytosol and it would be of obvious interest to
repeat these experiments on membranes solubilised in the absence of
cytosol. As shown in Figs. 5.30 and 5.31. cholera toxin had no effect
on the rate of background ADP-ribosylation in crude rat liver membranes,
again suggesting the importance of cytosolic factors in mediating
the inhibitory effect of cholera toxin on endogenous ADP-ribosyltrans¬
ferases. Since the effects of cholera toxin on these enzymes were
greatly enhanced in the solubilised preparations (compare Figs. 5.25.B.
and 5.37.), it is possible that solubilisation renders the ADP-ribo¬
syltransferases more accessible for inhibition by the unknown factor
after toxin treatment.
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Although there was insufficient time to pursue these
results further, the advantages of an ADP-ribosyltransferase-
.inhibiting action of cholera toxin are obvious. In nature it seems
likely that only a few molecules of cholera toxin subunit A will
penetrate cell membranes and reach their intracellular site of
action, and the probability of such few molecules initiating the
pathogenic processes of cholera would be greatly increased if the
toxin was capable of inhibiting at least some of the endogenous
NAD+-utilising activities. However, it should be emphasised that
the solubilised preparations used in the above experiments represent
an unphysiological situation and thus extensive inhibition of endogenous
ADP-ribosyltransferases may not occur in vivo. The true situation
may be more closely related to the results shown in Fig. 5.24.B.
for rat liver homogenates, where the toxin had a smaller effect on
the endogenous activities after a longer time period. Because of
the time taken for a significant inhibitory effect to occur in this
experiment, the possibility that ADP-ribosyltransferase inhibition
is an indirect secondary effect as a result of adenylate cyclase
activation and elevation of cAMP levels, is not ruled out. Further
work in this area is necessary to establish the true nature of the
inhibitory effect and of its possible significance in the mechanism
of cholera toxin action.
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Chapter 7. Conclusions and future prospects
The mechanism of action of cholera toxin has now been
defined with some certainty. Recent studies have provided strong
evidence in favour of Gill's original suggestion (Gill, 1975) that
the toxin was an enzyme catalysing the l\IAD+-dependent ADP-ribosylation
of some component of the adenylate cyclase complex. In several
different tissues the toxin has been "-shown to ADP-ribosylate a
42,000 dalton GTP-binding protein which is involved in adenylate
cyclase regulation, and the consequent inhibition of this protein's
GTPaSE activity is probably responsible for the stimulation of adenylate
cyclase (Cassel end Selinger, 1978;- Cassel and Pfeuffer, 1978; Gill
and Meren, .1978; Kaslow et al, 1979; Malbon and Gill, 1979, Farfel et al, 1979 )
Although the action of cholera toxin in rat liver membranes was not
defined in such detail in this work, all results were consistent with
the above hypothesis and under conditions in which interference from
endogenous NAD+ - utilising activities was minimised, it was possible
to demonstrate an ADP-ribosyltransferase activity of cholera toxin.
It is now possible to note some striking similarities between
the action of cholera toxin and that of diphtheria toxin. Some similarities
in the structures of these two toxins have already been discussed
(Ch. 6.1.) and both are now also known to catalyse the ADP-ribosylation
of an intracellular target protein. Most striking however, are the
similarities between these target proteins. Like the GTPase component of
adenylate cyclase which is attacked by cholera toxin, EF-2, the diphtheria
toxin substrate, is also a GTP-binding protein which acquires a GTPase
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activity when in association with another macro-molecular complex
(mRNA, ribosome, and aminoacyl fcRNA) "(Skogerscin and- Moldave, 1968;
Raeburn et al, 1968). ADP-ribosylation of EF-2 by diphtheria toxin
specifically inhibits this factor's ribosome-dependent GTPase activity
(Raeburn et al, 1968; Honjo et al, 1969), and therefore both toxins
attack an intracellular GTPas'e, the activity of which is inhibited
upon ADP-ribosylation.
In this respect it is interesting to note an early observation
of Bennett et al (1975b) who, while • investigating the effect of protein
synthesis inhibitors on the action of cholera toxin, employed diphtheria
toxin to eliminate protein synthesis before treatment with cholera toxin.
Under these conditions, the authors noted a small, but consistent,
activation of adenylate cyclase after incubation with diphtheria toxin
alone. The observation received no further attention but in retrospect,
it seems possible that diphtheria toxin, as well as ADP-ribosylating EF-2,
may also have had some limited effects on the cyclase-associatsd GTPase,
causing a slight stimulation of adenylate cyclase activity. It seems
likely therefore that the substrates for the two toxins probably exhibit
some similarities in amino acid sequence around the GTPase active site.
In the light of these observations, it is possible to envisage
for the first time, an effective treatment for cholera (and possibly also
for closely related diseases such as the diarrhoea induced by E. coli
heat-labile enterotoxin) based on detailed biochemical considerations.
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Any treatment aimed at lowering the levels of cyclase activity elicited
by cholera toxin would probably be ineffective since the possibilities
of interfering with the normal hormonal responses of adenylate cyclase
would be significant. However the substrate for ADP-ribosylation by
cholera toxin is now known specifically and furthermore, the toxin will
also catalyse the ABP-ribosylation of several artificial acceptor .
molecules such as arginine (Moss and Vaughan, 1977) and related compounds
(Mekalanos et al, 1979 a,,b). The possibility of a unique sequence in
GTPase enzymes which is recognised by ADP-ribosylating toxins, makes it
feasible to define the target amino acid, and the surrounding sequence,
for toxin-catalysed ADP-ribosylation and thus to manufacture an artificial
substrate which is at least as effective, and possibly more effective, as
an acceptor for ADP-ribose than the natural substrate. Such a compound
would be a potent competitive inhibitor of cholera toxin action.
Several other aspects of cholera toxin action are not well
understood and are worthy of further, research. For example, the process
of membrane penetration by subunit A of the toxin remains obscure.
Although Gill (1976a) has suggested several possible mechanisms for this
process, in which the B subunits, bound to Gm^ ganglicsides, form a
'tunnel' in the membrane through which subunit A is extruded, direct
evidence for any such mechanism is still lacking. Similarly, the role
of cytoplasmic factors required for toxin action in pigeon erythrocytes
(Gill 1975; 1976b) has not been studied in detail. Since these factors
were not required for toxin action in rat liver (Ch. 5.1.), their
involvement in avian erythrocytes may indicate some fundamental
evolutionary differences in adenylate cyclase systems between birds and
mammals.
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Toxin production and secretion by V. choleras are also poorly
understood phenomena and in particular, the recent report by Fernandez,
et al (1979) describing membrane-bound NADases of V. cholerae which
may represent cholera toxin precursors, is especially interesting.
Their observation that the inner membrane NADase was also capable of
ADP-ribosylating a 44,ODD dalton protein, also in the inner membrane,
raises the possibility that the ADP-ribosyltransferase activity of
cholera toxin may also be involved at some stage in toxin production and
secretion. Studies on the nature of the 44,000 daltbn protein ADP-
ribosylated in this system should be undertaken in order to investigate
any possible similarities between this and the toxin substrate in
eucaryotic cells, and to study the possible role of this protein in
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Crude culture filtrates of V. cholerae were kindly supplied
by Dr. R.O. Thompson of the Wellcome Research Laboratories, Langley
Court, Beckenham, Kent.
Purified cholera toxin prepared by the method of Einkelstein and
LoSpalluto (1970) was a gift from the National Institutes of Health,
Bethesde, M.D. U.S.A., for whom it wasy prepared under contract.
A sample of purified cholera toxin received from Dr. R. Rappaport
is also gratefully acknowledged.
Radioactive chemicals
14[b- h]cAMP, [adenine U- c] cAMP, [8- H ]
NAD+, and [adenine U-^c] NAD+ were obtained from
-173-
APPENDIX II Determination of kinetic rate parameters by the
Direct Linear Method.
Kinetic rate parameters were determined using the Direct
Linear Plot as described by Eisenthal and Cornish-Bowden (1974). In
this method, each experimental observation of substrate concentration
and velocity (s and v) are mai-ked off on the -x and y axes respectively
and a line is drawn through th£ two points and extended into the first
quadrant. For a theoretically ideal experiment, all lines will intersect
at a common point in the first quadrant whose co-ordinates provide
values for Vmax and Km.
In real situations which are subject to error, lines will net
intersect at a common point and in these cases Vmax and Km values are
taken as the median of all points of intersection. When there are an
even number of observations the median is taken as the mean of the
middle two estimates, and where more than two lines intersect at a
common point, the total number of intersections taken into account in
calculating the median value is yn (n-1), where n = the number of
intersecting lines.
The theory behind the Direct Linear method for calculation
of rate parameters is discussed in detail by Eisenthal and Cornish-
Bowden (1974) and the same authors have also presented theoretical
arguments which indicate that the method is statistically more accurate
than other existing techniques (Cornish-Bowden and Eisenthal, 1974).
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For some of the results presented in this report (Figs.
5.15. and 5.16.), where l<m values were high (and therefore intersection
points were far along the x - axis), data were more conveniently
presented by a later modification to the Direct Linear Plot (Cornish-
Bowden and Eisenthal, 1978), in which values corresponding to s/v and
1/v for each observation are marked off on the x and y axes respectively
and joined by a line. As above, the median of all intersection points
has co-ordinates equivalent to 1/Vrnax and Km / Vmax.
As described by the authors, this modification also improves
the statistical accuracy of the method by eliminating the bias given
by intersections in the third quadrant which sometimes occurs when
using the original method. Such intersections yield negative values
for both Km and Vmax and lead to inaccuracies in the final estimate
if taken at face value. In the modified method, intersections which
do not occur in'the first quadrant require no special treatment
(Cornish-Bowden and Eisenthal, 1978).
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The Adenylate Cyclase-Activating Activity of Cholera Toxin is not
Associated with a Nicotinamide—Adenine Dinucleotide
Glycohydrolase Activity
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The NAD+ glycohydrolase activity of cholera-toxin samples can be separated from their
adenylate cyclase-activating activity by polyacrylamide-gel electrophoresis and is inhibited
by sodium dodecyl sulphate (which does not inhibit the action of toxin on cells), but not by
antibodies to pure toxin. It is therefore probably not a true property of the toxin.
Cholera toxin is a potent activator of adenylate
cyclase [ATP pyrophosphate-lyase (cyclizing), EC
4.6.1.1 ] in a wide variety of eukaryotic cell membrane
systems (for general review, see van Heyningen,
1977a). The activation requires NAD+, ATP, a
thiol reducing agent, and an unidentified factor
from the cell sap, which is probably a protein (Gill,
1976). Recent evidence also indicates a requirement
for GTP (Cassel & Selinger, 1977). There have been
several reports that purified cholera toxin has an
NAD+ glycohydrolase activity (Moss et al., 1976,
1977) and evidence that the toxin can catalyse an
ADP-ribosylation with arginine as acceptor has been
presented (Moss & Vaughan, 1977). There is also
evidence for self ADP-ribosylation of cholera toxin
(Trepel et al., 1977). It has therefore been suggested
that cholera toxin, in an analogous way to diphtheria
toxin, may act in catalysing an ADP-ribosylation
perhaps of adenylate cyclase itself, or at least of some
component of the cyclase complex, thus leading to the
activation of this enzyme.
This paper provides evidence that the simple
NAD+ glycohydrolase activity is not associated with
the activation of adenylate cyclase, and so may well
be due to contaminating protein.
Experimental
Purification of cholera toxin
Cholera toxin prepared from crude culture filtrates
tof Vibrio cholerae, kindly given by Dr. R. O. Thomson
pf the Wellcome Laboratories, Beckenham, U.K.
(batch number VT 2214E), was purified as follows.
All operations were carried out at 4°C, and all
buffers were made 0.1 rruvr in phenylmethanesulphonyl
fluoride immediately before use. The crude solution
was made up to 30% of saturation (measured at 25°C)
in (NH4)2S04, the precipitate discarded, and the
supernatant made up to 60% of saturation in
(NH4)2S04. The precipitate was dissolved in water,
dialysed against 50mM-Tris/HCl, pH 7.4, and applied
to a column (2 cm diameter x 26 cm) of DEAE-
cellulose (Whatman DE-52) previously equilibrated
with the same buffer. Material reacting with cholera
antitoxin (van Heyningen, 1976a) was eluted with
200ml of a linear gradient of 0 to 0.1 M-NaCl in the
buffer, freeze-dried, dissolved in water, dialysed
against 0.1 M-Tris/HCl/0.1 M-NaCl, pH7.4, and ap¬
plied to a column (2cm diameter x 92cm) of
Ultrogel AcA-44 (LKB, South Croydon, Surrey,
U.K.). The antigenic product was homogeneous
as judged by the visible bands present on polyacryl-
amide gels in the presence and absence of sodium
dodecyl sulphate and migrated with the same
mobility as a sample of toxin purified by the method
of Finkelstein & LoSpalluto (1970) given to us by the
National Institutes ofHealth, Bethesda, MD, U.S.A.,
for whom it was prepared under contract.
Polyacrylamide gels
Polyacrylamide gels at pH8.3 were run by the
method of Davis (1964), without a stacking or sample
gel. Crude cholera toxin (150/rg) and purified toxin
(50//g) were applied to gels in duplicate. One of the
duplicate gels was stained for protein with
Coomassie Brilliant Blue R250, and the other was
sliced into 2mm segments which were eluted for 24 h
with shaking at 25°C in about 0.4ml of water. The
gel slices were removed, the eluates were freeze-dried,
and the residues were taken up in 30 /4 ofwater. Then
5/4 of each eluate was taken for NAD+ glycohydro¬
lase assay, 10/4 for adenylate cyclase-activating assay,
and 5/4 for immunodiffusion against rabbit antitoxin
(van Heyningen, 1976a).
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NAD+ glycohydrolase assay
NAD+ glycohydrolase activities were determined
by the addition of 5p\ of each gel-slice eluate to 1 O^rl
of an assay medium containing 0.2M-sodium acetate/
0.02M-dithiothreitol/2mM-NAD+ and lOnCi of
[carbonyl-14C]NAD+ of specific radioactivity 53Ci/
mol (The Radiochemical Centre, Amersham, Bucks.,
U.K.), pH6.2. Incubations were conducted at 37°C
for 60min, after which time 10/d samples from each
assay were spotted on 20 cm x 2 cm strips of DF.-81
chromatographic paper (Whatman, Maidstone,
Kent, U.K.), and [14C]nicotinamide was separated as
previously described (Apps & Nairn, 1977), for the
separation of NAD+ and NADP. Under these
conditions, nicotinamide migrated with the solvent
front, and NAD+ had an RF of about 0.4.
Adenylate cyclase assay
The source of adenylate cyclase was a crude rat liver
homogenate prepared by the method of van
Heyningen (19766). The crude particulate adenylate
cyclase preparation was then made 2.5mM in NAD+,
ATP, dithiothreitol and isonicotinic acid hydrazide,
an inhibitor of endogenous rat liver NAD+ glyco¬
hydrolase that had no effect on the NAD+ glyco-
hydrolases of V. cholerae.
A lOyul sample of each gel-slice eluate was added to
15/A of crude particulate adenylate cyclase and
incubated at 37°C. After 20min, 15^1 of each
preincubation mixture was transferred to tubes
containing 10p\ of assay medium. Each assay (final
volume, 25 /A) contained 20mM-Tris/HCl/5mM-
MgCl2 / 5mM-KCl / 5mM-phosphoenolpyruvate /1 mM-
dithiothreitol / 0.5 mM-cyclic AMP /0.5 mM-isobutyl-
methylxanthine/0.58mM-ATP/80^g of pyruvate kin-
ase/ml/80/rg of adenylate kinase/ml and 0.6yuCi of
[8-3H]ATP (The Radiochemical Centre; specific
radioactivity 23Ci/mmol). The assay medium was
adjusted to pH8.0 with lM-NaOH by using Phenol
Red as internal indicator, before use.
Incubations were conducted at 37°C for 20min and
reactions were terminated by the addition of 10//1 of
25 % trichloroacetic acid. Precipitated protein was
removed by centrifugation and 10/rl samples of each
clear supernatant were spotted on 20 cm x 50 cm glass
plates spread to a layer thickness of 0.3mm with cellu¬
lose microcrystalline (Merck; obtained from BDH
Chemicals, Poole, Dorset, U.K.), impregnated with
a 1 % solution of poly(ethyleneimine) (BDH Chemi¬
cals), and cyclic [3H]AMP was separated by the
method of Keirns et al. (1974) Cyclic [adenine-U-14C]-
AMP (5nCi) (The Radiochemical Centre; specific
radioactivity 287Ci/mol) was spotted along with
each sample to act as a check on individual plate
recoveries. Cellulose scrapings were placed in 10ml
of a Triton X-100/xylene-based scintillation cocktail
(Fricke, 1975), 2ml of 25mM-MgS04 was added to
solubilize the cyclic AMP from the cellulose particles,
and the samples were counted for radioactivity in a
Searle MK III liquid-scintillation spectrometer.
Results and Discussion
During our routine purification of cholera toxin
from concentrated culture filtrates of V. cholerae,
NAD+ glycohydrolase activity was consistently
found to decrease in fractions containing toxin and
increase in fractions not containing toxin after each
step in the purification procedure. In particular those
fractions eluted from a DEAE-cellulose column
containing no material precipitating with antibodies
to pure cholera toxin were found to have about 90-
99% of all the NAD+ glycohydroiase activity eluted
from the column. This immediately suggested that the
NAD+ glycohydrolase was a property of proteins
other than the toxin. To test this hypothesis several
experiments were done.
Treatment of purified cholera toxin with sodium
dodecyl sulphate, a procedure known to increase the
activation of adenylate cyclase by toxin (Gill, 1976;
van Heyningen, 19776), brought about a loss of most
of the NAD+ glycohydrolase activity in several differ¬
ent experiments. An identical treatment of the
NAD+ glycohydrolase eluted from DEAE-cellulose
as described above caused a loss of nearly all the
activity (Table 1).
Antibody prepared in rabbits against a different
sample of cholera toxin purified by the method of
Finkelstein & LoSpalluto (1970) (see van Heyningen,
1976ff) inhibits the adenylate cyclase-activating
activity of crude and purified toxin in cells. However,
it had no effect on the NAD+ glycohydrolase activity
(Table 1).
Table 1. Effect of sodium dodecyl sulphate and cholera
antitoxin on the NAD+ glycohydrolase activity of toxin and
non-toxin preparations






Purified toxin preincubated with 9.5
rabbit antitoxin
Purified toxin preincubated with 2.7
0.1% sodium dodecyl sulphate
for lOmin at 37°C
Non-toxin protein eluted from 5400
DEAE-cellulose
Same non-toxin protein preincu- 47
bated with 0.1 % sodium dodecyl
sulphate for lOmin at 37°C
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It is also possible to separate the two activities by
polyacrylamide-gel electrophoresis. Figs. 1(a) and
1 (b) show the activity of NAD+ glycohydrolase and
adenylate cyclase-activating activities eluted from
slices of gels of purified and crude toxin respectively.
Activities are plotted against the mobility of the mid¬
point of each gel slice. In the pure-toxin gel, cholera
toxin was detected by Ouchterlony immunodiffusion
with mobilities 0.02-0.18, and in the crude-toxin gel
(where cholera toxin constitutes only about 2/ of
the total protein) the toxin was detected with
mobilities 0.09-0.20. In both gels at these mobilities
there is, as expected, a strong peak of adenylate
cyclase-activating activity. However, also in both
cases, the NAD+ glycohydrolase activity at these
mobilities is virtually zero.
The very powerful NAD+ glycohydrolase activity
in crude culture filtrates of V. cholerae runs at
mobility 0.5-0.6. The corresponding band on a gel
stained for protein was very faint. Specific enzyme
activities could not be calculated owing to the small
0 0.2 0.4 0.6 0.8 1.0
Relative mobility
- ig. 1. Activity ofmaterial elutedfrom polyacrytamide gels
Purified (a) or crude (b) cholera toxin was subjected to
polyacrylamide-gel electrophoresis at pH8.3. Slices
from each gel were immersed in water and the eluted
protein wasassayed forNAD+ glycohydrolase activity
(O) and for activation of adenylate cyclase in rat liver
membranes (•) as described in the text.
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amounts of material in each gel-slice eluate, but in a
separate experiment the Kmax. of this NAD+ glyco¬
hydrolase (partially purified) was found to be in
the region of 3000-4000nmol of NAD+/min per mg
of protein. In the pure-toxin gel in which only one
band was visible on protein staining, that of cholera
toxin, some of this NAD+ giycohydrolase activity
has persisted (mobility 0.5-0.6 in Fig. la). Thus
although the purified material gives only one band on
protein staining with a characteristic mobility for
cholera toxin, the toxin is evidently not pure, and
contains a significant amount of contaminating
NAD+ glycohydrolase activity.
A similar gel of cholera toxin, prepared by the
method of Finkelstein & LoSpalluto (1970), gave
similar results showing more than one band of
adenylate cyclase-activating activity, but in this
material the NAD+ glycohydrolase activity was
lower.
The peak of adenylate cyclase-activating activity
at mobility about 0.4 in both gels may be due to free
subunit A of the toxin. A similar gel of subunit A
alone (purified by the method of van Heyningen,
1974) gave one band running in this position.
Evidently the majority of this material has been
removed from the toxin during purification. The other
minor peaks of adenylate cyclase-activating activity,
particularly on the gel of the purified toxin, may be
due to small proteolytic fragments of cholera toxin,
which are still capable of activating adenylate cyclase.
Such fragments have been observed previously
(Matuo et al., 1976).
In neither of the two gels does the position of
cholera toxin, nor the putative position of free sub-
unit A, coincide with any appreciable NAD+ glyco¬
hydrolase activity. Rather, this latter is present only
as a contaminant clearly separable from the peaks of
adenylate cyclase-activating activity.
One possible reason for differences between our
results and those of other workers (Moss et al., 1976,
1977; Moss & Vaughan, 1977), may be that their
experiments were done in 0.2-0.4M-phosphate buffer
at pH7.0. At this pH, even small concentrations of
phosphate are known to catalyse the non-specific
breakdown of NAD+ to ADP-ribose and nicotin¬
amide (Colowick et al., 1951). In our experiments the
use of such phosphate buffers resulted in as much
NAD+ hydrolysis whether cholera toxin was present
in the assay mixtures or not. Acetate buffer at pH6.2,
which does not lead to extensive NAD+ breakdown,
was therefore used in the experiments described
here.
Although NAD+ is a strict requirement for adenyl¬
ate cyclase activation by cholera toxin, the results
presented in this paper do not support the hypothesis
that cholera toxin (and specifically subunit A)
acts as an enzyme directly catalysing the transfer of
ADP-ribose at least to water. It remains possible that
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the ADP-ribosylation of some other acceptor is part
of the normal mechanism of the toxin.
We are grateful to the Medical Research Council for a
grant to S. van H. R. M. T. has a Research Studentship
from the Science Research Council.
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